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ABSTRACT 
Introduction: Pelvic organ prolapse is present in up to 50% of women. It is commoner in 
older women, often above 50 years of age and associated with hormonal e.g. oestrogen 
decline, and stiffer vaginal tissue. Pregnancy, on the contrary is a physiologic condition with 
higher oestrogen level and exhibits reversible structural and mechanical changes in pelvic 
tissues. Advanced glycation products, the ageing markers, stiffen connective tissues. There has 
been no previous systematic study on the relationship and action mechanisms of oestrogen, 
glycation level and mechanical property of vaginal tissues.  
Aim: The aim of this project was to study the ultrastructural and mechanical properties of 
vaginal tissues, and understand the relationship and possible mechanisms of accumulation of 
glycation (pentosidine), vaginal wall mechanics and oestrogen receptor (ER- expression in 
the vaginal tissues in both pregnancy and prolapse. It was hypothesised that prolapse is a 
disease of accelerated ageing and that mechanical and ultrastructural changes in prolapsed 
tissues and oestrogen decline are related to the elevation of glycation content in the tissues.  
Methods: Following ethical approval, vaginal tissues from 49 women with prolapse and 16 
controls were obtained and proformas containing information on known and suspected 
prolapse associations were completed for each participant. Female Sprague Dawley rats‘ 
vaginal tissues were used for the pregnancy study. Nano-scale, micro-scale and tissue level 
mechanical characterizations of the tissues were performed using ball indentation technique, 
scanning electron microscopy, peakforce nanomechanical property mapping atomic force 
microscopy, and optical coherence elastography, which was applied for the first time to the 
study of vaginal tissues. The glycation contents of vaginal tissues in pregnancy and prolapse 
were quantified by high performance liquid chromatography and values obtained were 
analysed in comparison to medical comorbidities. Tissues were qualified by histological and 
immunological staining for structure (haematoxylin &eosin, trichrome and picrosirus red 
stainings), glyoxalase I, ER- elastin and neural stain. A sulphated glycosaminoglycan 
(sGAG)-collagen model was used to study the role of sGAG in collagen fibrillogenesis.  
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Results: Rat vaginal tissues in pregnancy contained significantly lower amounts of 
pentosidine, higher oestrogen receptor- and glyoxalase I (antioxidant enzyme) expression 
with larger creep, lower elastic modulus, larger fibril diameter and higher sGAG content than 
their non-pregnant counterparts. Observed morphological changes of the collagen fibrils in 
pregnancy were attributed to sGAG, which was noted to influence collagen fibril aggregation 
and bundling. Skin pentosidine content was reflective of vaginal tissue pentosidine in the same 
subjects. Pentosidine was significantly higher in prolapsed tissues and increased with age; with 
more age-dependent increase observed in the prolapse population and also significantly 
different between the 6
th
 and 7
th
 decades. Glyoxalase I and ER- were poorly expressed in the 
prolapsed tissues in comparison to controls. Prolapsed tissues had notably disorganized 
ultrastructure and higher collagen fibril modulus. At all levels of tissue organization, prolapsed 
tissues were stiffer than controls, with increased stiffening at the more superficial layers of the 
tissue. Hypertension and smoking were associated with higher glycation and prolapse. In both 
pregnancy and prolapse, higher expression of glyoxalase I and ER- were associated with 
lower glycation content of the vaginal tissues and lower modulus. These observations have led 
to the suggestions that oestrogen plays an important role in increase or reduction of glycation 
through an oestrogen-gluthathione-glyoxalase (antioxdant) pathway, which directly affects 
vaginal tissues‘ mechanics.  
Future implications: These findings have implications to the current understanding of how 
prolapse may occur and can inspire future translational research on improved treatment of 
women with prolapse. Oestrogen may significantly influence the temporary and permanent 
mechanics of pelvic tissues such as the vaginal wall through its modulation of glycation 
accumulation within the tissues. Oestrogen thus shows promise of a potential future medical 
treatment for early stages of prolapse. The knowledge of new prolapse comorbidities can aid 
the early detection and possible prevention of prolapse through a high index of suspicion.  
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1.1 STRUCTURAL AND FUNCTIONAL ASPECTS OF THE FEMALE PELVIS 
 
1.1.1 OVERVIEW 
The female pelvis contains the organs of reproduction (ovaries, fallopian tubes, uterus, and 
vagina), storage and excretion (urinary bladder, and rectum) (1) as shown in figure 1.1. The 
uterus (horn, body and cervix), ovaries and vagina have reproductive functions i.e. mating, egg 
production, fertilization, implantation and growth and delivery of the fetus. Physiologically, 
these are all involved in various degrees of load bearing. 
 
Figure 1.1: Female pelvic organs(2) 
1.1.2 BONY PELVIS 
The pelvic organs are supported by an intricate layout of muscles and ligaments connected to a 
bony frame work (Figures 1.1 and 1.2). This frame work of pelvic bones comprises of the two 
innominate bones fused to the spinal sacrum posteriorly and anteriorly. They are joined by the 
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pubic symphysis (3). The innominate bones are made up of the iliac, ischium and pubis. These 
give shape to the pelvic basin (greater and lesser), which is wider and more circular in females 
than in males (4). 
 
Figure 1.2: Image of the bony pelvis showing attachment of pelvic diaphragm muscles 
and fascial condensations (tendinous arch and levator plate) (3) 
1.1.3 PELVIC DIAPHRAGM, LIGAMENTS AND FASCIA 
Muscles, ligaments and fascial layers within and around this bony frame work constitute the 
pelvic support; preventing prolapse when intact and directly or indirectly maintaining faecal 
and urinary continence (5). 
The pelvic diaphragm (Figure 1.2) is the deepest layer of muscular support on which the 
pelvic organs rest directly (1). It comprises of the paired coccygeus, levator ani and the two 
muscles that originate in the pelvis but attach to the femur (obturator internus and piriformis 
muscles). The coccygeus and levator ani are innervated by the branches of the anterior rami of 
the 4
th
 and 5
th
 sacral nerve roots (S2 - S4) and the S2 to S4 pudendal nerve branches (3). The 
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coccygeous muscle makes up the posterior aspect of the pelvic diaphragm and its inferior 
surface is the sacrospinous ligament. The levator ani muscle is made up of the pubococcygeus 
and iliococcygeus muscles (6). These originate and attach within the lesser pelvis.  
Different parts of the most medial muscle, the pubococcygeus, form the periurethral muscles 
that insert into the vagina walls and loop around the rectum, sub dividing the muscle into the 
pubo urethralis, pubovaginalis and puboanalis respectively. Fibers also insert into the perineal 
body and the external anal sphincter (3). The iliococcygeous is the thinner and more lateral 
aspect of the levator ani muscle and its paired fibers fuse with fibers of the pubococcygeous 
posteriorly to form the levator plate, on which the pelvic organs rest. This plate regulates the 
diameter of the urogenital hiatus, an external opening for the lower pelvic visceral. When a 
female is in the standing position, it remains horizontal if undamaged and in this way, closes 
the urogenital hiatus, preventing prolapse. 
1.1.4 LEVELS OF PELVIC ORGAN SUPPORT 
Three levels of ligamentous support and suspension of the pelvic viscera shown in Figure 1.3 
have been described (4,7). These anchor the uterus and, upper, middle and lower third of the 
vagina to the pelvic wall. Level I support involves the uterosacral ligament that suspends the 
uterus to the sacrum. It is continued downward as the paracolpium, which attaches the vaginal 
apex to the pelvic wall. 
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Figure 1.3: Levels of pelvic support (4) 
Endopelvic fascia attaches the middle third of the vagina to the pelvic sidewall. It is a layer of 
connective tissue comprising structural proteins (1). Like ‗cling-film‘, this fascia encompasses 
the organs and muscles with differential thickening in the arcus tendineous region (6). It links 
with supporting pelvic ligaments such as the cardinal ligament and fuses to form the adventitia 
layer of the viscera, enforcing strength and enclosing the pelvic structures as a discreet unit 
(Figure 1.4). 
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Figure 1.4: Superior cross sectional view of female lesser pelvis showing the urinary 
bladder (B), the uterine cervix (C), part of the vagina (V), the rectum (R) and the 
endopelvic fascia as a continuation of the adventitial layers of pelvic viscera. 
Ligamentous continuations (uterosacral and cardinal ligaments are shown) 
More superficial layers of pelvic support comprise the urogenital membrane or perineal 
membrane, ischiocarvenosus and bulbocavenosus muscles and the superficial transverse 
perineal muscle (3). They support the region between the perineal body and the inferior pubic 
rami, providing extra support for the anterior and lower pelvic viscera (urethra and vagina). 
This is the third level of support. 
The fibromuscular perineal body is located between the vagina and anus, and serves as an 
attachment to vaginal, perineal and anal sphincter muscles (3). It is a convergence point of 
some muscles of the pelvic diaphragm and structures of the perineal membrane (8). It plays an 
important role in maintaining pelvic organ support and also in changing the elasticity of the 
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pelvic cavity during childbirth. Damage to or weakness of this structure typically predisposes 
to prolapse. 
1.2 VAGINAL CONNECTIVE TISSUE STRUCTURE AND BIOMECHANICS 
1.2.1 HISTOLOGY OF THE VAGINA 
The vagina has an inner mucosal layer, a sub-mucosal dense connective tissue layer, an 
intermediate muscularis layer and outer adventitia or loose connective tissue layer as shown in 
Figure 1.5 (3,9). The mucosa is made up of a layer of stratified squamous epithelium. 
Underneath this is the thick lamina propria (LP) or dense connective tissue layer comprising 
mainly of collagen and elastin fibers which gives the vagina its elastic and tensile 
characteristic alongside the observable longitudinal folds and ruggae of the entire mucosal 
layer (8). 
 
Figure 1.5: Haematoxylin and Eosin stained section of vagina showing mucosal, 
muscularis and adventitia layers. (9) 
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Within the muscular layer is an inner, less defined circular and outer longitudinal layer (1). 
The LP and muscularis layer make up the fibromuscular supporting layer. This lies adjacent to 
the fibrous connective tissue layer –the adventitia.  
Mast cells, adipocytes, myocytes and fibroblasts are the constituent cells of the vagina and 
they are few in number. Fibroblasts are responsible for producing the  extracellular matrix 
(ECM), which includes the fibrous structural proteins (collagen and elastin) and an amorphous 
ground substance made up of glycoproteins, hyaluronan and proteoglycans (8). Production and 
degradation of fibrillar proteins are maintained in equilibrium in an on-going remodeling 
process. Imbalance in this process may lead to loss of tissue integrity which may predispose to 
prolapse. 
1.2.2 VAGINAL MECHANICS 
The vagina, like many other soft tissues, is anisotropic, that is, its mechanical property 
changes with changes in the direction of applied force (10,11). It also exhibits visco-elastic 
and temporary plastic properties. It stretches in response to applied force and has the ability to 
return to its original length immediately (12), demonstrating its elasticity. Plasticity, on the 
other hand, is observed in preparation for childbirth, where it distends progressively to 
accommodate delivery of fetus. It is a physiological effect lasting only during labour. In some 
mammals, it stretches to approximately 3 times its original size to accommodate the delivery 
of the fetus (13).  
1.2.3 THE VAGINA AS A CENTRAL PELVIC SUPPORT 
The vagina is a pivotal point of attachments for pelvic support, involved in the development or 
non-development of prolapse. It has a central location within the pelvic cavity and serves as 
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the communication of the female reproductive tract with the exterior as well as providing an 
outlet to excess intra-abdominal pressure (4). It is a hinge point for the three levels of pelvic 
support (Levels I, II and III, previously described in Figure 1.3) (3). It is thus susceptible to 
intra-pelvic pressure changes and the integrity of its fibromuscular walls plays a vital role in 
preventing development.  
In a study carried out to assess the influence of levetor ani muscle damage on prolapse, 
transection of the levetor ani nerve resulted in atrophy of the muscles but not loss of support in 
the nulliparous monkeys (14,). This finding suggests that, aside from the levetor ani, other 
supporting structures such as the vagina may play a role in the development of prolapsed. 
Furthermore, in women with prolapse, structural protein composition of the vaginal wall are 
significantly altered (16). These suggest the involvement of the vaginal wall in maintaining 
pelvic support and preventing or limiting.  
The vagina offers indirect active and passive mechanical support to the pelvic organs. Having 
smooth muscle cells, it cannot generate force but can transmit applied force (6). It is closely 
associated with the arcus tendineous fascia, which is largely comprised of striated muscle cells 
that have the capacity to generate contractile forces to control vagina wall motion (1). The 
overall mechanical function of this pivotal tissue is enabled by its mechanical constituents at 
the histological level and the nano-level organization of the same. This forms the unique 
spatial arrangement of an organ that can distend to accommodate physiologic load demands, 
withstand periodic stresses and recoil to its original state.  
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1.2.4 VAGINAL TISSUE  EXTRACELLULAR MATRIX (ECM)  
1.2.4.1 OVERVIEW 
Collagen and elastin are structural proteins produced by fibroblasts (8). Collagen constitutes 
over 80% of the structural proteins of the vagina connective tissue (11). It can stretch to 4% its 
original length before failure. Elastin fibers, comprising about 13% of the structural proteins in 
the tissue, can distend to double their original length without permanent deformation (5). 
Mature elastin comprises an inner region of amorphous cross-linked elastin surrounded by a 
microfibriller scaffold (17). Elastin is formed following deposition of its secreted soluble 
precursor, tropoelastin on a fibrillin-rich microfibril template (18). Elastin gives the tissue its 
elastic recoil property whereas tensile strength is largely maintained by structural collagens. 
After extensive tissue deformation, elastic recoil would typically occur, utilising minimal 
energy (19). Elastic fibers are synthesized continuously in the female genital tract for a 
lifetime with degradation and re-synthesis occurring post-partum (20). Due to the higher 
composition of collagen fibers in the vaginal tissue, the present study has focused on collagen 
ultrastructure. Therefore, its formation and crosslinking is discussed further in the following 
section. 
1.2.4.2 COLLAGEN FORMATION AND MATURATION 
Differential arrangements of collagen in connective tissues give them their specific unique 
morphologies and strength. Collagens are formed by triple -chain helices linked together by 
hydrogen bonds as well as covalent bonds, which reflect protein maturation and tensile 
strength (8). Each helix comprises of repeats of Glycine-X-Y monomers where X and Y could 
be any amino acid but are typically hydroxyproline or proline (21). Extracellular assembly of 
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hydrogen bond-linked procollagen into tropocollagen fibrils via action of peptidases and a 
further self-assembly of the tropocollagen gives rise to collagen fibers and bundles. The 
covalent crosslinks and arrangement of collagen fibers within the vagina tissue, determine to a 
large extent the innate tensile strength of the tissue (19). Lysly oxidase is involved in 
formation of crosslinks that stabilize collagen fibers during maturation process, enabling them 
withstand increasing load (22). Divalent crosslinks, dehydro-hydroxylysinorleucine (-HLNL) 
and hydroxylysino-keto-norleucine (HLNL), are first formed and subsequently reinforced by 
conversion to trivalent crosslinks, histidinohydroxylysinorleucine (HHL) (23) as shown in 
Figure 1.6. These crosslinks are present to lesser degrees in elastin and in both cases are 
formed via oxidative deamination of an amino group of lysine to form a reactive lysyl 
aldehyde. Cross linkages generally prevent gliding between collagen fibers, imparting optimal 
tissue stiffness whereas in elastin cross-linkages prevent excessive stretching of tissue. 
 
Figure 1.6: Illustration of collagen organization of mature collagen within the ECM. 
Immature divalent crosslinks (black vertical arrows) are stabilized by mature divalent 
crosslinks (brown arcs). 
The fibrillar collagens, type I, III and IV are present in the vagina with a predominance of 
Type I in healthy tissues. Type I collagen imparts toughness and resilience to deformation to 
the tissue (16). It is responsible for the tensile properties whereas type III is present where 
there is room for tissue distension and growth (5,24). Both are structural, fibril-forming 
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collagens. Collagens type III and V associate with type I to produce smaller collagen fibers 
with reduced mechanical strength (11,25). Optimal strength of the tissue is, thus, maintained 
via a balance between synthesis and degradation of these collagen types by various Tissue 
Inhibitors of Matrix Metalloproteinases (TIMPs) and Matrix Metalloproteinases (MMPs). 
1.2.4.3 GROUND SUBSTANCE 
Proteoglycans bind all cellular and acellular components of the connective tissue matrix 
together. These include aggrecan, perlecan, versican, luminican, fibromodulin, chondroadherin 
and decorin (11). Amongst other functions, this amorphous aspect of the connective tissue 
confers visco-elasticity to the tissue and modulates its nano-architecture (5,26). The higher 
molecular weight glycoproteins have brush-like structures which by trapping water, ensure 
tissue hydration, hence enabling its resistance to compressive force. This implies that basic 
factors such as tissue hydration influence tissue mechanics. sGAG are known to be involved in 
collagen fibril formation or parallel association with other fibrils without the involvement of 
chemical or physical crosslinks, and this is another mechanism by which they indirectly 
influence the mechanical property of tissues (27). They modulate collagen fibril diameter. For 
example, dermatan sulphate (DS) can increase collagen fiber diameter but decorin has the 
opposite effect (28).  
1.3 PREGNANCY AND OESTROGEN EFFECTS ON THE VAGINAL WALL 
CONNECTIVE TISSUE 
1.3.1 OVERVIEW 
Pregnancy is a unique time in which the female reproductive tract undergoes rapid 
physiological changes and pelvic floor adaptation. Interestingly, despite high strain undergone 
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by the pelvic floor muscles during pregnancy, the majority of women do not have obvious 
pelvic floor injury during pregnancy (29,30). It is therefore useful to study some pregnancy 
adaptations alongside changes in prolapse in order to understand prolapse pathology.  
Pregnancy influences the metabolism of pelvic tissues. The collagen content of the uterus and 
cervix change during pregnancy (31). Oestrogen, relaxin and progesterone are pregnancy 
hormones with direct effects on connective tissue protein breakdown and re-synthesis. 
Research reveals that there is a loss of pelvic tissue collagen during pregnancy due to a 
paracrine effect of relaxin. To effect softening and relaxation, relaxin may cause collagen 
degradation and restructuring in the vagina and uterus during pregnancy (32). 
 Oestrogen and progesterone are, however, more notable pregnancy hormones whose 
metabolic effects on pelvic tissues have been more widely studied. Oestrogen and 
progesterone are modulated not only in pregnancy but also during the normal menstrual cycle, 
resulting in a more continuous effect on pelvic tissues. They are maintained at a higher level in 
pregnancy by hypothalamic-pituitary-gonadal axis control (33). Whilst progesterone helps to 
maintain pregnancy and prevent preterm labour (34) oestrogen appears to directly influence 
pelvic tissue metabolism in pregnancy. For example collagen induced arthritis and rheumatoid 
arthritis are significantly improved with oestrogen treatment and temporarily remitted in 
pregnancy, a state of high oestrogen levels (35). Another study carried out using Female 
Sprague-Dawley rats noted that ovariectomy resulted in reduced epithelial height which 
responded to treatment with oestradiol, which influenced vaginal epithelium and nonvascular 
smooth muscle (36). Progesterone did not have such an effect.  
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1.3.2 THE RELATIONSHIP BETWEEN COLLAGEN, MATRIX REMODELLING 
ENZYMES AND OESTROGEN 
Results from studies investigating effects of oestrogen on the pelvic tissue of women with 
pelvic floor disorder are varied. Some findings suggest that oestrogen is associated with 
increased break down and reduction in total amounts of collagen (37). On the contrary, 
oestrogen treatment has also been associated with fibroblast mitotic activity, increased 
turnover of collagen and other structural proteins (38,39). Similarly, increased activity of 
tissue inhibitors of matrix metalloproteinase (TIMPs), inhibitors of collagen breakdown have 
been observed with oestrogen therapy (40). In a 6 month prospective study, oestrogen 
treatment was associated with both increased breakdown and neo-synthesis of collagen in 
vaginal tissues (41). A significance of this observation is the potentially lower amounts of 
older collagen and higher amounts of newer collagen due to the influence of oestrogen. An 
understanding of this matrix remodeling effect would be useful in explaining findings from 
past studies regarding the effects of oestrogen on pelvic connective tissue collagen 
metabolism.  
Many studies showing improvements in pelvic tissues‘ properties with oestrogen treatment 
have been associated with premenopausal and healthy states (39,40). Transient symptomatic 
improvement with oestrogen therapy has been observed in pelvic floor dysfunction as well as 
worsening of the condition in post-menopausal women (42–44). These pelvic floor problems 
in women are associated with altered vaginal connective tissue metabolism (8,45). Up-
regulation of genes encoding matrix metalloproteinase (MMPs) and tissue inhibitors of matrix 
metalloproteinase (TIMPS) was observed to occur during the proliferative and secretory 
phases of the normal menstrual cycle, respectively (46). In the same study, the cyclical change 
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in expression of genes encoding pelvic tissue metabolic enzymes was noted to be absent in 
post-menopausal states, which were associated with up-regulation of TIMPs. Female steroid 
receptors are expressed in most urogenital tissues with cyclical expression and down 
regulation of these occurring in the vaginal epithelium in response to hormonal changes 
occurring during the menstrual cycle (47). The vaginal tissue is thus metabolically susceptible 
to cyclical variations in female hormones during the menstrual cycle and subsequent changes 
at menopause. Due to the higher composition of collagen (81%) in the vaginal wall compared 
to other pelvic tissues (48), changes in collagen metabolism would significantly influence the 
vaginal wall‘s mechanical properties. These changes therefore need to be studied in depth in 
order to understand pregnancy adaptations and pelvic floor disorders. 
1.4 CONNECTIVE TISSUE AGEING 
1.4.1 OVERVIEW  
Macroscopically, ageing is observed (in external organs such as skin) as the development of 
fine wrinkles, loss of elasticity and reduction in tissue thickness. Functionally, the ageing 
process has been associated with various age-related diseases (49). Microscopically, there are 
various alterations linked with these visible effects. Cellular, biochemical and genetic changes 
have been noted but there is still an uncertainty as to what triggers the overall process, the 
onset of which apparently varies from person to person. 
Ageing cells have reduced proliferative capacities and productive abilities. Fibroblasts, for 
example, have been shown to have a lifespan equivalent to about 50 passages in vitro (50). 
Cellular changes in ageing connective tissue are largely reflected in resulting biochemical 
changes such as altered synthesis and modification of cellular products by differentially active 
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cell organelles such as lysosomes (19). The result is alteration in quality and quantity of 
cellular products that make up the ECM (ground substance and fibril-forming proteins). 
With increasing age, constituents of the ground substance such as hyaluronic acid, versican, 
neutral and acid muccopolysaccharides reduce significantly (51). Decreased amounts of 
versican, a molecule involved with maintaining viscosity and elasticity suggests affectation of 
the viscoelastic property of ageing connective tissues (52). In view of the moisture retention 
function of the ground substance, its alteration with age implies a loss of cushioning effect in 
older connective tissues. 
Elastin and collagen are fibril-forming proteins that decrease with age in connective tissues 
(53). These changes have the potential to influence tissue behavior under passive loading (19). 
Collagen, a cellular product is the most abundant protein in the body and is responsible for 
maintaining connective tissue form and shape (54). Ageing changes are particularly observed 
in collagen, reflecting the altered shape and form of organs grossly observable in older 
superficial connective tissue such as aged skin (19). 
1.4.2 AGEING THEORIES AND GLYCATION MARKERS OF AGEING 
Several ageing theories have been adduced to attempt to explain the ageing process. These 
range from the free radical theory to the theories of telomere shortening, oxidative stress and 
mitochondrial DNA changes, although none entirely explains all known age-related changes in 
biological tissues (22). Investigations have thus recently shifted to cellular and extracellular 
modifications through glycation reaction as markers of ageing. The resultant substances are 
called advanced glycation end-products (AGEs) (55). Glycation is a process in which proteins, 
fats and nucleic acids in body tissues get modified non-enzymatically with reducing sugars, it 
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typically occurs over months or years (56). It predominantly affects ECM collagen and elastin 
because they have slow turnover rates within the ECM (55). Glycation results in stiffer, less 
digestible proteins and can permanently alter connective tissue properties (57). Advanced 
glycation is implicated in ageing and many diseases including gynecological disorders such as 
prolapse and urinary incontinence (4, 5). Pelvic tissue glycation has been further studied since 
the observation of higher amounts of insoluble collagen or glycation products in prolapsed 
pelvic tissues by Jackson et al in 1996 (23).  
Age-related crosslinking of cellular components such as proteins, lipids and nucleic acids upon 
prolonged contact with reducing sugars has been noted (58). These modifications change the 
properties of affected cellular components and hence, the overall cellular function. Of 
particular interest to ageing is the crosslinking of long-lived structural proteins such as 
collagen and elastin. Crosslinking of collagen (Figure 1.8) reduces its solubility, significantly 
influencing connective tissue property since collagen is the main structural protein of 
connective tissues (59). 
Older connective tissues contain glycated proteins, nuclei and fatty acids formed by prolonged 
contact of reducing sugars with susceptible amino acids of proteins (8). Glycation occurs by a 
maillard reaction in which reducing sugars covalently bind to amino acids. Intermediate 
products of oxidation formed are rearranged over months or years into AGEs. Within tissues, 
this process is non-enzymatically regulated. Collagens are prime targets for the glycation 
process because of their long half-life that leads to prolonged contact with reducing sugars. 
They also contain significant amounts of susceptible lysine and arginine residues along their 
chains for the reaction (9–11).  
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 This added crosslinks confer higher resistance to proteolytic degradation to the collagens (57). 
While there has been no change in amounts of enzymatic crosslinks of aged collagen, non-
enzymatic crosslinks have been greatly increased in aged connective tissue collagen (19). This 
increase is thought to contribute significantly to increased stiffness of ageing tissue. Notably, 
elastin is less susceptible to non-enzymatic glycation due to presence of reduced amounts of 
lysine residues per molecule compared with collagen (19,60). 
 
Figure 1.7: Illustration of advanced glycation of mature collagen fibers. Mature and 
immature enzymatic crosslinks are shown by black single arrows and brown arcs 
respectively. The double arrows (red) represent advanced glycation. 
1.4.3 FORMATION OF ADVANCED GLYCATION END PRODUCTS (AGEs) 
AGEs are produced in a maillard reaction which was first described in 1912 (61). The 
carbonyl group of a reducing sugar reacts with free amino groups in proteins leading to the 
formation of an unstable Schiff base which may rearrange to form a ketoamine (amadori) 
product (62) as shown in Figure 1.8. These undergo oxidative changes to form the unstable 
AGEs. Stable crosslinks may form after years of contact of amadori product with amino acids, 
leading AGEs formation. Slow turn over proteins such as collagen, elastin and fibronectin are 
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therefore particularly susceptible to this process (19,22). AGEs are found in increased 
quantities ageing tissues and have become markers of ageing. 
 
Figure 1.8: Formation of AGEs by reaction of reducing sugar with a lysine or arginine 
based protein segment. After series of rearrangement of the unstable ketoamine product, 
advanced glycation may occur over months or years 
(55). 
1.4.4 TYPES OF AGEs 
There are various types of AGEs. The glycated hemoglobin was the first discovered AGEs and 
has since been used to monitor the treatment progress and compliance of diabetes mellitus 
patients (55). Others are Carboxymethyl-lysine (CML) (the most prevalent AGE in the human 
body), glucosepane, fructo-lysine, methyl-lysine, hydroimidazolones, pyrraline, Carboxy 
ethyl-lysine (CEL) and pentosidine. Of the aforementioned, only pentosidine forms auto-
fluorescent protein cross-links. Pentosidine can thus be detected by UV or fluorescent 
wavelengths (63), making it a useful analytical tool for ageing studies. 
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Pentosidine (Figure 1.9) is formed by the reaction of a pentose sugar with arginine and lysine 
(64). The involvement of free radical oxygen species in its formation makes it a fluorescent 
glycoxidation product. It was first identified and characterized by Sell and Monnier (65). Since 
then it has been extensively used as a marker of ageing. Its fluorescent property is exploited 
for detection and quantification of ageing in mammals (66,67). 
 
Figure 1.9: Chemical structure of pentosidine 
1.4.5 ACCUMULATION AND REMOVAL OF AGEs IN VIVO 
Various factors promote or inhibit the glycation process. Indeed the amounts of AGEs in vivo 
are determined by a balance between factors promoting their accumulation and factors 
involved in their removal. AGEs can be produced within the body as earlier described or 
directly ingested from foods. The method of production of foods is important in accumulation 
of AGEs. Frying and baking favour AGE production in contrast to boiling or steaming foods 
(56). AGEs are known to impart a brown colour to foods. Smoking and exposure to Ultra 
Violet radiation also favour the formation of AGEs through suggested oxidation stress 
mechanisms and increased expression of AGEs receptors (55).  
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Genetic susceptibility in the accumulation or otherwise of AGEs has also been observed (68). 
Ascorbic acid counters the glycation process. Reduced dietary intake of AGE-promoting 
compounds (reducing sugars) or foods rich in AGEs such as roasted coffee and fried foods 
might thus be useful in limiting the accumulation of AGEs in vivo. 
Contrary to previously held beliefs, AGEs, once formed, can be removed by cells. Cells have 
innate detoxification pathways to prevent accumulation of AGEs. These mechanisms have 
been noted to be attenuated with physiological ageing. The enzyme systems, glyoxalase I and 
II (GLO-I and II (glutathione-dependent glyoxalase system) and fructosamine kinases are 
involved with the removal of AGEs from cells (69,70). They break down ketoamine products 
and some are widely expressed in various tissues of the human body. Gluthatione, for example, 
converts glycoxal methlyglycoxal -oxoaldehyde to a less toxic compound, lactate. AGE 
receptor systems, AGER 1, 2 and 3 promote the internalization of AGEs into cells for 
subsequent degradation (55). 
1.4.6 AGEs REACTION MECHANISM 
AGEs promote deleterious effects via the RAGE group of receptors. These are encoded on 
chromosome 6 near the Major Histocompatibility Complex III (68). The binding of AGEs to 
their receptors signals various metabolic pathways including Mitogen-Activated Protein 
Kinases (MAPK), Extracellular Signal Regulate Kinases (ERK) and P21 (56). Transcription 
factor nuclear Factor Kappa B (NFkB) is activated and pro-inflammatory genes are 
transcripted. This fosters a positive feed-back regulatory mechanism that overrides the natural 
autoregulatory negative feedback loop. Inflammatory signals and enzymes accumulate and 
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protective mechanisms such as super oxide dismutase are deactivated, leading to oxidative 
damage. 
1.4.7 EFFECT OF AGEs ON THE ECM 
The ECM is the major target of the glycation process. There are notable age-related changes in 
the diameter of collagen fibers. These may become thicker and coarse (71). Reflecting this 
structural changes are altered mechanics. Glycated collagen is increasingly stiff and less 
flexible with higher vulnerability to mechanical load (72). Affected proteins have less 
available domains for cellular interaction, leading to distortion of ECM rearrangement (19). 
Additional glycation of the collagen increases their molecular weight and viscosity (73), 
making them less soluble. These insoluble, ‗aged‘ collagen are more resistant to degradation 
by MMPs, preventing replacement by newer ones (74). Thus mechanical changes in 
connective tissue may appear permanent. Glycation of elastin has been associated with tissue 
wrinkling (actinic elastosis) (51). CML-modified elastin is associated with this process (75). 
The elastins lose their elasticity and are also more resistant to degradation. 
Cells are also affected by the glycation process. Since nucleic acids are susceptible (76), the 
viability of cells significantly reduces. This is associated with early cell death. There is also a 
decline in the production of ECM proteins. The overall effect is an ECM with mechanically 
altered structural proteins resistant to degradation and having less efficient interaction with 
cells.   
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1.5 PELVIC ORGAN PROLAPSE 
1.5.1 OVERVIEW 
Pelvic organ prolapse (Figure 1.10), also known as utero genital or uterovaginal prolapse, is a 
debilitating condition with severe effects on the quality of life of those affected. This is the 
downward descent or protrusion of the female pelvic organs below or away from their 
anatomical position and often visible through the vaginal wall (6) Although not life 
threatening, prolapse affects the quality of life of individuals with the disease. The first 
surgery was self-performed by a female sufferer in 1697. Faith Ratworth was so distressed by 
the debilitating symptoms that she pulled down on her uterus and cut it with a knife, surviving 
severe haemorrhage but remaining incontinent for life (77). Multiple pelvic organs that 
surround the vaginal wall are typically involved in prolapse. Cystocele involves urinary 
bladder and sometimes the urethra, rectocele  accommodates the rectum and utero-vaginal  
involves a direct descent of the uterus or vagina vault (in patients who have had hysterectomy) 
(77). 
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Figure 1.10: Illustration of pelvic organ prolapse types (78). Anterior (cystocele) and 
posterior (rectocele) vaginal wall prolapse, uterine prolapse, vaginal wall prolapse and 
enterocele (prolapse involving the small intestine) are illustrated. 
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1.5.2 EPIDEMIOLOGY 
Prolapse is present in up to 50% of women presenting for routine gynecological visits (79), 
with symptoms in the general population of 8.4% (80). In the United Kingdom (UK), prolapse 
is the commonest indication for hysterectomy in post-menopausal women. Approximately 
20% of women undergoing major gynecological surgery present with prolapse. Up to 76% of 
women seen for routine gynecological visits in developed countries were noted to have lost 
some degree of vagina support (81,82). Prolapse is found to result in 18 percent of all 
gynecological surgical procedures in all age groups. Its prevalence is higher in the aged 
population with a 41% prevalence in those aged 50-79 years (6). The commonest of the three 
kinds of prolapse is the cystocele (34% prevalence). Rectocele and uterine prolapse account 
for 19% and 14% of cases, respectively (83). The high prevalence of this disease translates to 
a high economic burden on society; in the United States it costs over $1 billion dollars yearly 
(79). With increased longevity, finding the cause of and proffering a solution to prolapse 
would not only lead to improved quality of life in affected individuals but also, indirectly 
improve the economies of many countries. 
1.5.3 GRADING OF DISEASE SEVERITY AND SYMPTOMS 
As previously noted prolapse either involves the protrusion of the urinary bladder into the 
anterior wall of the vagina (cystocele or urethrocele), an outpouching of the anterior rectal 
wall into the posterior wall of the vagina (rectocele) or a downward descent of the uterus or 
vagina vault (in patients who have undergone hysterectomy) known as uterovaginal prolapse 
(77). This is the traditional anatomical site and vaginal wall-based classification. The various 
types of prolapse result in the different symptoms that are typically associated with the 
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disease. Although, an understanding of this means of classification gives insight to the origin 
of the various presenting symptoms, many clinical cases do not exactly fit into the groups. 
Rectocele is associated with faecal incontinence, constipation, tenesmus, faecal urgency and 
straining (6). In some cases, manual pushing within the vagina is required to achieve 
defaecation. Cystocele is associated with urinary incontinence, urinary hesitancy, frequency, 
urgency and the feeling of incomplete voiding. As with rectocele, manual pushing against the 
anterior vaginal wall might be required to ensure voiding. Uterine or vaginal prolapse might 
result in a feeling of fullness within the vagina, the sensation of downward descent and 
dyspareunia (84).  
For surgical grading and treatment purposes as well as the assessment of quality of life, 
various grading systems have been developed. Originally, assessment was simply made based 
on level of prolapse in relation to the hymen. More objective and detailed scoring systems 
have since then been developed. 
The Baden-Walker grading system directly references the descent of prolapsed tissue from the 
ischial spine to the hymen and beyond, with half-way points to and from the hymen (85). Its 
advantage is that it is quick and encodes a lot of information. 4 grades of prolapse are 
described:  
grade 0 which implies no evidence of prolapse, grade 1 (prolapse halfway to hymen),  grade 2 
(prolapse up to the hymen), grade 3 (prolapse halfway past hymen), and grade 4 (maximum 
descent). This method has been criticized as permissive of intra and inter-observer variations 
as well as making no note of the severity of individual patient symptoms as it is purely an 
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anatomical measurement. This has resulted in the search for grading systems that better assess 
the severity of symptoms and impact on the quality of life (86).  
The Pelvic organ prolapse quantification (POP-Q) system is a more widely accepted scoring 
system than the Baden-Walker half way system (87). Using the hymenal ring as a fixed 
reference point (0), there are six defined points and 3 other reference points, measured and 
assigned a positive number when located above or a negative number when below the hymen. 
Although not routinely used in most clinical practices due to time constraints of taking 9 
measurements, it is said to be more objective and reliable, having little variations across 
various observers. The International Consultation on Incontinence Vaginal Symptoms (ICIQ-
VS) questionnaire on prolapse scoring gives insight into the quality of life of sufferers. It asks 
questions on the impact of the disease symptoms on the patient‘s activities with attention to 
the social aspects of the disease impact (86). It comprises of 9 vaginal symptoms questions 
with corresponding symptom severity assessment on a scale of one to ten with one denoting 
least severity and ten, very severe symptom. It further contains 4 sexual matters question also 
assessed based on severity and a grading of the impact of prolapse on the sufferer‘s quality of 
life on a scale of 1-10 (86). Vaginal symptoms and quality of life scores obtained reflect 
disease severity. Properly categorizing the disease is vital for research and can be used to 
assess differences in ageing and the various sub-groups of prolapse. 
1.5.4 CURRENT TREATMENT  
Symptomless prolapse is treated by conservative management. When there are debilitating 
symptoms, palliative methods such as vaginal pessaries can be used (85). Various surgical 
methods are in use from removal of redundant vaginal wall and support of the underlying 
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tissue, to suspensory operations such as sacrocolpexy and sacrospinous fixation procedures. 
In these later procedures the prolapsed tissue is respectively suspended with an artificial 
mesh to the sacrum or fixed to the sacrospinous ligament (6). Synthetic meshes such as 
polypropylene have been used in the treatment of  prolapse but with significant side effect in 
up to 20% of patients (88). Although these therapeutic techniques offer symptomatic relief, 
they do not cure the underlying disease process. Despite various measures to improve the 
quality of life of women prolapse, a definitive solution is yet to be found. Up to 30 percent 
of those treated surgically require repeat surgery (81,89) suggesting non-reversal of any 
prior underlying connective tissue alterations that led to the prolapse in the first instance. 
Unraveling key points in disease pathology would be a step towards more lasting therapies.  
1.5.5 KNOWN AND POTENTIAL RISK FACTORS  
1.5.5.1 REPEATED VAGINAL DELIVERIES 
Vaginal delivery has been associated with the highest risk of developing prolapse (1,82,90) 
and has been categorized as an independent risk factor (80,91,92). Since fetal passage during 
delivery is one of the vagina‘s main functions, suggesting it to be a cause of prolapse would be 
synonymous with saying cardiac failure, for example, is the direct result of the hearts normal 
physiologic function of pumping blood around the body. Furthermore, prolapse has been noted 
to occur in a few nulliparous individuals (93). This observation and findings from studies 
carried out to assess the postpartum mechanics of the vagina are challenges to the widely held 
concept of vaginal delivery being the major cause of prolapse. 
In a study carried out using rodent models, it was revealed that the vagina and other pelvic 
tissues demonstrated significant changes in mechanical properties during the middle and late 
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stages of pregnancy but these returned to normal 4 weeks post pregnancy (94). It has also been 
observed that following vaginal delivery; there was no significant change in vaginal strength 
(95) . The innate function of an organ can scarcely be said to be the cause of its failure. Rather, 
abnormal functioning or excessive use beyond its limit of functionality could result in organ 
failure. This, however, would be determined and to a large extent, modified by genetic and 
lifestyle factors. So, a more likely risk factor would be repeated and traumatic vaginal 
deliveries. Additional deliveries have been noted to increase the chances of prolapse by 10-20 
percent up to a maximum of 5 deliveries (6). Repeated vaginal delivery potentially exposes the 
pelvic organs, nerves and blood vessel to traumatic damage. Expectedly, the reproductive 
organs in their healthy states are well adapted to withstand the birth process, expanding where 
necessary and returning back to their resting states afterwards (8). Disruption in this 
mechanism may result in prolapse. 
Instrumental deliveries and prolonged labour are direct traumatic events associated with higher 
risk of prolapse. Forceps delivery has been associated with a higher risk of prolapse (6). This 
could be due to direct damage to the pelvic structures or the primary indication for the use of 
forceps. Vaginal delivery of macrosomic babies (>4.5kg birth weight), for example, could 
result an obstructed labour leading to intervention by the use of forceps. In this case, both 
indication and intervention predispose to pelvic organ damage that may lead to future prolapse 
(82).  
1.5.5.2 FACTORS LEADING TO RAISED INTRA-ABDOMINAL PRESSURE 
Factors that raise the intra-abdominal pressure have been linked with the development of the 
disease is increasing body-mass-index. Obesity, which also raises the intra-abdominal pressure 
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is one of the three major risk factors associated with prolapse (96). Women with lower body 
mass index (BMI) are less likely to undergo surgery for prolapse when compared with those 
with higher BMI. The odds ratio of developing prolapse is high in overweight women (2·51; 
95% CI 1·18–5·35) and higher in obesity (2·56; 1·23–5·35) (83). Heavy weight lifting, 
chronic cough and repeated constipation may also lead to prolapse via a similar mechanism. 
Studies have shown that a higher percentage (61%) of women with prolapse have reported 
straining while stooling as young adults than women without prolapse (4%) (97). Individuals 
with stage II or greater prolapse had an increased risk of constipation (odds ratio 3·9; 95% CI 
1·4–11·9) compared with women with stage 0 or 1 prolapse (98). Furthermore, women who 
perform more physical work or occupations involving heavy lifting are more at risk for 
prolapse than those whose job are less physically demanding(99). 
1.5.5.3 AGEING 
Ageing, previously discussed in 1.4.2 is a known risk factor of pelvic organ prolapse. The risk 
of developing prolapse is noted to increase with increase in age (6). In a study in the United 
States, a 40% risk increase per decade of life was observed. Studies carried out in other parts 
of the world have also observed an increase in prevalence of the disease in the older 
population, even in regions with a relatively low incidence of the disease (95). Prolapse is 
rarely seen amongst women less than 30 years of age but thereafter, there appears to be a 
consistent increasing prevalence with age up till age 80 (82). In some populations, over two-
fifths of women aged 50 to 79 years have some form of prolapse.  
A study carried out to determine the incidence of pelvic floor muscle trauma during delivery 
found more damage in association with higher maternal age (30). Ageing influences the 
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composition, mechanics and metabolism of pelvic tissues as well as relevant hormones (100). 
Age also influences the tissues‘ regenerative ability, which is particularly useful when injury is 
sustained. Research has shown that vaginal fibroblasts decrease with age (101).  This may 
influence their capacity to maintain the pelvic tissue in a healthy state. Furthermore, tissue 
glycation, which alters its mechanical property, increases with age. While age may appear to 
be a non-modifiable risk (100), its study is relevant as the effects of ageing on tissues can be 
slowed down by lifestyle changes (102).  
1.5.5.4 OTHER POTENTIAL RISKS AND DISEASE ASSOCIATIONS  
Other risk factors, including previous hysterectomy and wider pelvic inlet, have been 
associated with prolapse (93). This is believed to occur as a result of wider outlet for 
transmission of raised intra-abdominal pressure, leading to more pressure on the pelvic viscera 
and subsequent prolapse. The incidence of prolapse in women who have undergone previous 
hysterectomy is slightly higher than in the control population (91,103,104). This risk is higher 
in women who underwent hysterectomy for prolapse. The prolapse however, when it does 
occur, takes place many years after hysterectomy (104). 
Ethnic and familial factors appear to have a role in the development of  (82,83,105). Studies 
also show that women with first degree relatives having prolapse have a higher risk of disease 
occurrence than those without this familial association (99). A study carried out involving 
genetically matched women with a known family history of prolapse revealed the presence of 
a minimum of 6 nucleotide repeats in association with the disease, most of which are directly 
involved in maintaining connective tissue structure and function (106). This suggests that 
development of prolapse may result from connective tissue alteration.  
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1.5.6 CONNECTIVE TISSUE CHANGES IN PROLAPSED TISSUE 
1.5.6.1 OVERVIEW 
There is a paucity of information detailing exact connective tissue that may lead to prolapse. 
In many aspects where knowledge exists some contradictory evidence is also present. No 
consensus has been reached regarding the exact role of all connective tissue components and 
sex steroid hormones in the aetiology of the disorder. Unraveling this may be the key to 
understanding the complex interplay between known risk factors and more certain triggers of 
the disease. Despite this observed lack of consistency in findings regarding pelvic connective 
tissue cells, certain aspects such as ageing of connective tissue structural proteins, repair after 
damage, ECM remodeling and hormonal effects show remarkable trends. This lights the path 
for new research linking connective tissue ageing, remodeling and development of prolapse. 
Conditions affecting the integrity and elasticity of the connective tissue also influence the 
development of the disease. The increased occurrence of prolapse in patients with connective 
tissue disorders such as Ehlers Danlos syndrome and cardiomyopathy has been observed (6). 
In cases where prolapse has been noted in nulliparous individuals, the presence of a genetic 
connective tissue defect has been suggested (8). 
1.5.6.2 COLLAGEN  
Pelvic supporting ligaments from women with prolapse have shown decreased amounts of 
total collagen (23) but collagen Type III, which is associated with reduced fiber size and low 
mechanical strength of the connective tissue is generally increased in prolapsed vaginal tissues 
(6). Type III collagen is present in the skin of babies at birth whereas mature skin has collage 
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type I (11,25). Its presence at early stages of development suggests that it is relevant in 
enabling connective tissues to expand to accommodate growth. Its increase in prolapsed 
tissues is a pointer to prolapse being a response to increased vaginal tissue loading. Findings 
on the levels of collagen I and collagen I/III ratios in prolapse tissues have been inconclusive 
(8,23,107).  
Studies on collagen I mRNA in vaginal fascia and immunofluorescence of collagen in full 
thickness vagina apex tissue revealed no significant change between controls and test subjects 
(108,109). Another study comparing the total collagen content of the vaginal apex and 
parametrium of women with and without prolapse revealed a reduction of collagen in the 
parametrium where prolapse was present but no significant differences in the vagina apex 
(110). Others carried out on the arcus tendinous fascia and periurethral fascias showed 
decreased collagen type I (111,112). Differences observed could be the result of use of varied 
tissue types and different analysis techniques. It is however noteworthy that similar 
observations of low levels of collagen I have been noted in vagina tissue where disease is 
present (8). 
1.5.6.3 MATRIX REMODELING ENZYMES 
An increase in matrix metalloproteinase (MMP)-2 and MMP-9 has been consistently noted in 
prolapse tissues (23,108,113). Despite the use of different analytical methods, research 
suggests higher activity of these fibrillar collagens‘ degrading enzymes in various regions of 
the vaginal tissue and uterosacral ligaments. A congruent decrease in associated TIMPs 
activity has also been noted (45). Increase in tenascin, a marker of wound healing (113) and 
the aforementioned markers of collagen degradation suggests that prolapse reflects an on-
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going remodeling or tissue healing process with loss of homeostasis of this remodeling 
process. Overall, studies on amounts of collagen subtypes and regulatory enzymes suggest a 
dysfunctional regulation of collagen that results in its qualitative decline and quantitative 
imbalance in prolapsed tissues. 
1.5.6.4 FIBROBLASTS  
Fibroblasts are the predominant cells of the vagina connective tissue (3). These slow growing 
cells have been shown to change morphology and biochemistry in response to applied force. 
They are mechanosensitive (114). They undergo mechanotransduction like other 
mechanosensitive cells in load bearing tissues of the body (96). They are also responsible for 
the production of matrix remodeling enzymes (115). The mechanical function of fibroblasts 
can be hindered by abnormal underlying matrix architecture and in disease states they may 
produce abnormal ECM. For example, fibroblasts in prolapsed tissues were also noted to 
produce stiffer connective tissue matrix (116).  Ageing also has an impact on vaginal tissue 
fibroblasts. It has been revealed that the fibroblasts show a numerical decline and reduced 
contractile ability (109) and reduced MMP-2 production (115) with age. The ageing 
sfibroblasts showed decreased wound healing abilities as well as a lack of ability to maintain 
tissue architecture. 
Oestrogen can also influence vaginal fibroblasts behaviour and modulate its biochemical and 
mechanical activities. Repeated stretching of the fibroblasts correlates with production of 
matrix degrading enzymes (96). This effect can be modulated by the reproductive hormones, 
such as oestrogens via pro-trophic mechanisms (117). Oestrogen may increase cellularity but 
has no overall effect on maintaining tissue structure (8). Studies reveal the role of oestrogen in 
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stimulating collagen turnover stress urinary incontinence (38,41), and this process can 
influence pelvic tissue ageing and remodeling. ECM genes associated with breakdown and 
resynthesis are altered during the female reproductive cycle and menopause (46). The pelvic 
tissues also change mechanically in response to cyclical changes in the hormones as well as 
during menopause (118). Further suggestive of the influence of ovarian hormones such as 
oestrogen on vaginal fibroblasts is the observation that the vaginal wall, like other pelvic 
tissues, undergoes remodeling during pregnancy (119). Although, there are few studies on 
fibroblasts in pregnancy, it is known that there is a control of the vaginal wall cell numbers by 
a poorly understood homeostatic balance between apoptosis and cellular proliferation. The 
apoptotic process is noted to decline in the second trimester (120). This is suggestive of 
increasing cell numbers and potentially increased vaginal tissue remodeling in pregnancy 
(120). 
1.5.6.5 NON ENZYMATIC CROSSLINKING OF COLLAGEN  
The most consistent connective tissue findings are the development of new crosslinks in 
prolapsed tissues (8). This is in keeping with the early hypothesis by Jackson suggesting 
prolapse to be the result of increasing trivalent non-enzymatic crosslinks gradually dominating 
slow turn-over proteins ultimately leading to an older, stiffer connective tissue (23). Notably, 
he found higher amounts of an AGE, pentosidine, in the tissues. Since then a few other studies 
have reiterated this finding, showing no change in divalent, enzymatic pyridinoline crosslinks 
but an increase in advanced glycation of pelvic connective tissue collagen (8,45). This, as well 
as the presence of disorganized collagen structure in prolapsed tissues correlates with the 
increasing incidence of the disease observed with increasing age.  
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1.6 VAGINAL WALL MECHANICS IN PREGNANCY AND PROLAPSE 
1.6.1 PREGNANCY 
Various studies have been carried out in attempts to understand the mechanical behaviour of 
the vagina under various conditions. Known prolapse risk factors such as pregnancy have been 
studied to understand their effects on mechanical changes that may lead to prolapse. Both 
pregnancy and prolapse affect pelvic tissues‘ metabolism and mechanical property. 
Pregnancy-induced mechanical changes occur during a relative short period of time and under 
a female reproductive hormone rich condition in contrast to prolapse, which may take years to 
develop. Understanding pelvic tissue mechanical changes in pregnancy will therefore provide 
useful insight into what may occur in prolapse.  
Pregnancy is associated with increased elasticity and reduction in stiffness of these tissues 
prior to delivery (13) Pregnancy influences structural and functional components of the ECM. 
Collagen alignment, for example has been noted to reduce in pregnancy. Decreased stiffness in 
the vagina and its supporting structures (to about 50% less than in non-pregnant states) was 
noted in mice models during second and third trimesters of pregnancy (11). It resolved post-
partum. This finding is congruent with similar observations in another research carried out 
using non-pregnant and pregnant (late stage) using Fibulin 5 knock-out mice, pelvic tissue. 
Pregnant rodents were found to distend up to 3 times their original size in the last two 
trimesters of pregnancy. Reduced tissue strength has also been noted in association with 
maximum distension at delivery (121). A study by Feola et al also noted reduced tangent 
modulus of the vaginal wall in mid and late pregnancy and immediate peuperium when 
compared with virgin rats. These normalised 4 weeks postpartum although the tissue was more 
sensitive to active stimulation in pregnancy (122). 
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The findings imply that pregnancy alters vaginal tissue mechanics in preparation for distension 
during delivery but this returns to normal post-partum (13). The return to normal post-partum 
(11) correlates with findings in other studies showing no observable residual mechanical 
change in the vagina of women post-partum (95). 
Another study recorded increased vaginal weight and length through pregnancy with 
progressive decline in ultimate load and stress capacity occurring with repeated pregnancies 
(123). Altered vaginal mechanics observed during pregnancy are said to be similar to observed 
changes in prolapsed tissue (13). Pregnancy however, is followed by healing and re-synthesis 
of structural proteins in the vaginal and pelvic tissues.  
An age-dependent hormonal effect was observed in rat models. The ultimate load and linear 
stiffness properties of younger rats with surgically induced menopause was lower than in rats 
with active hormones (124). The same effect was noted in older rats. Hormone replacement 
therapy (HRT) or MMPs reduced this effect in younger but not older rats. This observation 
highlights a possible age-dependent hormonal benefit of HRT and a different mechanism by 
which ageing influences tissue mechanics.  
There is significant remodeling of the vaginal wall during pregnancy as a delivery adaptation 
(122). These changes in vaginal tissue mechanics are the result of underlying qualitative, 
organizational and quantitative changes in the extracellular matrix (ECM), with passive 
mechanics more influenced by the fibrillar component (122,125). The vaginal wall is noted to 
have the capacity to distend up to 4-11 times its original size in pregnancy (13) but the 
underlying mechanisms leading to this are not fully elucidated. More is known about these 
biomechanical changes in the vaginal wall than the underlying connective tissue or 
biochemical modifications that effect such mechanical changes. The stiffness of the vaginal 
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wall, tensile strength and maximum load at failure is known to be reduced in pregnancy while 
maximum elongation increases (121). Vaginal wall smooth muscle cell phenotype and 
characteristics change during pregnancy. The smooth muscles have been shown to change into 
a less contractile phenotype and further studies show reduced contractility of the cells in 
pregnancy (48).  
1.6.2 PELVIC ORGAN PROLPASE  
Human studies on vaginal wall mechanics in prolapse have shown great variations between 
mechanical properties. In a study to determine the tensile and bending properties of the vaginal 
tissue of 16 post-menopausal women with or without prolapse, tissues from women without 
prolapse were noted to have higher strength (126). Another study compared the properties of 
vaginal tissue from women with prolapse with cadaveric specimens without evidence of 
prolapse, showed no significant differences in stress, strain and load at failure. A wide 
variability in the mechanical parameters was noted within the test groups (127). Rahn et al 
observed increased distensibility in prolapsed vaginal tissues compared with controls when the 
tissues were strained to failure (13) but Jean-Charles et al observed significantly higher 
stiffness in anterior and posterior prolapsed vaginal walls (128). Furthermore, there is a 
contrast in results of tests carried out in vitro and in vivo. While many in vitro tests have 
revealed increased modulus and stiffness of the isolated prolapsed vaginal tissue, in vivo tests 
note the contrary. Two in vivo studies using a suction technique and 10 mm orifice probe 
respectively noted more extensible vaginal tissue in  (129,130). The inconclusive findings 
necessitate further studies on the mechanics of prolapsed vaginal wall. 
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1.6.3 AGE AND MENOPAUSE 
Age and menopause are other factors that may influence the vaginal tissue‘s mechanical 
properties, with many studies noting increased stiffness and elastic modulus of the vaginal 
tissues in association with both factors (118). An experiment aimed at determining the visco-
elastic property of vaginal tissue showed that pre-menopausal vaginal tissues were more 
resistant to shear force while menopausal vaginal tissue from women without prolapse had a 
higher complex modulus, an indicator of reduced elasticity (12). In the same experiment, 
hormonal therapy in post-menopausal women was associated with higher tissue stiffness when 
compared with post-menopausal tissue without hormonal therapy. A study by Chantereau et al 
comparing mechanical properties of vaginal wall in young female cadavers with data from 
literature on mechanical properties of the vaginal wall in older women revealed significant 
differences in keeping with increased stiffness occurring with age (131). Overall decreased 
tissue elasticity or increased stiffness has been associated with both age and menopause. 
These studies give insight into the mechanical properties of prolapsed tissues compared with 
non-prolapsed ones but make no direct link to exact micro-structural connective tissue changes 
responsible for the observed altered mechanics. Also, many studies have made use of animal 
models, which despite their usefulness; do not represent the in vivo human system. Researches 
performed using human tissue samples either had constraints of small tissue sizes or sample 
inconsistences.  
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1.7 METHODS FOR CONNECTIVE TISSUE STRUCTURAL AND 
MECHANICAL ANALYSIS 
1.7.1 CONNECTIVE TISSUE STRUCTURAL AND MORPHOLOGICAL ANALYSIS  
The function of a biological tissue is determined by its physical and chemical structure. 
Abnormal functioning thus reflects altered structure. Characterization techniques have been 
developed and are continuously being developed to detect these alterations. Available methods 
have their benefits and limitations. A non-destructive, fast, multi-parameter technique is 
required to holistically characterise connective tissue. 
1.7.1.1 ELECTRON MICROSCOPY 
1.7.1.1.1 SCANNING ELECTRON MICROSCOPY (SEM) AND TRANSMISSSION 
ELECTRON MICROSCOPY (TEM) 
In this technique, an electron beam strikes the surface of structures being observed and is 
reflected to a screen for viewing after signal amplification (132). It is useful for viewing 
structures at the cellular level (133). By observing the relationship between cell and matrix 
proteins information can be obtained on the ultrastructural organization of connective tissues. 
It enables visualization of the alignment and dimensional properties of fibrillar proteins like 
collagen (132). Although it achieves good ultrastructural resolution, it has the disadvantage of 
requiring stringent sample preparation steps, with the potential of introducing artefacts to 
images (132).  
Scanning electron microscopy (SEM) is useful for surface analysis of tissues. The electron 
beams generated in the SEM scan the surface of the object so it has the advantage of 
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bombarding the sample less than would occur with transmission electron microscope (TEM) 
(134). This however results in imaging of structures at the surface of the specimen only 
(Figure 1.11). This limitation is overcome by the TEM which uses a transmission beam; which 
penetrates the surface of objects (135) making it more suitable for tissue ultrastructural 
analysis (Figure 1.12). It however requires the preparation of very thin (5-100 nm if using 100 
KeV voltage) tissue slices to permit adequate penetration of electron beams (132).  
 
Figure 1.11: Scanning electron micrograph of collagen fibrils (136). 
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Figure 1.12: TEM image of intracellular organelles within an intact cell (137). Scale bar= 
1 m 
1.7.1.1.2  IMMUNOGOLD LABELLING 
This is a staining technique useful in electron microscopy. Various sizes of gold particles are 
conjugated to antibodies, which target antigens on different biological structures (138). It 
gives detailed resolution of ultrastructure and the density of gold particles targeted at a specific 
antigen can be used to quantify the antigen or substrate it represents (139,140). It is useful in 
distinguishing protein components in biological specimens, hence improving sensitivity and 
specificity of electron microscope imaging. 
Drawbacks of this technique include the requirement of specific fixation of samples in 
order to preserve their antigens for antibody binding and the likelihood of non-specific antigen 
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binding occurring (141). These specialized fixation or antigen preservation methods differ 
depending on the target antigen for preservation and can alter ultrastructure (142). 
1.7.1.2 POLARISED LIGHT MICROSCOPY 
This is an optical imaging technique to reveal the alignment features in tissues. A transverse 
light wave with directional vibrations (polarised light) strikes the surface of an object and 
bifringence is measured (143). Polarized light can be produced by applying a polarising filter 
plate to natural light (144). The bifringence of a polarised light gives insight into the structural 
properties of the object being imaged. Collagen bifringence changes with increasing age so 
this characteristic can be exploited for ageing studies (145). A linearly or circularly polarised 
light can be used to highlight differential characteristics of an anisotropic tissue, e.g. revealing 
the alignment of structural fibers (Figure1.13). This alignment can be semi-quantified (146). It 
however, has the disadvantage of a low resolution and magnification typical of light 
microscopy causing errors in semi-quantitative image interpretation (147). 
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Figure 1.13: Polarised microscopy image of human bone biopsy. The amount of 
bifringence reflects the alignment (0
o
, 45
o
 and 90
o
) of collagen fibers in the different 
specimens (148). Scale bar 250 m 
To improve the quality of the images, picrosirus red is frequently used as a contrast 
enhancement agent made from picric acid and sirus red dye. It has the unique property of 
staining both thin and thick collagen fibers (149). Fiber hue reflects density in a particular 
region of the sample. It can be used with polarized light microscopy to achieve semi-
quantitation of collagen fiber and its orientation in a tissue sample (150). Also, the spatial 
distribution of structural proteins can also be obtained by employing image-subtraction 
software techniques to remove regions of little interest and reveal the arrangement of 
structures being viewed (150).                
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1.7.1.3 ATOMIC FORCE MICROSCOPY (AFM) 
 AFM is a type of scanning probe microscopy which uses a sharp-tipped solid probe to scan 
the surface of the object being assessed (151). The force between the probe‘s tip and sample is 
measured over the entire surface of the object being imaged (152). This gives a topographic 
view of the objects surface, showing the vertical relationship of surface structures to each 
other (Figure 1.14). AFM can be used in non-touch mode and repeated scanning can be 
minimized to make it suitable for biological specimens (153). 
 
Figure 1.14: AFM image of collagen I fibrils (154) 
1.7.1.4 SECOND HARMONIC GENERATION (SHG) 
 Imaging in second harmonic generation is achieved by generating more energetic photons 
from photons striking a nonlinear material, yielding better image resolution than optical 
methods (155). This makes SHG suitable for imaging thick specimens down to nano-scale 
resolutions (156). It is a particularly useful technique for fibrillar collagen imaging because 
such collagens generate bright second harmonic signals (157) as shown in figure 1.15. This 
lends it as a potentially important tool for tracking connective tissue changes. It is useful for 
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imaging both fresh and fixed tissue samples. Interpretation of generated image however 
requires some level of expertise (155) 
 
Figure 1.15: Second harmonic generation image of airway collagen fibrils (157). 
1.7.1.5 FOURIER TRANSFORM INFRA-RED SPECTROSCOPY (FTIR) AND 
RAMAN SPECTROSCOPY 
The infra-red spectrum or Raman scattering of collagen gives insight to its native structure as 
well as structural alterations (158). FTIR has been used in the attenuation mode and also on a 
complementary basis with Raman spectroscopy to detect glycation-induced changes in 
collagen structure (158,159). These microspectroscopic methods are non-invasive and 
particularly useful for in vivo and diagnostic studies. They also do not require prior protein or 
peptide hydrolysis or tissue labeling lending them useful in non-destructive in vitro studies 
(160). Expertise is however, required for data analysis and interpretation and, the result 
obtained is semi-quantitative (158).  
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1.7.2 MECHANICAL TESTS 
Connective tissues are load bearing. Mechanical characterisation reflects their function. To 
characterise human soft tissue in vivo, limitations of system complexity and technique 
invasiveness are considered (161). For this reason, in vitro studies are relevant first steps. In 
vitro studies are particularly important in cause and effect and, correlation studies. In addition, 
they enable tissue characterisation that is important in the ultimate design of ideal in vivo 
diagnostic devices. In vitro mechanical tests for soft tissues involve simple manual devices as 
well as automated bioreactors and computational models (162,163).  
There are few studies and techniques available for the mechanical characterization of 
prolapsed tissues (5). Some of these have been used in prolapse studies but with inherent 
limitations. Most in vitro mechanical studies of the vaginal wall have used destructive 
methods which are often adaptations of tensile or compression tests (11–13,127,164,165). The 
forces applied using such methods are dissimilar to what is experienced by the tissue in vivo 
and such tests prevent simultaneous assessment of within tissue properties as the tissues are 
destroyed during testing. Some of the techniques used in mechanical assessment may be 
adapted or improved for use in the study of prolapsed tissues and hence are discussed below 
1.7.2.1 COMPRESSION TEST 
The compression test involves compressing test tissues or materials in between two plates with 
or without confinement of the tissues in a chamber that restricts its lateral deformation 
(166,167). The compressive force (applied load) and corresponding tissue deformation give 
mathematical insight into tensile properties of assessed tissue (168).  
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Using the compression method, the viscoelastic property of prolapsed vagina tissue has been 
assessed (115). Information on the altered mechanical characteristic of prolapsed tissue can be 
obtained but the tissue is destroyed in the process and the method gives no insight into the 
cause of disease development. When testing biological tissue, factors such as tissue 
inhomogeneity and anisotropism should be considered (169). For this reason, a non-
destructive method is preferred. 
1.7.2.2 TENSILE TEST 
The tensile test has also been used to study prolapse tissue mechanics (11,94). Tissue 
anchorage devices such as wires or sutures, are loaded until the tissues‘ break point is attained 
(13,170) or devices are adapted for use with tissue biopsies (5). The test is based on the 
changes in force required to deform the test tissue at a constant rate of elongation. The force 
per cross-sectional area of the tissue is used to obtain tensile stress and strain values for 
calculation of Young‘s modulus, and determine both yield and ultimate tensile strength (171). 
Despite its usefulness, the tissue is also destroyed in the process and there is increased strain at 
tissue anchorage points (168). Testing to breaking point is an un-natural test of prolapse and 
does not simulate disease outcome. It is important to develop a mechanical test that would 
highlight the mechanical property of the prolapsed tissue that reflects or closely simulates 
disease outcome.  
1.7.2.3 BULDGE TEST 
This is another method for determining the mechanical characteristic of soft tissues (172). It is 
useful for testing membrane compliance. Liquid is passed through an opening at a constant 
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rate to deform the tissue (168). Applied force is more symmetrically distributed to the tested 
material but leakage can occur, making it less suitable for many biological tissues (168) 
1.7.2.4 NON-DESTRUCTIVE AND MINIMALLY DESTRUCTIVE TESTS 
1.7.2.4.1 CUTOMETER-LIKE MEASUREMENT (IN VIVO STUDIES)  
Some in vivo studies on prolapsed tissue with non-destructive modes have been reported. The 
tests used are tactile imaging (10), suction technique and skin probe method (128,130). In the 
skin probe method 1.5 mm skin probe was adapted for use in the study of vaginal wall tissue‘s 
mechanical property (128). The suction method developed by Chuong et al was an adaptation 
of Cutometer-like technique. It involves the application and release of suction pressure to the 
vaginal wall (130). These are of diagnostic use but require significant adaptation for use in 
understanding prolapse. An ideal prolapse research method should have a set up that closely 
mimics the disease pathology, that is, vaginal wall deformation. Considering the central role of 
pelvic support played by the vagina tissue (4), descent of pelvic organs may occur as excess 
pressure is consistently transferred to the central vagina tissue. Therefore, the load-dependent 
creeping property of vaginal tissue may reflect, in an in vitro setting, prolapse. A mechanical 
test to assess tissue load deformation over time (creep) in a non-destructive way is thus 
required. 
1.7.2.4.2 IN VITRO STUDIES 
These include spherical ball indentation and optical coherence elastography (OCE), which are 
discussed in 34.1 and 3.4.3. 
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1.7.3 QUANTIFICATION OF COLLAGEN  
To accurately quantify AGEs in connective tissues, especially in collagen, it is important to 
first quantify collagen to enable analysis of the relationship between the presence of these 
markers and amounts of tissue collagen. Collagen quantitative assay methods have been 
limited by the extensive crosslinks formed by collagen molecules (173). Methods that exist for 
its quantitation include: the use of precipitating dyes for in-situ measurement of soluble 
collagen (174) the use of HPLC or colorimetric methods to analyse the hydrolysed protein. 
HPLC and colorimetric methods are based on collagen quantification in relation to the amino 
acid, hydroxyproline (173).  
1.7.3.1 HYDROXYPROLINE ASSAYS 
Hydroxyproline is a collagen-specific amino acid oxidation product constituting 
approximately 14 percent of collagen (175). It is a post-translational modification of collagen. 
Collagen, which is comprised of tri-peptide repeat sequence, has hydroxyproline often 
recurring at the Y position of its glycine-X-Y repeat (176). Thus assaying hydroxyproline 
enables collagen quantification in the presence of other protein types.  
Hydrolysis of collagen is pre-requisite to obtaining hydroxyproline. This is the cleavage of 
peptide bonds of proteins and peptides to obtain constituent amino acids. Various technical 
variations exist for tissue hydrolysis but in principle, heating a solution of proteins or 
polypeptides 110
o
C in concentrated hydrochloric acid over 18 to 24 hrs results in cleavage of 
the amino acid bonds within polypeptide chains (177). 
Colorimetric methods have been used to quantify hydroxyproline. The principle is the 
formation of a chromphore by an oxidation reaction with hydroxyproline (178). This method 
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is cheaper, less laborious and less time consuming than HPLC. The intensity of the 
chromophore directly relates to the amount of hydroxyproline present in the hydrolysed tissue 
sample (173) . 
1.7.3.2 HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC)  
HPLC can be utilized in the extraction of hydroxyproline following sample hydrolysis in 
hydrochloric acid (179). Hydroxyproline, derived from proline (using phenyl isothiocyanate) 
can be separated and isolated from other amino acids using reverse-phased HPLC. It is the 
detected at its absorption wavelength (180). Variations in the column size and HPLC settings 
determine the elution or separation time of amino acids (179). 
1.7.3.3 HISTOCHEMISTRY - PICROSIRUS RED ASSAY 
The picrosirus red dye stains specifically for collagen. The dye intensity after staining is 
directly proportional to the amount of collagen present in the sample hence stained biological 
sample can be dissolved and assessed colorimetrically (181). The OD reflects the amounts of 
collagen present in a biological sample. Although this assay method permits simultaneous 
structural and quantitative assessment of tissue samples, sirus red stains some collagen fiber 
types less intensely giving a less accurate representation of the amount of collagen in a sample 
than the oxidative colorimetric assays (174). 
1.7.4   AGEs DETECTION 
1.7.4.1 IIMMUNOHISTOCHEMISTRY 
Antibodies to AGEs receptors have been used to detect the presence of AGE in tissues (182). 
Antibodies to AGE scavenger receptors or polyclonal antibodies to RAGE enable visualization 
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of concentrations of the markers within tissues. This method can be employed in vivo by using 
anti-sera but it cannot be used for absolute quantification of the ageing marker (183). Also, 
quantifying these receptors does not give an accurate picture of the amount of AGEs present in 
the biological sample.  
1.7.4.2 HPLC 
HPLC requires complete hydrolysis of the proteins to be analyzed as earlier described. 
Pentosidine, a fluorescent ageing marker is detected via HPLC coupled with an ultraviolet 
(UV) or fluorescent detector (184). UV detection has been achieved at 325  while fluorescent 
detection occurs at excitation and emission spectra of 335 and 385 nm respectively (185). An 
online screen display gives a graphical representation (chromatogram), showing peaks of the 
amounts of various amino acids. Running various known concentrations of a stock solution of 
the ageing marker and comparing with relative amounts of unknown test samples gives 
absolute amounts of the ageing marker in the tissue (177). Furthermore, the HPLC can be 
coupled to a mass spectrometer which takes advantage of the mass shift conferred on amino 
acids by glycation for a mass-based detection (186). HPLC, unlike immunohistochemistry for 
AGEs detection enables absolute quantification of the amount of AGEs present in a tissue. 
Although it has cumbersome and time-consuming sample preparatory steps and cannot be 
used in vivo, the same hydrolysed tissue can be used for both collagen and pentosidine 
quantification. 
1.7.4.3 COLLAGEN ALIGNMENT CAPACITY 
The alignment of collagen fibril monomers under a magnetic field has been noted to change 
with age. In a study carried out using extracted collagen (from new born to 24 month old rats), 
52 
 
the degree of re-alignment of procollagen monomers reflected fluorescence due to AGEs (73). 
Younger collagen with lesser AGE-specific fluorescence had better alignment than older 
collagen. The less anisotropic AGEs were suggested to inhibit the re-alignment of collagen 
monomers in older collagen. This quantification of collagen monomer alignment can be 
exploited for future in vitro quantitation of fluorescent AGEs in collagen extracts. 
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2.1 HYPOTHESES 
2.1.1 PROLAPSE IS A DISEASE OF ACCELERATED AGEING AND  VAGINAL 
TISSUE ARE STRUCTURALLY AND MECHANICALLY ALTERED IN 
RELATION TO THEIR GLYCATION CONTENT 
There is an increased prevalence of prolapse in the aged population and minimal occurrence in 
younger women (82,91). Prolapse, once thought to be a disease of the multiparous has been 
observed in some nulliparous women (45). This is a challenge to some widely held concepts 
about its aetiology. In view of this lack of clarity it is important to further investigate another 
notable risk factor, ageing. Considering the above observations and striking similarities 
between ageing connective tissues in other parts of the body and prolapsed tissue and the 
observed associations of the disease with ageing, prolapse could be another disease of ageing. 
There is a need to investigate the relationship between presence of ageing markers and 
development of disease, an understanding that may be beneficial in future prediction of 
prolapse even before disease becomes apparent.  
The structure of tissues dictates their function in healthy and disease states. Chronic disorders 
are typically the result of multiple cellular and tissue level changes, which accumulate to result 
in the disease phenotype appreciable at the organ level. (187). It is therefore expected that the 
vaginal wall, a major adaptable tissue in pregnancy and prolapse, would exhibit notable 
ultrastructural changes in keeping with functional changes.  
Most studies on prolapse have only focused on biochemical or ageing changes of the 
prolapsed tissues or mechanical properties (8). This leaves a gap in understanding the exact 
relationship between these two properties. There is a need for a combined comparison of 
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mechanical and biochemical changes. Markers of ageing are known to be present in higher 
quantities in prolapsed tissues compared with controls (8,23,45). The prolapsed vaginal tissues 
have shown significantly different mechanical properties from normal tissues. Despite rising 
interest in the mechanics of prolapse, much remains to be done. A recent review of the state of 
pelvic tissue biomechanics reveals a need for the collection of more mechanical data to add to 
the body of knowledge and potentially aid the creation of useful study models (118). 
The ageing process is believed to be a key determinant of prolapse. It is hypothesized that age-
related changes correlate directly with mechanical changes of vagina tissue. This correlation 
may reflect prolapse occurrence and severity. In other words, ageing can predict vaginal tissue 
mechanics, and development. In addition, since physical ageing is a global phenomenon 
occurring in all cells to varying degrees, these changes are also reflected in other parts of the 
body. Therefore, it is expected that there should be correlation between the progression of 
ageing in various body tissues, both superficial and deep.  
2.1.2 GLYCATION ACCUMULATION IN PELVIC TISSUES IS INFLUENCED BY 
OESTROGEN 
Oestrogen is associated with pelvic tissue remodelling, involving breakdown and re-synthesis 
of the key structural proteins (188). Pregnancy, a high oestrogen state is known to cause 
increased elasticity of pelvic tissues (13,121). It is also thought that glycation of structural 
proteins leads to stiffer, less elastic connective tissues, an effect noted in prolapsed tissues 
with higher glycated proteins (12,55). Understanding that pregnancy is associated with higher 
amounts of oestrogen than in non-pregnant states and that pelvic tissues are sensitive to 
oestrogen (47) leads to the hypothesis that a state of high oestrogen such as pregnancy is 
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associated with breakdown of structural crosslinks of collagen and elastin in the vaginal ECM, 
resulting in reduced amounts of glycation products and reduced tissue stiffness. Gestation and 
delivery are associated with pelvic tissue remodeling, involving breakdown and re-synthesis of 
the key structural proteins (188). Pregnancy is known to cause increased elasticity of pelvic 
tissues, and high oestrogen level (13,121). It is also thought that glycation of structural 
proteins leads to stiffer, less elastic connective tissues, an effect noted in prolapsed tissues 
with higher glycated proteins which occur more frequently in aged women  who have low 
oestrogen level (12,55). Considering the modulations in oestrogen levels during pregnancy and 
in preparation for delivery of the foetus and, the sensitivity of vaginal tissue to the hormonal 
changes (47), it is hypothesised that high oestrogen levels correlates with breakdown of 
structural crosslinks of collagen and elastin in the vaginal ECM, resulting in reduced amounts 
of glycation products. This may enhance the loss of older stiffer collagen and cause improved 
compliance of the female pelvic tract to accommodate passage of the fetus. This implies a 
potential relationship between vaginal tissue oestrogen expression and glycation content. 
2.2 RESEARCH AIMS  
The aims of the research were: 
1. To investigate the relationship between vaginal wall mechanics and glycation content 
during pregnancy, understanding the association between ER- expression in the 
tissues with the process, to understand a possible mechanism where present and to 
investigate vaginal tissue ultrastructure in pregnancy as well as the influence of sGAG 
on the same and to study the relationship between skin and vaginal tissue glycation in 
the same subjects. These have been studied in Chapter 4 under sections 4.1, 4.2 and 4.3 
respectively 
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2. To quantify and study the glycation compound, pentosidine in prolapsed tissues and 
study this in relation to known and suspected risk factors and glycation associations 
including age, hypertension, smoking, cholesterol level and diabetes. A further aim 
was to understand the reason for glycation increase in prolapsed tissues by studying the 
glycation changes, ER- expression and the expression of a glycation lowering 
antioxidant, glyoxalase I in the tissues. Chapter 5 addresses this aim. 
3. To mechanically characterize the vaginal tissue in prolapse at nanoscopic, microscopic 
and macroscopic scales using multiple new techniques in the study of prolapse, and to 
assess vaginal tissues‘ structural properties with a view towards understating prolapse 
pathology. This has been studied in chapter 6. A further goal was to correlate the 
glycation content of the vaginal tissue in pregnancy and prolapse with observed 
mechanics. This has been addressed in chapters 4 (4.1) and 6 in pregnancy and 
prolapse, respectively. 
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3.1 TISSUES AND ETHICS 
3.1.1 RAT TISSUES: ETHICAL APPROVAL AND DISSECTION 
Outbred 6-8 month old female Sprague Dawley rats were used following local ethical approval 
by the Animal Welfare & Ethical Body Review, in accordance with the Animal act of 2006. 
From these, non-pregnant and E15-E18 (last trimester) pregnant rats were humanely culled by 
a Schedule 1 method. Both fresh and defrosted tissues frozen at -20
0
C were used after the 
Schedule killing. Following midline dissection of abdominal wall and location of pelvic tissue 
complex in rats (shown in Figure 3.1), full thickness vaginal tissues were obtained by blunt 
dissection and separation of posterior vaginal wall from rectal tissue and detachment of 
anterior wall form urethral tissue.  
 
Figure 3.1 Dissection of Female Sprague Dawley rats. A mid-line abdominal section was 
made followed by blunt dissection to locate the pelvic tissues. Dissection of the abdominal 
wall with intact viscera is seen on the left, while the image on the right shows the vagina 
(V) lifted off from the rectum following blunt dissection. 
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The vaginal wall was subsequently separated from the bicornuate uterus and surrounding 
pelvic tissue complex shown in figure 3.2. 
 
Figure 3.2: Reproductive organs of Female Sprague Dawley rats isolated from pelvic 
cavity. The vaginal wall (V), uterine horns (H), cervix (C), urinary bladder (B), and an 
ovary (O) are shown. 
3.1.2 HUMAN TISSUES: ETHICAL APPROVAL, PARTICIPANT RECRITMENT, 
CONSENT TAKING AND DATA CHARACTERISTICS  
National and local ethical approval was obtained. National ethical approval was sought from 
the Health Research Authority. The approved Research Ethics Committee (REC) reference 
number was 13/LO/1655. National Research Ethics Service London and local approval was 
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obtained from the University Hospital of North Midlands (UHNM) Research and 
Development department. Information sheets and proformas were designed by participating 
scientists and clinicians with the approval of the University Hospital of North Midlands 
National Health Service (UHNM NHS Trust) Research and Development department prior to 
study commencement. Women 41 years and above were recruited. Clinicians obtained 
informed consent from women scheduled for elective prolapse and other relevant 
gynecological surgery. Redundant vaginal tissues excised during surgery and otherwise 
discarded were collected and used for study. Prolapsed regions of the vaginal wall were 
obtained from women undergoing surgery for prolapse. Control samples were vaginal tissue 
obtained by surgeons from participants undergoing surgery for conditions such as 
gynaceological or urological cancers. Sixty-five samples were obtained (49 prolapse and 16 
controls). Full thickness vaginal tissue segments were obtained from upper middle zones 
(prolpase) and apical regions (controls) of the vaginal wall based on surgical availability. 
Samples not containing vaginal tissue segments were excluded. Proformas were created to 
obtain data on age, parity, mode of deliveries, presenting symptoms, type of prolapse, co-
morbidities such as hypertension, diabetes, smoking, etc, type of surgery, grade of prolapse 
based on Baden-Walker half way system and (International Consultation on Incontinence 
Questionnaire-Vaginal Symptoms) ICIQ-VS score described in 1.5.3, diagnosed incontinence 
and prolapse types and grades, and previous prolapse surgery. Proformas were completed by 
the research student and participating surgeon from clinical notes‘ data and patient interviews 
with information obtained logged onto Microsoft Excel spreadsheet. Known and potential risk 
factors were compared against pentosidine amounts in the tissue.  
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3.2 STRUCTURAL AND MORPHOLOGICAL STUDIES 
3.2.1  HAEMATOXYLIN AND EOSIN (H&E) 
Histological sections were obtained to confirm the presence of the various histological zones 
and for structural assessment. 4-6 m cryosections were cut from middle zones of vaginal wall 
segments by a microtome cryostat (Leica Biosystems) after proper orientation of the tissues 
anatomically. They were fixed with 4% formalin or 4% paraformaldehyde for routine 
histology. Samples were supported in optimal cutting temperature embedding medium from 
CellPath Ltd. Samples were rehydrated and stained with Weigert‘s haematoxylin (Sigma-
Aldrich) for 8 minutes followed by bluing in tap water for 10 minutes. They were 
subsequently stained with eosinophilic eosin (Sigma-Aldrich) for 3 minutes followed by 
dehydration in two changes of 95% alcohol for 30 seconds each time, clearing with histoclear 
(Fisher Scientific) for 5 minutes and mounting with a xylene based mounting medium 
(distyrene, tricresyl phosphate plasticiser and xylene, DPX from Fisher Scientific). For the 
human tissues, cell counts from routine H&E staining were performeed in each x20 image 
obtained using image J and comparisons were made between prolapse and control samples. 
3.2.2 ELASTIN STAINING 
For elastin staining, a modified Verhoff‘s stain (kit from abcam, UK) was used with and 
without counterstaining. Hydrated sections were placed in working elastic solution for 15 
minutes, dipped 15 times in a differentiating solution, rinsed briefly in tap water and placed in 
Sodium thiosulphate solution for 1 minute. For counterstaining, slides were rinsed in running 
tap water and placed in Van Gieson‘s Solution for 5 minutes. They were subsequently rinsed 
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twice in 95% alcohol and dehydrated in 100% alcohol and mounted with a xylene based resin 
prior to light microscopy imaging. 
3.2.3 NEURAL STAINING 
For neural stain, tissue sections were washed in phosphate buffered saline (PBS) and fixed in 
4% PFA for 10 minutes. These were subsequently washed thrice in tris buffered saline (TBS) 
and blocked using 5% Normal Goat Serum (NGS) in TBS-T for an hr at 4
o
C. Primary 
antibody, 2.4 g/L anti-glial fibrillary acidic protein (GFAP) purchased from Dako, UK was 
diluted in TBS-T at ratio 1: 100. And added to tissue sections and left overnight at 4 0C. 
Samples were counterstained with goat anti-mouse flourophobe 547H at dilution ratio 1:300 in 
TBS-T. The experimental set up was placed in a dark room for 2 hours, followed by washing 
in TBS. Coverslips were introduced to samples using DAPI containing mounting medium and 
left to stand for 2-3 hours at room temperature covered in aluminium foil prior to imaging 
under a inverted flourescent microscope (Nicon Eclipse Ti-SR, Japan). 
3.2.4  TRICHROME STAINING 
4 m thick cryosections of the vaginal tissues were stained using Masson-Goldner-trichrome 
staining kit from CarlRoth, Germany. Sections were rehydrated and stained with Iron 
haematoxylin (a 1:1 ratio mix of solutions A and B) for 3 minutes. They were rinsed with 1% 
acetic acid solution for 30 seconds followed by 10-15 minutes bluing in tap water. Slides were 
stained with Goldner‘s counter stain I for 10 minutes, rinsed with 1% acetic acid solution and 
subsequently placed in Goldner stain II for 20 minutes. Following rinsing, counterstain with 
Goldner stain III for 2-5 minutes and a further 1% acetic wash step was performed. 
Dehydration in alcohol, clearing in xylene and mounting using resin based mounting medium 
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followed. Results were interpreted as follows: green for connective tissue areas, orange for 
erythrocytes, red for cytoplasm and muscular layers.  
3.2.5  SIRUS RED STAINING 
Picrosirus red solution was prepared with 0.5 g Sirius red (sigma Aldrich, direct red 80) and 
500 ml aqueous solution of picric acid. Hydrated 4 m tissue sections were placed in 
picrosirus red solution for a minimum of one hour to attain equilibrium and thereafter washed 
twice in acidified water, dehydrated in three changes of 100% ethanol, cleared in xylene 
solution and mounted as described in 3.2.1 for viewing. 
3.2.6 SCANNING ELECTRON MICROSCOPY (SEM) OF VAGINAL TISSUES 
Freshly dissected whole vaginal tissues from pregnant and non-pregnant rats were segmented 
to obtain whole tubular rings. These were fixed with glutaraldehyde (GA) and washed with 
sodium cacodylate buffer. Critical point drying of the tissues occurred in a chamber filled with 
dry ethanol. This was gradually replaced with carbon dioxide over few hours at 31
0
C and ~ 73 
atm. And subsequently anchored to metallic stubs by carbon stickers, further coated with a 
metallic paint to improve conductivity. Improved specimen conductivity was achieved by 
incubation in osmium tetroxide (OsO4). Specimens were then gold coated within a vacuum in 
a sputter gold coating chamber in preparation for imaging. Low and high (1k- 15k) 
magnification images were obtained for native tissues and collagen gels fluids and gels using a 
field emission SEM (Hitachi S4500) of resolution 1.5 nm. 
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3.2.7 OPTICAL COHERENCE TOMOGRAPHY (OCT) 
Freshly dissected vaginal tissues of pregnant and non-pregnant rats were imaged using OCT 
prior to mechanical testing and for assessment of structure and cross-sectional thickness 
measurement. OCT can provide useful information about the internal structure of a biological 
tissue. Its longitudinal resolution depends on the coherence length of its light source and some 
devices are unsuitable for use to determine thickness of larger tissue samples due to a limited 
field of view in the mm range (189). An OCT instrument (TELESTO-II, Thorlabs) was used. 
The instrument can achieve up to 3.5mm depth penetration. Near-infrared light at 1300 nm 
wavelength was transmitted through specimens placed flat on clear petri dishes. The intensity 
of the backscattered light produced 2-D images of cross sectional images of the tissues across 
selected areas from screen displays of the tissues. 
3.2.8 AFM ANALYSIS 
AFM was conducted using a Bruker Multimode instrument (Nanoscope VIII MultiMode 
AFM, Bruker Nano Inc., CA) equipped with a 150 x 150 x 5m scanner (J-scanner) operated 
with PeakForce Quantitative Nanomechanical Mapping (PFQNM) modality. For PFQNM 
measurements, the spring constant of the cantilever and deflection sensitivity were measured 
on a clean sapphire sample and then, the set up was calibrated with a polymer of known elastic 
modulus (PSI, Vishay Measurements Group, UK) (190). 4m thick vaginal tissue cryosections 
of pregnant and non-pregnant rats without fixation were collected onto coverslips and stored at 
-20
0
C until testing. The coverslips were glued to metal support stubs prior to testing. To obtain 
high resolution images air dried setions were used. A silicon nitride tip (Burker Bruker 
TAP150) with a nominal tip radius of 8 nm and a 5 N/m spring constant was used for imaging. 
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2-D and 3-D height images were obtained from the Nanoscope software (version 1.5) for 
structural analysis. Data on collagen fibril size, count and alignment were obtained using 
image J software. 
3.3 BIOCHEMICAL ANALYSES 
3.3.1 SULPHATED GLYCOSAMINOGLYCANS (sGAG) AND WATER CONTENT  
The sulphated glycosaminoglycan (sGAG) content in both pregnant and non-pregnant rat 
vaginal tissues was determined by staining of 4-6 m vaginal tissue sections using alcian blue. 
To prepare the staining solution (0.1%w/v alcian blue solution), 0.1g of alcian blue powder 
from Sigma-Aldrich, UK was dissolved in 3% acetic acid prepared from 3ml glacial acetic 
acid (Sigma-Aldrich,UK) and 97 ml 97mL dH2O. Rehydrated tissue sections were placed in 
the resulting solution of pH 2.5 for 30 mins, then washed in running tap water for 2 mins. 
Following distilled water rinse, dehydration occurred in two changes of absolute ethanol. 
Clearing and mounting of coverslip preceded light microscopy imaging of samples. A strong 
blue stain was indicative of the presence of sGAG. For sGAG quantification, DMMB (1, 9-
dimethlymethylene blue) method was used. In brief, lyophilized and weighed rat vaginal 
tissues were digested in papain enzyme solution (50 ml of 200 mM phosphate buffer 
containing 1 mM ethylenediaminetetraacetic acid (EDTA) at (pH 6.8), 25 mg papain from 
papaya latex and 48 mg N-acetylcysteine) (191). Three hundred μl of digestion solution was 
added to 6-12 mg dried and weighed tissue samples and incubated for 16 h at 60°C. 
Thereafter, 200 μl of DMMB solution (DMMB solution prepared by dissolving 4mg of 
DMMB dye (Sigma-Aldrich, UK) in a 250 mL solution comprising of 0.58g NaCl and 0.75g 
glycine (both from Sigma-Aldrich, UK) and 2.08 ml of 0.1M HCL (Fisher Scientific, UK) was 
67 
 
added to each well of 96 well-plate containing 50 μl of samples or standard solution aliquots, 
followed by immediate absorbance reading at 530 nm (BioTec Synergy 2). The standard curve 
was made by using serial dilutions of bovine chondroitin sulphate stock solution. For the 
measurement of water content, the freshly dissected vaginal tissues were weighed initially and 
then dried to constant weight. Water content of the tissues was determined as the difference 
between wet and dry tissue weights tissues and expressed as a percentage of the wet weights.  
3.3.2 AGEING BIOMARKER DETECTION 
The glycation product, pentosidine, which is formed by the reaction of arginine and lysine 
with a pentose sugar (19) was chosen for detection (192) by an ultraviolet detector. Freshly 
dissected vaginal tissue portions from aged-matched pregnant and non-pregnant rats were 
hydrolysed in 6 M hydrochloric acid at 110
o
C over 20 hours. Hydrolysed samples, following 
removal of hydrochloric acid in a lyophiliser, were redissolved in deionised water at a 
concentration of 0.1mg/l and separated using high performance liquid chromatography 
(HPLC, Agilent 1220 LC, USA).  Separation occurred in a C-18 250 x 4.60 analytical column 
and detection at 325 nm wavelength by an ultraviolet detector. Pentosidine eluted at 9.6 
minutes in a 30 minute run  (figure 3.3) using 0.1% trifluoroacetic acid made from 1ml of 
HPLC grade triflouroacetic acid (Sigma-Aldrich) and 1L distilled water  and 80% acetonitrile 
made from 800 ml of HPLC grade acetonitrile (Fisher Scientific) and 200ml water as solvents 
A and B, respectively at a flow rate of 1 ml/min with gradient of 0-18% from 0 to 12 minutes 
and 100% for 12 to 18 minutes for solution B and 100% - 82% from 1 to 12 minutes of 
solution A. 
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Serial dilutions of pure pentosidine compound (Caymann Chemical, USA) was used for 
standard quantification. A linear standard curve, figure 3.4 (r
2
=0.99) was obtained from serial 
dilutions of the pure pentosidine compound and areas of peak which were proportional to 
pentosidine content. For human tissues, full thickness prolapse and control tissues were 
analysed.  
 
 
 
Figure 3.3: HPLC chromatogram showing pentosidine elution at 9.6 minutes. 
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Figure 3.4: Pentosidine standard curve. 
 
3.3.2.1 VALIDATION TESTS FOR PENTOSIDINE ANALYSIS 
Validation tests were carried out on the human samples. The tests were designed to test the 
effect of the use of different locations of the same tissue for pentosidine analysis, stored versus 
freshly obtained tissues for analysis and lyophilisation versus oven drying methods. For 
sample validation, full thickness tissue bits from 3 non-contiguous regions of each randomly 
selected samples were obtained and tested for pentosidine content to determine repeatability of 
pentosidine testing on the same tissue. In order to examine the impact of sample storage on 
pentosidine content, repeat testing of samples stored at -20 degree C for more than 12 months 
using the same protocol was carried out. Two types of sample drying methods prior to 
hydrolysis were assessed. The same samples were dried using a 60 degree oven and 
lyophilisation overnight and tested for pentosidine content. 
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3.3.3 COLLAGEN ASSAY 
A colorimetric assay was used to detect hydroxyproline for collagen quantification in age-
matched control and prolapsed tissues, n=8 per group. The assay kit was purchased from 
Sigma-Aldrich (St. Louis, MO). 100 mg full thickness tissue sections were weighted and the 
homogenized inside PTFE capped glass vials. To each of these 100 ul deionized water and 100 
ul 12 M (37%) HCL were added and hydrolysis took place at 110 °C oven over 3 hours. 
Hydroxyproline standard was diluted in deionized water and standards, ranging from 0-1.4 ug 
were made prepared in a 96 well plate. 20 ul of diluted test solutions were inserted in wells of 
a 96 well plate and left to dry in a 60 degree oven. After drying, each well was incubated with 
6 L of Chloramine T Concentrate and94 L of Oxidation Buffer for 5 minutes at room 
temperature, followed by 100 L of the Diluted DMAB Reagent (within the kit) and subsequent 
incubation at 60 degrees for 90 minutes. Following colour development, reading was carried 
out at 560nm for standards and samples in a 96-well plate on a spectro-photometer. 
Conversion of OD readings to amount of hydroxyproline in the solutions was made using 
standard curve equation which were subsequently converted to total collagen content using a 
factor of 14 (193).  
3.3.4 IMMUNOCHEMISTRY 
6 µm-thick sections of vaginal tissues were cut in a cryostat machine, fixed by 4% 
paraformadahyde and rehydrated for ER-α and Glo-I immunostaining. For oestrogen (ER-α) 
receptor detection, sections were permeabilised with triton-X after blocking for 4 hours with 
5% bovine serum albumin, BSA soluton made by dissolving 5mg of BSA powder in 100 ml 
phosphate buffered saline, PBS. Following incubation with mouse monoclonal IgG antibody 
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to ER-α (from Santa Cruz Biotechnology) directed against the intranuclear steroid receptors, 
goat anti-mouse IgG (Life Technologies) was incubated against the primary antibody. The 
primary antibody (1:100 dilutions in 1% bovine serum albumin, BSA solution) was incubated 
with the tissues overnight at 4
0
C. and thereafter washed thrice with phosphate buffered saline. 
The tissue sections were incubated at room temperature with secondary antibody solutions at 
the same dilution ratio. For negative control samples, the primary antibody was not added to 
tissues. For the antioxidant staining, rabbit polyclonal IgG against glyoxalase I antibody 
(Abcam, UK) was used to detect its expression with mouse anti-rabbit IgG as the secondary 
antibody. Three wash steps (to remove non-specific staining) were followed by cover slip 
mounting with 4',6-diamidino-2-phenylindole (DAPI) coated mounting medium for nuclei 
counterstaining and fluorescent microscopy. 
3.4 BIOMECHANICAL TESTS 
3.4.1 BALL INDENTATION MECHANICAL TESTING  
Ball indentation method is a minimally destructive method that enables in vitro 
characterization of soft tissues and can provide information on tissue creeping and modulus 
(168). The deformation of the test tissue over time can be imaged in real-time. This technique 
incorporates advantages of the tensile test and the blister test; there is even distribution of 
applied force and the tissue remains intact through the test. In addition, it achieves a high 
resolution of 10N and 10m for force and displacement respectively (168).  Briefly, the 
mechanical test device consisted of two transparent plastic O-rings held securely in place by 
stainless steel screwed plates as shown in figure 3.5 below. Prior to tersting, tissues were 
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mounted between the O-rings and the set upwas screewed securely in place (Figures 3.5 and 
3.6)  
 
Figure 3.5: Schematic illustration of tissue sample holder for indentation ball instrument 
(168). 
 
Figure 3.6: Mounted vaginal tissue segments within plastic O-rings secured within a 
metal screw and plate system. 
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Distension of tissues was achieved by central displacement, produced by a spherical Teflon or 
stainless steel balls of weights 0.027 g and 0.27 g for creep and modulus testing respectively. 
The deformation images were acquired using a microscope with a long focal distance 
connected to a charge coupled device (CCD) camera (XC-ST50CE, Sony, Japan) and 
computer as shown in figure 3.7. To obtain creep data, time 0 and 24 hour deformation images 
(deformation image pictured below, Figure 3.8) were taken with the tissues deformed and 
incubated in a moist chamber at 37
o
C and 5% CO2. Image deformation profiles were  
recorderd on an image acquisition software, the Labview program (National instruments,UK). 
 
Figure 3.7: Ball indentation deformation imaging system. The CCD camera (C), the stage 
(S) for sample placement and computer monitor and central processing unit are shown. 
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Figure 3.8: Displacement images of vaginal tissues at time 0 (t 0) and after 24 hours (t24) 
obtained using the CCD camera 
The following equation based on the initial displacement, δ, was used for elastic modulus, E, 
measurement (168): 
6w/EhR = 0.075(δ/R)2 + 0.78(δ/R)          [1] 
where ‘h’ represents the tissue’s thickness, measured by optical coherence tomography, 
‘R’ is the radius of the spherical ball (4 mm) and ‘w’ is the weight of the ball. 
 
3.4.1.1 RAT TISSUE TESTING 
Using the ball indentation method, the 24 hour creep deformation and modulus of the intact 
vaginal tissue segments were measured following pre-established protocol (168). Whole intact 
tubular vaginal organs from the rats were placed in cylindrical tubes as shown in figure 3.9 
and carefully dissected dissected by a mid-line incision and opened up into a rectangular flat 
piece prior to mounting between the O-rings secured within a plate and screw system as 
previously described.  
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Figure 3.9: Insertion of tubular vaginal wall over a cylindrical object to enable precise 
incising in the process of creating a rectangular flat sheet for mounting on mechanical 
test device. The arrow indicates the tissue’s location. 
 
3.4.1.2 HUMAN TISSUE TESTING 
Ball indentation testing of prolapsed vaginal tissues was carried out for assessment of the 
relationship between glycation and tissue-level creep and modulus. Prolapsed tissues with a 
diameter of 12 mm or more were selected for ball indentation testing. This enabled adaptation 
of tissues tested to the mechanical testing device. The test was carried out using the method 
described in 3.4.1. For the human samples, central displacement was produced by a spherical 
stainless steel ball of weight 0.27g. Image acquisition and calculations were performed as 
previously described. Human vaginal wall tissues were much thicker than rat tissues. They 
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could not directly been mounted in the ball indentation ring and generate detectable 
deformation. Furthermore, thicker samples do not meet the dimensional criteria for modulus 
calculation by the equation [1]. Two slicing tools have been developed to prepare samples 
with appropriate thickness for the testing. 
3.4.1.2.1 CREATION OF TISSUE SLICING TOOL 
To enable slicing of isolated human vaginal tissue segments with appropriate thickness for the 
mechanical testing, a load stage (Figure 3.10) was conceptualized. The aim was to achieve 
secure tissue holding and simultaneously apply downward load to stabilize tissue during 
horizontal slicing motion in the z-plane. The design consisted of a biologically inert block 
made of poly tetrafluoroethylene (Teflon) and moveable stainless steel tissue holders.  
 
Figure 3.10: Mechanical test load-stage designed to support tissue during slicing. 
Design improvement (Figure 3.11) was made with the aim of controlling tissue thickness with 
minimal dependence on the dissecting skill of the user. 
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Figure 3.11: Design of mechanical test load stage with tissue cutter. 
Sliding movement through affixed tissue (with piece x, a mobile but fixable piece made of 
stainless steel (figure 3.11) was to be enabled by rollers on the blade stand and calibrator 
(BSC,). The calibration was to ensure accurate choice of sliced tissue thickness while the 
grooved plate is firmly affixed to an underlying platform to ensure uniformity of sliced tissue 
thickness along its entire length. Rollers, blade stand and calibrator, grooved plate and 
supporting platform would be non-compressible. 
The blade region was to be a thin (<0.25mm) segment that can be regularly re-sharpened or a 
disposable blade for safety reasons. A significantly sharp blade would produce a cut upon 
contact with biological tissue with minimal saw-like motion (which moves the soft tissue out 
of place. A protective sleeve (PS in figure 3.11) to which the blade is fixed was incorporated 
into the design for safe handling. PS would have a thinner segment which fits into calibration 
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groves to regulate thickness. The grooved plane, GP (in Figure 3.11) would have elevated 
vertical platforms that extend to one third the lower region of the blasé stand and calibrator, 
BSC in the same figure. These would support BSC bilaterally, guiding sliding movement 
during tissue cutting. BSC can be fitted with vertically oriented locks at grooved region to 
secure thinner segment of PS when in working position. This would prevent slipping of blade 
during cutting. 
A more cost-effective preliminary design (Figure 3.12) was however adopted with a 
compromise on automation of dissection. It consisted of a 1 mm groove created on the 
superior surface of the originally designed Teflon block to guide slicing of 1 mm thin tissues 
after downward fixing unto block. It was useful however in producing approximately 1.6 -2.3 
mm thick tissue slices. Due to this variation in thickness, Young modulus calculations were 
carried out for each sample. 
 
Figure 3.12: Slicing stage (final product). 
79 
 
The stage produced was a fixed polytetraflouroethylene (Teflon) block with moveable 
stainless steel clamps over a 1mm groove for mounting and slicing of tissue. A detachable 
front piece of Teflon block was anchored by a screw and used for additional tissue support. 
3.4.1.2.2 TISSUE SLICING PROTOCOLS 
Vaginal tissue segments were sliced using 2 methods to adapt the tissues to the ball 
indentation device. The first method was manual slicing of tissues at room temperature by 
placing tissues on slicing stage. This was an improvised technique developed using readily 
available instruments. Sliced adventitial layers of the tissues were mounted on the ball 
indentation sample holder and imaged as previously described (3.1.7, obtaining t0 and t24 
images (section 3.1.7), obtaining T0 and T24 images. The imaging of a ruler was also carried 
out alongside tissues to enable thickness determination (figure 3.13). Measurement of tissue 
deformation and thickness was performed using image J calibrated by the image of the ruler as 
the reference. 
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Figure 3.13:  Thickness measurement illustration on T0 and T24 images of sliced vaginal 
tissue layers using method 1. The imaged ruler alongside tissues has been illustrated. 
Each division in the ruler (left panel) was 1 mm. 
A second method of tissue slicing was developed to obtain thinner tissue slices. Whole tissue 
segments were mounted and secured on the slicing tool and the entire set up was kept at -80C 
for 30 minutes. Thereafter the system was removed and the slightly frozen, firm tissues were 
sliced, by first removing the epithelial layer and then the subsequent layers (figure 3.14).  
An optical coherence tomography instrument (OCT, section 3.2.7) was used for determination 
of the thickness of the tissue slices via obtained cross-sectional images as shown in figure 
3.15. Measurements were taken at 3 points on each image and the average obtained. 
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Figure 3.14: Slicing of slightly frozen tissue mounted on tissue stage using method 2. The 
short freezing resulted in easier slicing of tissues. 
 
Figure 3.15: OCT image of sliced tissue using method 2. The thickness of the resulting 
tissue slices were obtained from the OCT image. Scale bar = 250 µm. 
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3.4.1.3 CORRELATION CALCULATION OF GLYCATION MARKER AND TISSUE 
MECHANICS 
The creep and modulus of sliced prolapse tissue layers obtained as described above using ball 
indentation method were compared with known pentosidine content of the corresponding 
tissues by calculating the Pearson‘s r2 correlation coefficient. Mechanical data by slicing 
methods 1 and 2 have been calculated respectively. Human control samples were too small in 
size to obtain the mechanical measurement data for correlation coefficient calculation. 
3.4.2  NANOMECHANICAL MAPPING BY ATOMIC FORCE MICROSCOPY 
(PFNMAFM) 
5m thick cryosections of non-fixed prolapse and non-prolapsed vaginal tissues were 
obtained. With the use of routine laboratory protocols, contiguous sections of each tissue 
tested was stained with Haematoxylin-Eosin stains, imaged and used as pictographic guides 
for orientation of sections and location of LP zones for AFM imaging as shown in figure 3.16. 
Sample location was carefully selected and a photograph of the region obtained for reference 
as shown in figure 3.16. AFM testing occurred as previously described using the nominal 
radius silicon nitride tip and a 5 N/m spring constant for imaging. To observe tissue 
architecture at the micro level, 5 micron squared regions were sampled in the LP and 
adventitial zones of the tissues. Within each 5 micron area, three 1.4 micron areas were 
imaged to obtain a better view of the individual collagen fibrils. The elastic modulus for each 
imaged region of the samples was extracted using the Derjaguin–Muller–Toporov (DMT) 
model (194) to extract image raw mean from Nanoscope analysis software version 1.5.  
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Figure 3.16: Sample location images (top) and histological images (bottom) of tissues 
studied using AFM. Real time images of tissues being assessed with the AFM probe were 
compared with histological images of contiguous tissue sections. (bottom) H&E stained 
images of contiguous sections of tissues imaged with AFM 
3.4.3 OPTICAL COHERENCE ELASTOGRAPHY (OCE) 
Whole tissue segments of some prolapsed and control tissue sections were further imaged by 
OCE. OCE is a method for non-invasive cross sectional assessment of biological tissues and it 
is useful in the determination of thickness and mechanics of the tissue (195). It has been 
widely used in the study of body tissues such as skin, blood vessels and retina. OCE can 
distinguish between properties of a normal and diseased tissue. For example, it has been noted 
to reveal differences between normal and atherosclerotic tissue (189,195). It utilizes optical 
reflections of infrared lights from tissues to determine thickness and structural organization. 
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OCE is useful for both cross sectional imaging of biological tissues and non-destructive 
mechanical charactierisation (196). First introduced in 1988 by Schmitt, OCE utilizes tissue 
deformation or displacement to provide information on its stiffness (197). The displacement of 
the tissue in response to an internal or externally applied load gives information about its 
mechanical property (196). By utilising Phase resolved OCT detection which has resolutions 
in the Nano scale, OCE can accurately analyse and extract tissue deformation parameters to 
give information about its mechanical property with high accuracy (198).  
This part of the study was a collaborative research conducted in Prof. Huang‘s lab. in Dundee 
University following the same system set up described by Guan G et al (199). The OCE 
system comprised of a phase sensitive OCT (Ph-S-OCT) and vibration stimulation. Ph-S-OCT 
detected the vibration signal using a superluminiscent diode light source with a wavelength of 
~1310 nm and band width of ~85 nm. In vibration stimulation, an electromagnetic actuator 
driven by a sine-wave modulated signal was used. The driving voltage was 500mV, the 
sampling frequency was 46 Hz and the driving frequency was 8 kHz. ~1 μm actuator 
displacement was applied to the specimens. Light delivery to the specimens occured through 
an objective lens of of ~30mm. Axial and transverse resolution of the system were ~8.9 μm 
and ~15 μm in air respectively. The acquisition rate was ~46,800 A-scans/s. The OCT probe 
beam scanning was controlled by a software created using LabVIEW language. It performed 
512 repeat scans at 256 locations with repeated application of the stimulus to enable 2-D 
image acquisition, with a resulting B scan comprising of 512 × 256 A-scans. A total number of 
12 age-matched tissues (6 control and 6 prolapsed) tissues were studied. Control and prolapsed 
samples were imaged in air and immersed in 2% agar prepared at 29 
0
C and cooled to room 
temperature prior to imaging. Images of specimen set up were obtained for an understanding 
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of sample orientation during data interpretation. Data was processed as described by Guan G 
et al (199) and the 3D stiffness of each tissue was estimated. This was based on the rationale 
that the tissue vibration amplitude is related to the tensile strain and elasticity of the tissue and 
within the same tissue, the vibration amplitude varies with changes in regional strain. The 
stiffer the tissue, the less the displacement in relation to its original length (strain), whereas the 
softer tissues or softer regions of the same tissue would undergo more strain if the same stress 
was applied. The OCE hinges on the assumption that the same force is applied to an area. 
Therefore a relative modulus of the tissues can be obtained. To obtain absolute modulus 2% 
agar with a modulus of 193 kPa was used as the reference. 
3.5 MODEL STUDY OF THE EFFECT OF sGAG ON COLLAGEN 
FIBRILLOGENESIS  
3.5.1.1 COLLAGEN TURBIDITY ASSAY 
To study the effect of sGAG on collagen fibrillogenesis, 0.1 mg/ml, 0.2 mg/ml, 0.5 mg/ml 
type I collagen solutions were prepared with and without introduction of sGAG. Corning 
100mg Rat tail type I collagen stock solution (3 mg/mL), sterile 10X phosphate buffered saline 
(PBS), sterile distilled water (dH2O), and 1M NaOH were placed in an ice during the process. 
The volume of reagents required were calculated using the following formulas: 
Volume of collagen required (Va) =  
(Target concentration of collagen solution) × (Total Volume of collagen solution (Vt))  
Concentration of collagen stock solution 
Volume of 10X PBS needed (Vb) =  
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Total Volume of collagen solution (Vt)/ 
10  
Volume of 1N NaOH required(Vc) = (Va) × 0.025  
Volume of dH2O required(Vd) = (Vt) – (Va + Vb + Vc) 
dH2O, 1N NaOH, and 10X PBS were mixed in a sterile tube. Collagen was slowly pipetted 
into the tube, and then the solution was gently mixed. The resulting mixture was at a neutral 
pH. The collagen solutions were retained in 5 ml bijou tubes on ice for immediate introduction 
of sGAG. Chondroitin sulphate and over sulphated dermatan sulphate (purchased from Sigma 
Aldrich) was the sGAG used in the study. The physiologic ratio of sGAG to collagen was 
calculated to be 1:50 (165). To maintain near physiologic environment but allow for 
observation of changes where present, 200 m of collagen monomer solutions – controls and 
samples containing sGAG in the ratio 1:50 and 1:100 were transferred to a 96 well plate and 
induced to fibrilogenesis by incubating at 37
0
C. In order to track collagen fibrillogenesis in 
real time, optical densities of the samples in the well plates containing test and control samples 
were obtained by placing plates in a BioTek Synergy 2 multi-mode microplate reader  and 
obtaining readings at 560 nm. To achieve uninterrupted reading at 5 minute intervals, the 
Gen5 software was pre-set for a 96 well plate at 37
0
C in a 1 hour kinetic run with 5 minute 
intervals. 
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3.5.1.2  MORPHOLOGY OF COLLAGEN HYDROGEL BY LIGHT MICROSCOPY 
AND POLARISATION MICROSCOPY  
After collagen fibrillogenesis, samples with higher collagen concentrations were lyophilised, 
gold coated and imaged using SEM. Semi-solid gels, were frozen in optical cutting medium 
and cryosectioned to obtain 8-12 m sections on poly-L-lysine coated slides. Collagen 
solutions containing sGAG were stained for confirmation of the presence of sGAG using 
alcian blue staining process and subsequent sections stained for collagen using picrosirius red 
solution made from 0.5g of sirius red dye (Direct red 80, Sigma-Aldrich, UK) and 500 ml 
aqueous solution of picric acid (Sigma-Aldrich, UK). Acidified water was prepared by adding 
5ml of glacial acetic acid (Sigma-Aldrich, UK) to 1 liter of tap water. Formalin fixed tissue 
sections were rehydrated in ascending series of ethanol and immersed in picrosirius red 
solution for 1 hour. Tissues were rinsed in two changes of acidified water. Stained sections 
were imaged by light and polarization microscopy. 
3.5.1.3 SEM IMAGING OF COLLAGEN HYDROGELS 
Drying of the collagen hydrogels took place in a lyophilisation chamber with controlled 
release of pressure in chamber after sample drying. Samples were anchored to tubular stubs in 
a plastic pot with regulated air spaces prior to dehydration and gold coated as previously 
described in section 3.2.6 prior to imaging.  
3.6 STATISTICS 
Unpaired t-tests were performed for comparison of means between prolapsed and non-
prolapsed groups and pregnant and non-pregnant groups, after determination of data normality 
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using D‘Agostino and Pearson omnibus normality tests. Data have been expressed as mean 
and standard error of mean.  
For the prolpase study, Gpower 3.1.9.2 software was used for calculation of effect sizes from 
means and standard deviations of prolapsed and control groups and post hoc power calculated 
based on difference between two independent groups. To compare multiple groups a single 
factor ANOVA was performed at 95% confidence interval. A p-value below 0.05 indicated 
statistical significance. In the graphs, statistical significance has been indicated at three levels: 
*p ≤ 0.05, **p ≤ 0.01, and ***p ≤ 0.001 respectively. Standard error of the means were used 
to measure variability. Powers of 85% were obtained for comparison of data between 
prolapsed and control groups‘ pentosidine and the blood pressure study. Pearson‘s correlation 
coefficient was calculated for determination of relationship between prolpased vaginal tissue 
mechanical properties and pentosidine as well as vaginal and skin pentosidine.  
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4.1 GLYCATION, MECHANICS AND STRUCTURAL CHANGES OF NATIVE 
VAGINAL TISSUES IN PREGNANCY 
4.1.1 INTRODUCTION  
It is known that ageing is associated with increased tissue glycation where it alters the 
mechanical properties of the connective tissues, resulting in stiffer tissues and diseases such as 
atherosclerosis (12). Age-related pelvic floor disorders in women such as prolapse and urinary 
incontinence are more common after the menopause when oestrogen levels are low. Since 
oestrogen may influence amounts of old and new collagen in pelvic tissues, and older 
connective tissue contains more glycation products, oestrogen therefore has the potential to 
affect the mechanical properties of the tissue by altering glycation content. 
Pregnancy, marked with high levels of female hormones including oestrogen, confers unique 
alterations to the mechanical properties of pelvic connective tissues in order to meet the 
physiological performance. However, there are few studies on glycation content and its 
influence on the mechanical properties of pelvic connective tissues during pregnancy. It was 
hypothesized that a relationship exists between oestrogen, glycation content and mechanical 
properties of pelvic tissues. 
It is expected that the glycation content in pelvic tissues will change with a corresponding 
change in their mechanical properties, and that these changes are influenced by hormone 
levels. Currently few studies correlate hormone level and glycation content of pelvic tissues 
during pregnancy and reveal relevant mechanisms.  
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4.1.2 AIMS 
This study aimed to investigate the correlation of vaginal wall mechanical properties with 
glycation content during pregnancy, in association with the expression of a key pregnancy 
hormone (oestrogen) receptor, and an antioxidant enzyme, glyoxalase I and investigate the 
possible mechanisms for observed correlations, where present, by utilising multiple new 
approaches in a rat tissue model.  
4.1.3 METHODS 
Samples were obtained as described in 3.1.1. Morphological and mechanical assessments were 
carried out using histological staining techniques, SEM imaging, AFM analysis, OCT imaging 
and ball indentation testing as described in 3.2.6, 3.2.7, 3.2.8, 3.4.1 and 3.4.2 respectively. 
Pentosidine was detected and quantified in the tissues as described in 3.3.2 and 
immunostaining of the tissue sections was carried out as described in 3.3.4. 
4.1.4 RESULTS 
4.1.4.1 STRUCTURE AND ORGANIZATION OF NATIVE PREGNANT AND NON-
PREGNANT VAGINAL TISSUES 
4.1.4.1.1  H&E STAINING 
Three distinct zones were notable in the vaginal tissues from both groups as shown in figure 
4.1. The epithelial cells were spindle shaped particularly at the superficial regions and neatly 
and more compactly arranged in the non-pregnant vaginal wall but in the pregnant vagina, 
cells were arranged in multiple layers and appeared rounded and swollen with many detached 
and present in the luminal region. Nuclei of non-pregnant tissues were darker in contrast to 
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pale appearance of pregnant vaginal nuclei. In all zones of the tissues, spindle shaped cells 
were seen in the non-pregnant tissues but in the pregnant tissues a more rounded appearance is 
appreciable. Darker and denser tissue architecture is notable in the non-pregnant tissues in 
contrast to the pale, loose architecture of the pregnant tissue. Physiologic ruggae was present 
in the luminal surfaces of tissues from pregnant and non-pregnant groups. This however is 
more pronounced in the non-pregnant tissue with deeper or more compact folds.  
 
Figure 4.1: Representative H&E stained images of pregnant and non-pregnant rat 
vaginal wall. More compaction and staining is notable in the non-pregnant vaginal wall. 
4.1.4.1.2 SEM IMAGING 
Scanning electron microscope revealed further ultrastructural differences between the groups 
(figure 4.2). In the low magnification images, full-thickness segments of the vaginal walls 
were appreciable. These were wider in the pregnant tissues. Notable compaction was present 
in the epithelial regions of the non-pregnant tissues in contrast to the loose appearance of the 
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tissues in pregnancy. Higher magnifications of the lamina propria (LP) regions showed that 
cells were more abundant and arranged in close proximity to each other in the non-pregnant 
tissues. Epithelial regions of the pregnant rat were covered with randomly arranged and loose 
collagen fibrils. The muscularis and adventitial layers of the non-pregnant tissues displayed 
sheet-like appearance with apparently thinner fibrils. The sheet-like appreance or compaction 
was altered in the pregnant tissues and more detached collagen fibrils are present. They 
appeared swollen or wider and in spirals projecting out of intact bundles. 
 
Figure 4.2: Low and high magnification images of representative SEM images of 
pregnant and non-pregnant vaginal tissues. LP=Lamina Propria, M=muscularis, A= 
adventitia. Scale bar =2 m 
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4.1.4.1.3 AFM ANALYSIS 
Fibrils within the pregnant tissues appeared wider and merged as shown in the 2-D and ‗3-D‘ 
images (Figure 4.3). They also exhibited more frequent banding, in contrast to the distinctly 
separated fibrils of the tissues in the non-pregnant group. The average fibril diameter of tissues 
in the pregnant tissue was significantly greater than that of the non-pregnant group (Figure 
4.4). Fibrils of the tissues in the pregnant group appeared flatter and often merged to form 
wider ‗fibers‘ unlike the fibrils in the non-pregnant group, which had more separated 
individual collagen fibers as shown in figure 4.3. 
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Figure 4.3: AFM images showing collagen fibril morphology of pregnant and non-
pregnant vaginal tissues. Representative 2-dimensional (A and B) and 3-dimensional (C 
and D) images of collagen fibrils are shown. Blue arrows point to merged, wider collagen 
fibrils. 
 
Figure 4.4: Quantification of collagen fibril dimensions of pregnant and non-pregnant 
vaginal tissues through AFM images. The mean diameters of 15 collagen fibrils from 3 x 
1.4 m2 regions of 3 x 5 m thick sections have been analysed (n=3 per group). 
***P=0.000 
4.1.4.1.4 OCT IMAGING 
2-D images of cross sectional views of the tissues were obtained across selected areas from 
screen displays of the tissues (Figure 4.5). Some structural changes were appreciable using 
OCT (Figures 4.5 and 4.6). Non pregnant tissues exhibited more ruggae and increased opacity. 
Pregnant tissues were thicker and less opaque, with a well-hydrated appearance. Due to the 
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presence of ruggae, the thicknesses of the non-pregnant tissues were variable across the whole 
length unlike the more uniformly thick pregnant vaginal wall. 
 
Figure 4.5: OCT imaging of rat vaginal tissues. Red arrows in A and B (on screen visible 
images) show areas of cross sectional imaging to obtain images C and D (OCT images) 
from which thickness measurements can be obtained. Scale bar = 250m 
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Figure 4.6: Cross-sectional appearance and thickness of representative pregnant and 
non-pregnant vaginal tissues across longitudinal trough (Lt), longitudinal peak (Lp) and 
transverse areas (T) of the ruggae. Scale bar = 250m 
4.1.4.2 sGAG CONTENT  
4.1.4.2.1 sGAGs STAINING  BY ALCIAN BLUE 
sGAG staining of the vaginal tissues revealed higher staining intensity in the pregnant tissues 
than non-pregnant one (figure 4.7). The stain was confined to top and lower regions of the 
tissues with minimal stain taken up in the middle muscularis regions of the non-pregnant 
tissues. For the pregnant tissues, a more generalized staining was appreciable. This 
necessitated quantification of sGAG in the tissues. 
 
Figure 4.7: Alcian blue staining of pregnant and non-pregnant vaginal wall. 
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4.1.4.2.2 QUANTIFICATION OF sGAG BY DMMB ASSAY  
DMMB assay revealed that sGAG content was significantly higher in the tissues from 
pregnant rats (p=0.02) than in the non-pregnant (Figure 4.8) group with corresponding 
significantly higher water content in the tissues  from the pregnant rats (Figure 4.9).  
 
Figure 4.8: Glycosaminoglycan (sGAG) content per dry weight of pregnant and non-
pregnant rat vaginal tissues (n=3 per group). *P= 0.015 
 
Figure 4.9: Water content per dry weight of pregnant and non-pregnant rat vaginal 
tissues (n=3 per group). *P=0.047 
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4.1.4.3 PENTOSIDINE LEVELS 
Pentosidine contents per gram of the dry tissues for both groups are shown in Figure 4.10. 
Vaginal tissues from pregnant rats contained an average of 0.02 mg pentosidine per gram of 
tissue while tissues from non-pregnant rats contained 0.04 mg pentosidine per gram of tissue. 
These differences were found to be statistically significant (P = 0.04).  
 
Figure 4.10: AGE marker level measured by HPLC showing the pentosidine content of 
vaginal tissues from pregnant and non-pregnant rats (n=5 per group). *P=0.042 
4.1.4.4 CREEP BEHAVIOR AND CORRELATION WITH PENTOSIDINE 
Using the ball indentation technique, tissues were deformed over 24 hours with a constant 
weight. Significantly higher deformation was observed in tissues from pregnant rats (p=0.003) 
as compared with non-pregnant rats tissues (Figure 4.11). There was a negative correlation 
(r
2
= -0.50) noted between 24 hour creep and tissue pentosidine content of the same rats 
(Figure 4.12). 
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Figure 4.11: Mechanical property (24 hour creep) of intact vaginal tissue segments from 
pregnant and non-pregnant rats measured by the ball indentation technique (n=5 per 
group). *p=0.003 
 
Figure 4.12: Correlation between pentosidine and vaginal tissue creep (r2= -0.50) 
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4.1.4.5 VAGINAL TISSUE MODULUS AT THE NANOSCALE AND TISSUE LEVEL 
The ball indentation test results showed that approximately five times more deformation and 
200% percent lower apparent elastic modulus were observed for the pregnant rat vaginal 
tissues compared with non-pregnant rats vaginal tissues (Figure 4.13). Collagen fiber modulus 
have been determined by peakforce quantitative nanomechanical mapping AFM. The mapping 
images shown in Figure 4.14 demonstrated a trend towards a higher elastic modulus in non-
pregnant rats. By quantification of 15 fibers per image,  the nano-scale measurements showed 
distinct differences between the two groups (Figure 4.15). It is clear that these tissue-level 
mechanical properties were consistent with nanoscale elastic modulus measurements obtained 
with AFM.  
 
Figure 4.13: Mechanical property (Elastic modulus) of intact vaginal tissue segments 
from pregnant and non-pregnant rats measured by the ball indentation technique (n=5 
in each group), *P=0.047. 
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Figure 4.14: AFM measurement of mechanical property by peakforce quantitative 
nanomechanical mapping mode. Representative maps showing modulus range over a 1.4 
m2 area of vaginal tissue sections from pregnant (A) and non-pregnant (B) rats. The 
color bars alongside the images indicate the modulus values. 
 
Figure 4.15: Average modulus of collagen fibrils in the pregnant and non-pregnant 
vaginal tissues derived from mapping images shown in Figure 4.14. (n=3 per group, 
P=0.355) 
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4.1.4.6 OESTROGEN RECEPTOR AND GLYOXALASE EXPRESSION IN 
PREGNANT AND NON-PREGNANT VAGINAL TISSUES 
ER- and anti-oxidant enzyme, glyoxalase I expression in both tissue groups were determined 
by immunostaining assays as shown in Figures 4.16 and 4.17. Tissue sections from both 
groups were well nucleated as shown by DAPI staining in Figures 4.16 and 4.17 whilst the 
intranuclear oestrogen recptors were much more strongly expressed in the tissues from 
pregnant rats than the non-pregnant tissue (Figure 4.16). Location of glyoxalase I enzyme was 
predominantly sub-epithelial and more expressed in the tissues from pregnant rats (Figure 
4.17).  
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Figure 4.16: Immunostaining images of vaginal tissue sections showing representative 
images of ER- receptor expression; P: pregnant; NP: non-pregnant; Tritc (red): ER-a 
receptor; BF: bright field and Dapi (blue): nuclei. Scale bars = 50 m. 
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Figure 4.17:  Immunostaining images of vaginal tissue sections showing representative 
images of glyoxalase I expression. P: pregnant; NP: non-pregnant; FITC (green): 
glycoxalse-1; BF: bright field and Dapi (blue): nuclei. Scale bars = 50 m. 
4.1.5 DISCUSSION  
Studies on pregnancy induced changes in the middle and last two trimesters of pregnancy have 
mostly focused on cervical changes rather than the vaginal wall changes. This study revealed 
for the first time that a glycation product, pentosidine, was significantly reduced during 
pregnancy, a high oestrogen state; and that this reduction in glycation correlated with higher 
mechanical creep. Vaginal tissues in pregnancy also expressed higher levels of the antioxidant 
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enzyme, GLO-I, than did tissues from the non-pregnant rats. The higher creep behaviour of 
whole vaginal tissue segments in pregnant rats correlated inversely with their modulus and 
glycation content. Nano-scale examination of the collagen fibers in pregnant tissue by AFM 
supported the change in bulk mechanics. The morphology and chemical composition changes 
were observed as significantly thicker collagen fibril diameter and higher sGAG content in 
pregnant tissues. The regulatory relationship between oestrogen and glycation content in 
pregnancy was evidenced in this study. 
AGEs accumulate in tissues, typically increasing with age and causing connective tissue 
stiffening (14). Although AGEs are associated with many pathologic states, their accumulation 
within tissues is not always permanent. Macrophages within the body may bind to and 
scavenge AGEs (201). The high oestrogen state in pregnancy associated with reduced AGEs 
in the vaginal wall is congruent with other research. Previous findings have noted a decrease 
in skin autoflourescence (a reflection of advanced glycation) during pregnancy (202). A 50% 
reduction of pentosidine has also been observed in blood vessels under chronic oestradiol 
therapy (203). Oestrogen treatment of vascular endothelial cells reduced advanced glycation-
induced inflammation (204). This suggests on-going physiologic changes in pregnancy such as 
modifications of connective tissues by pregnancy-related hormones. Pregnancy or states of 
high oestrogen expression may therefore involve mechanisms resulting in AGE cleavage and 
reduced formation. Relationships between glycation products and stiffening of other body 
tissues such as tendon, intervertebral discs, skin and arteries have been studied but for the first 
time a relationship is demonstrated in vaginal tissues during the pregnancy (205–207). Other 
studies have similarly reported the association of high glycation with tissue stiffness 
(205,208). 
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By a constant load procedure a significantly higher creep and lower stiffness of pregnant 
vaginal tissues was observed in this study. This is congruent with previous studies. The 
fibromuscular vaginal wall has been previously noted to increase in circumference during 
pregnancy with apparent collagen reduction (4). The vaginal wall and supporting tissues are 
more distensible during pregnancy, with a decrease in stiffness, or modulus in preparation for 
delivery with minimal injury (1,2,4). Collagen fibrils within the vaginal wall also undergo 
progressive disorganisation and remodelling through the middle and later stages of pregnancy 
(48). Although there was associated apparent thickening of the collagen fibrils in this study, 
other research suggest that individual fibril diameter may not account for overall tissue 
modulus (209). Higher tissue modulus typically is the result of crosslinking between fibrils 
with both enzymatic and non-enzymatic (glycation) crosslinks and is reflected in increased 
stiffness of the collagen fibers and tissues (19). The significance of reduced glycation 
crosslinks observed in pregnant tissues may therefore be correlated with altered mechanical 
properties of the tissues - reduced stiffness and enhanced creep.  
Crosslink changes were unlikely to account for the increased collagen fibril diameter observed 
in pregnant tissues in our study, leading to consideration of another possible mechanism for 
the observed wider fibrils. Type I collagen fibrils could increase diameter by lateral fusion of 
fibrils, possibly aiding fiber performance at high strain (210). Our AFM images revealed 
collagen fibrils which appeared fused to form the wider fibrils. To further understand the 
observation, sGAG contents were measured and were notably higher in the pregnant rats‘ 
tissues. Previous studies have also noted a progressive increase in sGAG content of pelvic 
tissues during pregnancy and its loss at delivery (48,211). Certain proteoglycans also modulate 
fibrillogenesis and fiber alignment (212). Studies have shown that removal of sGAG results in 
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disorganization of collagen fibrils (213). sGAG present between collagen fibrils in connective 
tissues may aid their arrangement, resisting complete fiber disorganisation during stretching. 
sGAG influence collagen fibril association through methods other than direct chemical or 
physical crosslinking (27), causing apparent increased fiber diameter and resisting complete 
deformation during sliding. Thus, the higher expression of sGAG in pregnancy may serve as a 
protective measure during tissue stretching by preventing complete disorganisation of fibrils 
In pregnancy, oestrogen may influence tissue glycation by modulating the oxidative stress 
pathway. Glycation is associated with oxidative stress and reactive oxygen species have been 
shown to trigger AGE formation (214,215). Excessive production of reactive oxygen species 
within the mitochondria of cells inhibits glyceraldehyde-3-phosphate dehydrogenase and 
diverts substrates from glucose breakdown pathways to increased AGE formation (216). 
Oestrogen administration has been associated with reduced oxidative damage and glycation 
induced stress within connective tissues (203,217). Oestrogens cause increased expression and 
activity of antioxidant enzymes and their co-factors (218). Reduced oestrogen is associated 
with decreased amounts of the thiol antioxidant, gluthathione (GSH) which is reversed by 
oestrogen administration (218). Oestrogen also influences the gluthathione-dependent 
glyoxalase system through glyoxalase I which plays a role in the removal and prevention of 
AGEs accumulation by detoxification of methylglycoxal, a reactive dicarbonyl intermediate 
and AGE precursor (215,219). Deficiency in glyoxalase I enzyme has has been implicated in 
increased AGE accumulation within tissues (220). In our study, we noted increased expression 
of glyoxalase I enzyme in the tissues from pregnant rats similar to findings in other studies 
(221). A high oestrogen level is also associated with increased activity of gluthathione 
peroxidase, a potent antioxidant (222). This would lead to more removal of reactive oxygen 
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species and subsequent reduced glycation. Thus, in addition to on-going physiologic removal 
of AGE by macrophages within tissues (223,224), a decrease in glycation of tissues resulting 
in reduced formation of AGEs is expected. Therefore, states of higher oestrogen such as 
pregnancy or the proliferative phase of the female menstrual cycle would be associated with 
reduced AGEs through a proposed oestrogen-gluthathione-glyoxalase pathway as depicted in 
Figure 4.18.  
 
Figure 4.18: Illustration of AGEs formation inhibition by oestrogen. Oestrogen increases 
antioxidant enzyme (GLO-I) and co-factor (GSH). In the detoxification processes, 
intermediate AGE precursors e.g. methylglycoxal, are diverted to other pathways, 
leading to reduced AGE accumulation 
As a result, whilst oxidative stress promotes AGEs formation, oestrogen increases the activity 
of glyoxalase and GSH leading to stronger detoxification, production of lactoyleglutathione 
and decreased AGEs. This physiologic pathway would also be useful in understanding the 
pathogenesis of prolapse which occurs predominantly in older, menopausal women. During 
the years preceeding the menopause oestrogen levels decline and this may halt the process of 
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cyclical removal of AGEs which should occur during the normal reproductive life of the 
female. Progesterone is another significant hormone during pregnancy. However there is 
minimal evidence for its influence on AGEs. Further investigation on the effects of 
progesterone on glycation may however be useful in obtaining a more roboust understanding 
of the effect of pregnancy on AGEs in pelvic tissues. 
This study used a minimally destructive technique for assessment of vaginal tissue bulk 
mechanical property and employed the AFM technique for the study of collagen fiber 
mechanics and morphology. In this way, assessment of the global and nano-scale mechanical 
and structural properties of vaginal tissues was achieved. The findings from this animal model 
study sets a foundation for to the study of human samples.  
4.1.5.1 CONCLUSION  
There was a reduction in vaginal tissue pentosidine in pregnancy with an associated increase 
in oestrogen receptor and glyoxalase I immunoexpression. Reduced glycation was associated 
with increased creeping of vaginal tissues. Oestrogen may therefore play a role in the increase 
in of the vaginal wall‘s capacity to stretch through glyoxalase I up-regulation and subsequent 
glycation reduction. This new insight into the correlation of women‘s oestrogen level, 
glycation reaction and pelvic tissue mechanical property from this study may enhance our 
understanding on some pelvic organ diseases. 
This study is the first of its kind and highlights a relationship between mechanical changes 
observed in pregnancy and collagen fiber changes within the connective tissue. It confirmed 
that vaginal tissues in pregnancy contain lower levels of advanced glycation end products. 
Glycation reduction may contribute to the increased flexibility (high creep) of pregnant 
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vaginal tissues in association with increased sGAG levels and collagen fiber fusion. Pregnancy 
reduced vaginal wall glycation by increasing both the antioxidant enzyme, glyoxalase I, 
content and oestrogen. This is potentially is a major reason for the observed changes. These 
observations generate novel insights into other pathways for vaginal tissue mechanical 
changes during pregnancy and provide some evidence that the alteration of glyoxalase 
concentration by the elevation of oestrogen level correlates with a reduction in AGEs level and 
vaginal tissue flexibility. 
4.2 INFLUENCE OF SULPHATED GLYCOSAMINOGLYCANS ON COLLAGEN 
FIBRILLOGENESIS AND STRUCTURE- AN IN VITRO STUDY 
4.2.1 INTRODUCTION 
While functional adaptations of the vaginal wall in pregnancy have been extensively studied, 
few studies have investigated ultrastuctural changes (13,48). Although, the focus has been on 
cervical changes in pregnancy and parturition the vaginal wall plays a significant role in 
vaginal delivery (13,48,188,225). Collagen is the major structural protein in body tissues (226) 
and sulphated glycosaminoglycans (sGAG) are  ECM components notable for their role in 
collagen formation (27,227). It is therefore useful to study the role of sGAG in vaginal tissue 
adaptation during pregnancy in order to gain deeper insight into ultrastructural changes of the 
tissue.  
Commonly employed tissue engineering techniques such as collagen solution and gel 
synthesis are useful methods in the preliminary study of diseases and physiologic processes 
(228). The relative ease of producing a-cellular engineered collagen scaffolds in the laboratory 
in comparison to obtaining and investigating human or animal tissues with associated ethical 
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requirements (229) favours the use of engineered collagen gels for preliminary studies. In 
addition, the pH and temperature regulated trigger of collagen fibril formation enables real 
time observation or tracking of the simulated biological processes (226). At an alkaline or 
neutral pH or warm temperature, collagen monomers are induced to polymerize by a 
―nucleation‖ and elongation process. Collagen gels are used in 3-D cultures, with or without 
the introduction of cells to simulate the native tissue environment, in near physiologic studies 
with remarkable success in the understanding of normal biology and disease pathology (230). 
It was therefore hypothesized that an in vitro collagen fibrillogensis model would be useful in 
understanding ultrastructural changes of the vagina wall in pregnancy.  
4.2.2 AIMS 
In 4.1., pregnancy induced changes in the ultrastructure of vaginal tissue and sGAG content of 
the native tissues were investigated. Although the findings strongly suggest that sGAG are 
responsible for the merging of the collagen fibrils observed in tissues from the pregnant 
vagina, they do not permit real-time observations of the process. This necessitated a study to 
investigate collagen fibrillogenesis in the presence of sGAG in real time for comparisons with 
observations in native vaginal tissues. The aim was to investigate the effect of the sGAG, 
Dermatan Sulfate on Type I collagen fibrillogenesis and ultrastructure for a better 
understanding of findings in 4.1. A further aim was to assess the effectiveness of a commonly 
used tissue engineering technique of collagen fibrillogensis in replicating changes seen in 
native tissues as a step towards future application of tissue engineering methods in the study of 
pelvic tissues.  
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4.2.3 METHODS 
Collagen gels of 0.1 mg/ml, 0.2mg/ml and 0.5 mg/ml concentrations were formed in the 
presence and absence of the sGAG, dermatan sulphate and oversulphated chondroitin sulphate. 
The process was tracked by monitoring the optical densities (OD) of the solutions in real time. 
The materials and methods used have been described in detail in 3.5. 
4.2.4 RESULTS 
4.2.4.1 ASSESSMENT OF FIBRILLOGENESIS BY TURBIDITY ASSAY 
Through turbidity assay, real-time measurements of the optical densities (ODs) of formed 
collagen fibrils were obtained via regular tracking of ODs of the collagen monomer solutions 
during and after fibrillogenesis in a microplate reader. The OD values at the given incubation 
time and rate of change of OD during the incubation period are the two important parameters 
that indirectly reveal fibrillogenesis rate and fibrils‘ morphology. A consistent effect of sGAG 
on OD of polymerizing and final polymerized collagen hydrogel was noted as shown in Figure 
4.19. Collagen gels without sGAG demonstrated higher turbidity during formation and also 
after completion of fibrillogenesis compared to test samples containing sGAG. The OD values 
were higher when collagen concentration was higher. There was a rapid OD value increase 
during the first 15 minutes of incubation then plateau was attained. A more gradual rate of 
change of OD was observable in less concentrated collagen solutions (0.1 and 0.2 mg/ml) in 
comparison to higher concentrations. The addition of the sGAG appeared to reduce the 
turbidity of formed fibrils. Both rate of change of ODs and ODs of final gel was less for 0.1 
mg/ml, 0.2mg/ml and 0.5 mg/ml solutions containing the sGAG. The OD of the formed 
collagen polymer solution was also influenced by the concentration of the monomer solution. 
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The higher the collagen concentration of the solution, the higher the rate of polymerization and 
final OD of the resulting gel (red line graphs compared from top to bottom in figure 4.19). At 
the near physiologic ratio of 1:50 sGAG to collagen ratio, a similar finding was noted (blue 
line graphs in sGAG ratio 1:50 from top to bottom). The higher ratio of sGAG (1:50) led to 
lower rate of fibrillogensis and lower final OD at 0.1mg/ml and 0.2 mg/ml concentrations 
(blue line graphs compared from left to right in figure 4.19). When sGAG was maintained at a 
steady concentration but collagen concentration was increased, the rate of fibrillogensis and 
final OD was increased with higher collagen concentrations but still attenuated by sGAG (blue 
line graphs from top to bottom in figure 4.19). This was clearly observed at sGAG ration 1:50 
but not 1:100.  
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Figure 4.19: Turbidity assay results showing effects of sGAG and collagen concentration 
on collagen fibrillogenesis in real time. Results from collagen solutions of 0.1 mg/ml, 0.2 
mg/ml and 0.5 mg/ml are shown. Time interval = 5 minutes 
4.2.4.2 Assessment of fibril morphology by light and polarised microscopy  
Light microscopy images of polymerized fibrils revealed loose, ―cotton wool-like‖ fibrils 
formed in the absence of sGAG as shown in figure 4.20. Fibrils formed in the presence of 
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sGAG were more defined, compact in appearance and took up more picrosirus red stain 
(Figure 4.20).  
 
Figure 4.20: Light microscopy images of type I collagen fibers (1mg/ml collagen solution) 
formed in the absence (A) and presence (B) of sGAG (ratio 1:50). Arrows show collagen 
fibrils. 
Further investigation using polarised microscopy confirmed that fibrils formed in the presence 
of sGAG were more compact as shown in Figure 4.21. In such images there were more fibrils 
per visualised area, suggestive of bundling. These changes were more appreciable in the 
polarised images than in the bright field images stained with picrosirus red only. Polarisation 
images only revealed polymerised collagen in contrast to the light picrosirus red stained 
images in which collagen monomers were visibly stained. Quantitative assessment (Figure 
4.22) revealed significantly more (p=0.00) fibrils per unit area in samples formed with sGAG 
compared to controls.  
117 
 
 
Figure 4.21: Polarisation microscopy imaging of the polymerized type I collagen fibrils 
(from 1 mg/ml solutions) formed in the presence and absence of sGAG (ratio 1:50). 
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Figure 4.22: Clustering of type 1 collagen fibrils formed in the presence and absence of 
sGAG (n=6 per group) by quantification of fibril per unit area. ***P=0.00 
4.2.4.3 Assessment of fibril morphology by SEM 
SEM imaging revealed fibril interaction at the micron level and merged fiber diameter. There 
were aggregations of collagen fibrils and more obvious merging of fibers formed in the 
presence of sGAG leading to larger fiber bundles (Figure 4.23).  
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Figure 4.23: SEM images of polymerized type I collagen fibers obtained in the presence 
and absence of sGAG. 
 
4.2.5 DISCUSSION 
OD of a solution indicates its ability to absorb light or prevent its transmission. This property 
has been used to assess polymerizing collagen solutions to observe the kinetics of collagen 
fibrillogenesis (231) with the use of SEM and confocal reflectance microscopy to study the 
nature of formed fibrils (232). In collagen fibrillogenesis, the OD may be influenced by the 
collagen fibril diameter (233). As a result, lower concentrations of collagen solutions with 
soluble monomers have lower optical densities. In collagen fibrillogenesis the rising OD is a 
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reflection of the rate of fibril formation (226). Particle size can also affect the OD of a solution 
in an opposite way. When the particle size is significantly larger than the wavelength, there is 
less scattering of light, improved transmission of light and a consequent reduction in OD of 
the solution. 
In the present study, the kinetics of type I collagen fibrillogensis has been assessed by OD 
monitoring in real time and the appearance of resulting fibrils as well as the effect of sGAG 
has been studied using light microscopy and SEM. Both light microscopy and polarization 
microscopy of picrosirus red stained images revealed compacting and definition of collagen 
fibers formed in the presence of sGAG. Qualitative assessment of the SEM images also 
revealed thicker, more aggregated fibers formed in the presence of sGAG. DS has been found 
to increase collagen fibril aggregation and bundling in other experiments (28). The OD of 
resulting polymerised type I collagen solutions were noted to decreased in the presence of the 
sGAG suggesting slower rate of type I collagen polymerisation in the presence of sGAG and 
wider, more light transmitting fibers formed. An initial lag phase at all concentrations in the 
presence of sGAG and significantly lower OD of 0.1 mg/ml solutions formed in the presence 
of sGAG was noted in the present study. Slower polymerization of collagen solutions formed 
in the presence of sGAG may have led to more soluble collagen monomers present per time 
and consequently lower OD. Collagen solutions formed from lower monomer concentrations 
also had lower ODs. With less collagen monomer concentration, the total number of insoluble 
fibers may be further reduced in the presence of sGAG, which causes fibril aggregation. These 
findings suggest that the rate of fibrillogenesis was influenced by interference from the sGAG 
(227) in a dose dependent manner and this effect was more pronounced at lower collagen 
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concentrations.  At lower concentrations of collagen monomer solutions, a longer time is 
required for contact and interaction for fibril formation.  
A study on the effect of chondroitin sulphate on fibrillogenesis of type II collagen revealed a 
pH dependent effect with a decrease in rate of fibrillogenesis at pH 7.3. Previous experiments 
by Reese et al (28), have shown that DS has a dose-dependent effect on collagen fibrilogensis 
resulting in both reduction of the rate of reaction and turbidity of  the final product. The 
change in fiber organization as a result of DS results in a decrease in turbidity of gels. Paderei 
et al (227) observed a dose-dependent delay in fibrillogenesis of type I collagen in the 
presence of DS. This was attributed to interference caused by interaction of the sGAG with the 
collagen monomers during polymerization. Such interference, though present in vivo, may be 
modulated by other factors influencing collagen fibrillogenesis.  
The present research has demonstrated effects of DS and chondroitin sulphate but decorin is 
also critical in collagen firbillogensis in vivo (234). Other  minor collagen types, fibronectin, 
integrins, also modulate collagen fibrillogensis (235). This study is therefore not an exact 
picture of the native process of type I collagen fibrillogensis but demonstrates the usefulness 
of collagen models in studying the role of sGAG in collagen fibrillogenesis and ultrastructural 
formation the findings are better understood in the context of the previous study in 4.1, 
corroborating the effect of sGAG on native vaginal tissue ultrastructure in pregnancy. 
It was also observed that even at low collagen concentrations, formed collagen fibers can be 
visualized inexpensively under light microscopes. We have further demonstrated the 
usefulness of polarization microscopy in studying the effect of sGAG on fibrillogenesis. 
Individual fibrils were not visualized under light (polarised and bright field) microscopy but 
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fibers were appreciable, sGAG resulted in the formation thicker fibers with better polarisation 
and spatial organisation which led to their visualisation under polarised light.  
The merging or tendency towards collagen fiber bundling notable in the presence of sGAG is 
similar to observations seen in native collagen tissues in the vaginal wall of pregnant rats 
containing higher amounts of sGAG as detailed in 4.1.4.1.3 and 4.1.4.2. This confirms a role 
of sGAG in ultrastructural arrangement of connective tissues and an influence on pregnancy 
related vaginal tissue adaptation. 
4.2.6 CONCLUSION 
The sGAG-collagen model was useful in demonstrating the effect of sGAG on collagen 
fibrillogensis in vitro, with results that mirror observations in the native tissue. sGAGs 
influence collagen fibrillogenesis in vitro. They may lead to clumping or apparent aggregation 
to form thicker fibers. The degree of influence of sGAGs on collagen fibrillogenesis is 
influenced by the concentration of the sGAG and the collagen solution. Observations of the 
effects of sGAG in vitro mirror observations in native vaginal tissues, with the added 
advantage of real time tracking. This study therefore also illustrates the relevance of in vitro 
tissue engineering studies in understanding in vivo processes. This model scan be considerably 
improved by clearly defining individual fiber dimensions for quantitative analysis and this 
might be more readily achieved with instruments such as the environmental SEM (236). 
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4.3 THE CORRELATION OF GLYCATION CONTENT IN THE SKIN AND 
VAGINAL TISSUE IN PREGNANCY  
4.3.1  INTRODUCTION  
The elevation of advanced glycation content in the vaginal wall in prolapsed tissues makes 
advanced glycation a significant association with the disease. Early detection of vaginal wall 
glycation could therefore be relevant in the prevention and management of prolapse. A vaginal 
wall biopsy to detect this would be ideal, but is invasive. Therefore the use of a more 
accessible organ, such as skin, would be beneficial. Our previous study suggests that 
conditions such as pregnancy, can induce a change in the vaginal tissues‘ glycation content 
(237).  
There are currently no predictive tools for prolapse. The most common diagnostic techniques 
are based on physical pelvic examination (79,80,86,87). Due to the personal and private nature 
of pelvic problems and symptoms, diagnosis of prolapse often occurs when sufferers present 
with symptoms. As a result, more women have clinically evident prolapse than actually 
present with symptoms to their health care provider (79). 
The consistent findings of higher vaginal wall glycation in women with prolapse in previous 
studies (8,23) suggest that the identification of vaginal wall glycation may be a useful tool for 
prediction, diagnosis and further management of prolapse. Vaginal tissue is poorly accessible 
and obtaining a vaginal biopsy is invasive and inconvenient for patients. The skin, on the 
contrary, is easily accessible and skin fluorescence can be measured non-invasively to reflect 
its advanced glycation levels (202). Since ageing is a generalized body process, it is expected 
that the various processes involved in ageing such as advanced glycation should occur at 
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similar rates in different body tissues. We therefore hypothesize that skin glycation would 
predict vaginal tissue glycation.  
4.3.2 AIM 
The aim of this study was to assess whether the skin glycation undergoes similar changes as 
observed in vaginal tissue glycation in the same subjects in order to evaluate the hypothesis 
that skin glycation would predict vaginal tissue glycation. 
4.3.3 METHODS 
Vaginal and skin tissues were obtained as described in 3.1.1 and pentosidine detection and 
quantification was carried out as described in 3.3.2.  
4.3.4 RESULTS 
The average skin pentosidine was obtained per gram dry tissue. Figure 4.24 shows that the 
average amounts of pentosidine were 0.007 mg/g and 0.014 mg/g in the pregnant and non-
pregnant skin tissues respectively. There was minimal variability within groups and the 
difference was significant (p = 0.0002). 
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Figure 4.24: AGE marker (pentosidine) level measured via HPLC in pregnant (n=5) and 
non-pregnant (n=5) skin tissues. ***P=0.000. 
Pentosidine in non-pregnant rat vaginal tissues was also significantly higher than in pregnant 
rat vaginal tissues (P=0.042) as shown in Figure 4.9, section 4.1.6. Although pentosidine 
levels in the skin were less than in the vaginal tissues, the pregnancy associated difference was 
more notable in the skin than in vaginal tissues. Pentosidine was higher in the vaginal tissue 
than in the skin of the same rats. Raised vaginal pentosidine was associated with raised skin 
pentosidine. A strong correlation (R
2
= 0.847) was present between the pentosidine content of 
vaginal and skin tissues of the same rats (Figure 4.25). 
 
**
* 
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Figure 4.25: Correlation between Skin and vaginal tissue pentosidine. R
2
=0.847 
4.3.5 DISCUSSION  
Advanced glycation is a cause of ageing that has gained significant attention in recent times 
(8). Glycation considerably affects the skin. It results in increased skin stiffness, decreased 
elasticity and higher resistance to MMP enzyme degradation (10) that enables connective 
tissue remodeling. Glycation induces inflammatory responses intracellularly and 
extracellularly (2). Advanced glycation end products can initiate DNA damage and stimulate 
cellular injury through their receptors; these are called the Receptor of Advanced Glycation 
End products, (RAGE) (11). 
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Ageing increases advanced glycation in body continuously. Other conditions can regulate 
glycation content of body tissues. For example, advanced glycation is facilitated by oxidative 
stress (201). As a result, increased oxidative stress such as occurs as a result of cigarette 
smoking and inflammation leads to highly glycation content (238). On the contrary, elevation 
of the female hormone, oestrogen causes the up-regulation of several antioxidants including a 
glycation reducing antioxidant, glyoxalase I. As a result, a lower glycation content has been 
observed in pregnant vaginal tissues in a rat model (237). Furthermore, it has been previously 
shown that skin glycation is lower during pregnancy (202). It is therefore expected that skin 
glycation would correlate with vaginal tissue glycation of the same animals because it is 
expected that hormone induced changes in vaginal wall glycation should be reflected in the 
skin in the same pregnant and non-pregnant states.  
 
In this study, glycation was lower in the skin during pregnancy. This is congruent with a 
previous study noting reduced skin glycation-induced autoflourescence in pregnancy (202) 
and corroborates the tested hypothesis. An implication is that skin glycation assessment in 
women would be useful in the management of women with prolapse and a relevant predictive 
tool which may allow future prevention. 
 
Recently, vaginal tissue glycation was noted to be lower in pregnancy through influences on 
ER- and glyoxalase I, an AGE lowering antioxidant (237). Another study observed reduced 
glycation in vaginal tissues under oestrogen therapy (41). Oestrogen has also been found to 
influence blood vessel glycation. These, in conjunction with the present finding of reduced 
skin glycation in pregnancy suggest that pregnancy effects on glycation may be reflected in 
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multiple body tissues and organs. The observation of known glycation-associated illnesses 
should warrant checks for other conditions.  
 
A positive relationship between vaginal and skin tissue glycation content was also noted in 
this study and supports the hypothesis that skin glycation reflects vaginal tissue glycation 
level. Advanced glycation content has been studied in different tissues in the body because it 
is believed to be global phenomenon occurring at reasonably similar rates in various sites of 
the body. Animal studies and human clinical trials have confirmed changes in advanced 
glycation content in other body tissues to be reflected in the skin (239–241). Mikulikova et al 
quantified pentosidine in tissues from rats with high fructose intake and found that pentosidine 
accumulation increased in tendon, skin and aorta occurred at different rates, with pentosidine 
increasing more in the skin and aorta than in tendons when 10% fructose was given (239). 
Skin advanced glycation level has been used to predict advanced glycation associated diseases 
in other tissues such as the retina and cardiovascular system (240–242) however no previous 
study has correlated advanced glycation levels between skin and vaginal tissues. We 
investigated glycation levels of vaginal and skin tissues in pregnancy, a physiological process, 
and found correlation between the collagen altering glycation product, pentosidine in both 
tissues in the same rats, implying that collagen changes in connective tissues across the whole 
body may provide vital information for physiological and pathological processes. The 
correlation of glycation products in skin and other tissues, and the ease of access of skin for 
sampling or biopsy, lays a foundation for future studies on the predictive value of skin 
glycation in relation to vaginal tissue glycation, and thus its potential role in the investigation, 
prevention and management of glycation related gynecological diseases. Our hypothesis is 
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also supported by a recent study which revealed that ultra-structural collagen changes in the 
skin of women with prolapse correlated with changes in pelvic tissues of the same women 
(243). 
 
Further studies are required to determine whether the correlation of advanced glycation levels 
in skin and vaginal tissue are observed in human subjects during physiological and 
pathological processes. Furthermore, in pathological cases, it is important to note that changes 
in collagen metabolism may be the result or cause of a disease. For example, in prolapse, the 
alteration of collagen metabolism in the vaginal wall may be a result of prior tissue weakening 
or stretching but not necessarily the cause of the prolapse (244). In such a condition, collagen 
metabolism alterations or glycation levels may be more expressed locally in the vaginal wall 
than in skin tissues. 
4.3.6 CONCLUSION 
Our animal model study reveals that skin glycation correlates with vaginal wall glycation as 
both tissues respond similarly to a state of elevated oestrogen. This, in addition to previous 
literature demonstrating similar changes within the skin in response to changes in levels of the 
hormone, strongly suggests that skin glycation is reflective of vaginal tissue glycation, which 
is implicated in pelvic floor disorders. Skin glycation is a potentially useful marker in the 
prediction and diagnosis of glycation-associated pelvic floor diseases, with a view towards 
promoting preventive lifestyle. This understanding should guide future screening tests for 
early detection of detrimental levels of ageing in the vagina tissue. 
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5 CHAPTER 5: GLYCATION CHANGES OF VAGINAL 
TISSUES IN PROLAPSE IN RELATION TO KNOWN AND 
POTENTIAL RISK FACTORS 
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5.1.1  INTRODUCTION 
Despite the high and increasing prevalence of prolapse in women, its aetiology and 
progression is unclear (8). There is no known cause of prolapse although several factors are 
implicated in its development. Common associations are vaginal delivery, particularly 
instrumental delivery, multiparity, obesity, elevated intra-abdominal pressure in conditions 
such as chronic straining and obstructive lung disease (6,104). Genetic and familial association 
of prolapse are also present, as is there the risk of occurrence in individuals whose first degree 
relatives are affected (99).  
Ageing is also linked with prolapse development since its prevalence has been noted to 
increase with age (6). The association of age with prolapse has gained more attention in recent 
times as advanced glycation products are found to be present in higher amounts in prolapsed 
pelvic tissues (8,23). Advanced glycation is linked with chronological ageing and some 
endocrine and cardiovascular diseases (55,57,214). The difficulty in breaking down glycated 
proteins over time, results in the accumulation of such older proteins within the tissues and an 
ultimately mechanically altered connective tissue matrix. This change in connective tissue 
breakdown fostered by advanced glycation accumulation may be useful in understanding 
prolapse development. The physical and chemical properties of connective tissues are 
influenced by AGEs. AGEs have been associated with decreased cell proliferation, cell death, 
oxidative stress and inflammation (245). AGEs and AGEs receptors (RAGE) and the RAGE 
gene SNP change the metabolism of collagen and this leads to many disease states and ageing 
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of the body (246). RAGE triggers signal transduction for AGEs, cascading several signals 
including inflammation (57).  
Glycation results in accumulation of older collagen. On the contrary, oestrogen treatment 
influences pelvic tissue collagen metabolism causing neosynthesis of collagen (23,41). Older, 
glycated collagen also may be difficult to degrade leading to retained changes in the pelvic 
tissues‘ mechanical property but factors influencing the accumulation of AGEs in the 
prolapsed tissues have not been well investigated. Although AGEs are known to be higher in 
prolapsed tissues with an influence on the tissues‘ mechanical properties by a possible effect 
on accumulation of old, MMP-resistant collagen and preferential degradation of newer 
collagen (23), the question of ―cause or effect‖ still boggles the minds of many stakeholders. 
An understanding of previously poorly recognized glycation associations, its mode of 
glycation accumulation within prolapsed tissues and glycation associations (risks or habits) is 
required to better predict and prevent prolapse. In addition this would improve understanding 
of the role of glycation in prolapse development.  
5.2  AIMS 
The research in this chapter was aimed at investigating glycation changes in human prolapsed 
tissues in association with known and potential risk factors, such as age, hypertension, 
smoking, cholesterol level and diabetes, oestrogen changes and antioxidant enzyme level in 
the vaginal wall to understand glycation accumulation in the tissues. A further aim was to 
understand how glycation accumulates in tissues potentially leading to prolapse by studying 
the relationship between and glycation changes, ER- expression and the expression of a 
glycation lowering antioxidant, GLO-I, within the tissues. 
133 
 
5.3 METHODS 
To obtain human tissues for study, ethical approval was sought as described in 3.1.2. 
Participant recruitment and categorization based on data characteristics were subsequently 
carried out as described in 3.1.2. ER-, and GLO-I immunostaining were performed as 
described in 3.3.4. Pentosidine quantification and validation tests were perfomed as described 
in 3.3.2.  
5.4 RESULTS 
5.4.1 VALIDATION TESTS FOR TISSUE STORAGE AND DRYING METHOD  
To assess the reliability of pentosidine values obtained for each tissue piece, pentosidine was 
quantified for the different non-contiguous locations of the same tissue. There was no 
significant difference in pentosidine content of the different locations (A, B, C) of the same 
tissue piece as shown in table 5.1 (p=0.97). For the same tissue, the calculated maximum 
variation in pentosidine value was 0.001 mg/g. 
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Table 5.1: Pentosidine content of prolapsed samples from different non-contiguous tissue 
regions (p=0.97) 
 
 
 
 
 
 
 
Pentosidine amounts were assessed for the same tissues before and after storage at -20 
0
C. 
Although, post storage was slight lowering of pentosidine content, the difference was notably 
non-significant (p=0.97). The average standard deviation and standard errors of mean were 
0.002 and 0.001 respectively and the maximum variation in reading was 0.003 as shown in 
table 5.2. 
 
 
 
 
Sample 
ID 
location 
A 
location 
B 
location 
C 
Average Standard 
deviation 
Standard 
error of 
mean 
H18 0.024 0.022 0.023 0.023 0.001 0.00056 
H32 0.021 0.021 0.02 0.021 0.0006 0.00033 
H30 0.016 0.014 0.015 0.015 0.001 0.00058 
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Table 5.2: Pentosidine content of the same tissues before and after storage at -20
0
C 
(p=0.97) 
Sample ID Before storage After storage Standard 
deviation 
Standard error 
of mean 
H36 0.013 0.012 0.0007 0.0005 
H40 0.022 0.025 0.0021 0.0015 
H26 0.031 0.028 0.0021 0.0015 
  Average 0.0016 0.0011 
 
Freeze drying was compared with drying samples at 60
0
C (table 5.3). Following oven drying, 
pentosidine content of the tissue was the same or slightly increased. The difference was non-
significant. The average standard deviation and standard error of mean were 0.003 and 0.002 
respectively. 
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 Table 5.3: Pentosidine content of the same tissues dried at 60
0
C in an oven or 
lyophilisation overnight. (p=0.66) 
 
 
5.4.2 OVERVIEW OF RECRITUTED PATIENT CHARACTERISTICS  
A total of 65 samples (49 prolapse, 16 controls) were studied (table 5.4). These were taken 
from women within the ages 41-91. There was a normal distribution of age. The modal 
numbers were 6, 12, 28, 15, 3 and 1 in the age groups 40-49, 50-59, 60-69, 70-79, 80-89 and 
90-99 respectively (Table 5.4). Comparisons in pentosidine were therefore made using age 
groups containing 3 or more n number. The average, mode and median ages of the total 
population studied were 64.8, 67.0 and 64.0 respectively. The average ages of women in the 
prolapse and control groups were 57.82 and 66.65, respectively (Figure 5.1). There was less 
variation in age in women with prolapse compared with controls (standard error of mean of 
2.89 and 1.21 respectively). 
 
Sample ID 60 degree oven Freeze drying Standard 
deviation 
Standard error 
of mean 
H39 0.025 0.029 0.003 0.002 
H38 0.017 0.014 0.002 0.001 
H21 0.033 0.023 0.007 0.005 
  Average 0.004 0.003 
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Table 5.4: Table showing the age distribution within the prolapse, control and entire 
study population 
 Control Prolapse Total population 
Age groups Number (% of 
total) 
Number (% of total) Number (% of total) 
40-49 5(83.33) 1(16.67) 6 (9.23) 
50-59 4(33.33) 8(66.67) 12(18.46) 
60-69 5(17.86) 23(82.14) 28(43.07) 
70-79 2(14.29) 12(85.71) 15(23.07) 
80-89 0(0) 3(6.12) 3(4.6) 
90-99 0(0) 1(2.04) 1(1.53) 
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Figure 5.1: Average age of women studied in control (n=16) and prolapsed (n=49) 
groups. 
The mean parity was 2.46 in the entire population studied and 2.3 and 2.5 in control and 
prolapse groups respectively (figure 5.2). Most women were parous but two women with 
prolapse had never been pregnant (Table 5.5). 2 women with prolapse and one woman without 
prolapse had parity of 0. The highest recorded parity in control group was 4 and in prolapse 
group, 6. 
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Figure 5.2: Parity in prolapsed (n=49), control groups (n=16) and total population (n=65) 
studied. 
Table 5.5: The number of women with parities of 0-6 in both groups 
Parity Control Prolapse 
P0 1 2 
P1 0 4 
P2 9 13 
P3 0 17 
P4 5 6 
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P5 0 1 
P6 0 3 
No response 0 3 
 
The predominant mode of delivery was vaginal delivery with 92% of the women having 
vaginal deliveries. This included 82.5% of the control population and 96.8% of women with 
prolapse. Of the control group, two women (5%) and 5 women with prolapse (4.6%) had at 
least one pregnancy with assisted delivery using forceps, ventouse or caesarean section (Table 
5.6). Although the incidence of assisted delivery was low, the use of forceps or the 
performance of caesarean section was more likely than ventuose use.  
12.5% and 10.2% of the control and prolapsed groups had taken HRT for at least five years 
(Table 5.6). Although none of the women in the control group had previous hysterectomies or 
removal of their ovaries, 32.6% of women with prolapse had reported prior hysterectomies and 
a quarter of these had associated oophorectomies. The commonest type of prolapse in this 
group was anterior prolapse (cystocele) with 67.34% of the women with prolapse presenting 
with this kind of prolapse. Rectocele was commoner than uterine prolapse. As expected, the 
most common group of symptoms were urinary symptoms. The most common complaint was 
a feeling of fullness within the vagina, a sensation of a lump in the vagina or a visible bulge 
from the vagina. Some women also experienced lower back or pelvic pain, and vaginal 
soreness and dryness. Grades II and III prolapse were more common than grades I and IV. Ten 
of the 49 women with prolapse had had previous surgery for prolapse resulting in a prolapse 
recurrence rate in the population studies of 20.4% as shown in Table 5.6. 
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There were a number of co-morbidities present in the population studied, predominantly 
cardiovascular problems such as elevated blood pressure. Thirty two women, representing 
47.69% of the study population had hypertension as a co-morbidity. Of these 23 (74.19%) had 
prolapse and 7 (25.8%) were controls. 43.75% and 51.02% of the control group and women 
with prolapse had been diagnosed with hypertension. There was a lower prevalence of 
diabetes mellitus in the groups with 12.5% and 10.2% of the control and prolapsed groups 
having co-existing diabetes mellitus. More women with prolapse (40.8%) had co-existing 
diagnosis of elevated cholesterol than the control group (12.5%). 
Table 5.6: Overview of participant characteristics in prolapsed and control groups. 
CHARACTERISTICS Sub classification Control Prolapse 
Mode of delivery, n 
(%) 
Normal vaginal delivery 
Cesarean section 
Forceps delivery 
Ventuosse 
15 (94.1) 
0(0) 
1 (5.9) 
0(0) 
46(94.0) 
1 (0.5) 
1 (0.5) 
1(0.5) 
 
HRT, n (%) HRT 
No HRT 
2 (12.5) 
14 (87.5) 
5(10.2) 
44(89.8) 
Hypertension, n (%) Hypertensive 
Non-hypertensive 
7(43.7) 
9(56.3) 
25(51.02) 
24(49.0) 
Smoking, n (%s) Smokers 
Non-smokers 
2(12.5) 
14(87.5) 
14(28.57) 
35(71.4) 
DM, n (%) Diabetic 
Non-diabetic 
2(12.5) 
14(87.5) 
5(10.2) 
44(89.8) 
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Cholesterol, n (%) Elevated cholesterol 
Normal cholesterol 
2(12.5) 
 
14(87.5) 
20(40.8) 
 
44(89.8) 
Prolapse types, n (%) Cystocele 
Rectocele 
Uterine prolapse and 
proscedentia 
Unrecorded 
n/a 
n/a 
n/a 
n/a 
33(67.3) 
9(18.4) 
6(12.2) 
1(2.0) 
 
Urinary symptoms, n 
(%) 
Frequency 
Urgency 
Dribbling 
Incomplete voiding 
Stress 
leak/incontinence 
Urinary retaintion 
Nocturia 
n/a 
n/a 
n/a 
n/a 
 
n/a 
n/a 
n/a 
8(10.67) 
6(8) 
5(6.67) 
5(6.67) 
 
9(12) 
1(1.33) 
1(1.33) 
 
Vaginal symptoms, n 
(%) 
Vaginal 
lump/fullness 
Drag in pelvis 
Vaginal sore/dryness 
 
n/a 
 
n/a 
n/a 
18(24) 
 
2(2.67) 
6(8) 
Bowel symptoms, n 
(%) 
Constipation 
Tenesmus 
n/a 
n/a 
6(8) 
1(1.33) 
Lower back pain, n Lower back pain n/a 7(9.33) 
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(%) 
Prolapse grade, n (%) I 
II 
III 
IV 
Unrecorded  
n/a 
n/a 
n/a 
n/a 
n/a 
7(14.3) 
12(24.5) 
21(42.9) 
7(14.3) 
2(4.0) 
Prolapse recurrence, n 
(%) 
Frist time prolapse 
Previous prolapse 
n/a 
n/a 
39(79.6) 
10(20.4) 
 
 
5.4.3 PENTOSIDINE QUANTITY IN PROLAPSED AND CONTROL GROUPS AND 
ITS POTENTIAL RELATIONSHIP WITH RISK FACTORS, PROLAPSE 
GRADE AND SYMPTOM PERCEPTION 
Pentosidine was significantly higher (p= 0.02) in vaginal tissues in women with prolapse 
compared with controls as shown in figure 5.3. The average values of pentosidine per gram of 
tissue were 0.02 and 0.03 mg in controls and prolapsed vaginal tissues respectively. 
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Figure 5.3: Pentosidine in prolapse (n=49) and control (n=16) tissues. (*p=0.02) 
There was a steady increase of pentosidine with age in the entire population studied, ranging 
from 0.014 mg/g to 0.037mg/g. Age group 40-49 was significantly different from age groups 
60-69 and 70-79 with p values of 0.00 and 0.01 as shown in figure 5.4. Age group 50-59 was 
significantly different from 60-69 with a p value of 0.04. The most significant differences 
were noted between age groups 40-49 and 60-69. Within the control population, there was a 
steady rise of pentosidine with age but this was non-significant between each age group 
(Figure 5.5). In the prolapse group, however the increase in pentosidine content with age was 
significantly different between age groups 50-59 and 60-69 with a p value of 0.012 (Figure 
5.6).  
* 
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Figure 5.4: Pentosidine and age in vaginal tissues from entire study population. ( n=6, 12, 
28, 15 and 3 in age groups 40-49, 50-59, 60-69, 70-79 and 80-89 respectively) 
 
Figure 5.5: Pentosidine amounts by age groups in vaginal tissues of controls. (n=5, 4, 5 
and 2 in age groups 40-49, 50-59, 60-69 and 70-79 respectively) 
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Figure 5.6: Pentosidine amounts in prolapsed vaginal tissues by age groups, p=0.012. 
(n=8, 23, 12 and 3 respectively for age groups 50-59, 60-69, 70-79 and 80-89) 
 
Pentosidine was higher after the menopause in both prolapse and controls but this difference 
was non-significant in the prolapse group. Pentosidine was significantly different between 
premenopausal controls and menopausal controls but not between prolapse sub groups 
(p=0.03), figure 5.7.  
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Figure 5.7: Pentosidine in prolapsed and control tissues based on menopausal status, 
*P=0.03. (n= 8, 9, 3 and 46 in premenopausal control group, menopausal control group, 
premenopausal prolapse group and menopausal prolapse groups respectively) 
Pentosidine in the vaginal tissues of women with hypertension were significantly higher 
(p=0.01) than in women without hypertension (Figure 5.8). Amongst the prolapse and control 
groups, the vaginal wall pentosidine content was higher in women with co-existing 
hypertension with p values of 0.04 and 0.05 respectively (figure 5.9). Women with both 
prolapse and hypertension had the highest average pentosidine (0.036 mg/g) while women in 
the control group without hypertension had the least pentosidine content (0.014 mg/g). 
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Figure 5.8: Amounts of pentosidine in vaginal tissues of hypertensive and non-
hypertensive patients in the entire study group, *p=0.01. (n=32 and 33 in hypertensive 
and non-hypertensive groups) 
 
Figure 5.9: Pentosidine in vaginal tissues of women with hypertension in control and 
prolapsed groups, *p=0.04 and 0.05. n= 7 and 9 in control groups with and without 
hypertension; 24 and 25 in prolapse groups with and without hypertension respectively. 
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There was a non-significant increase in pentosidine content in the vaginal tissues of women 
with prolapse and DM, p=0.4, (Figure 5.10). 
 
Figure 5.10: Pentosidine amounts in vaginal tissue of women with DM, p=0.4. (n=7 and 
58 for the DM and non-DM groups respectively. 
 Twenty four percent (12.5% of controls and 28.57% of women with prolapse) of the 
population studied were current smokers (Table 5.6), of these 87.5% had prolapse. The 
smokers had a borderline significantly higher pentosidine (p= 0.08) in their vaginal tissues 
than the non-smokers (Figure 5.11). The average pentosidine level amongst smokers was 
0.036 mg/g while non-smokers had an average pentosidine level of 0.026 mg/g.  
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Figure 5.11: Pentosidine content in the vaginal tissue of smokers and non-smokers, 
p=0.08. (n=16 and 49 for smokers and non-smokers respectively) 
An incidental finding of significantly higher amounts of pentosidine in the vaginal wall of 
women with anterior wall prolapse than in women with rectocele was made, p=0.03 (Figure 
5.12). 
 
 
 
 
 
 
Figure 5.12: Pentosidine content of vaginal tissues in prolapse involving the anterior and 
posterior walls of the vagina, *=0.03. (n= 33 and 9 for cystocele and rectocele 
respectively) 
* 
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There was a mild non-significant but steady increase in pentosidine with an increase in 
prolapse grade except for an unexpected decrease in pentosidine in tissues from grade 4 
prolapse (Figure 5.13) based on clinical examination findings. Average amounts of 
pentosidine in the control group were lower than pentosidine in grade 1-3. A weak positive 
correlation was observed between grade of prolapse and pentosidine amounts of the tissue (r
2
= 
0.129602), Figure 5.14. Higher amounts of pentosidine were observed in tissues from women 
with prolapse grade 3, with an average value of 0.034 mg/g. 
 
Figure 5.13: Pentosidine amounts in tissues in relation to grade of prolapse. (n=16, 7, 12, 
21 and 7 for control, grade 1, grade 2, grade 3 and grade 4 prolapse stages respectively). 
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Figure 5.14: Scatter plot sowing relationship between pentosidine amounts in the tissues 
and the grade of prolapse. 
Perception of symptom severity and impact on quality of life by the patients themselves as 
assessed by ICIQ-VS correlated positively (r
2=
0.455747) with pentosidine content of the 
tissues, shown in figure 5.15, and increased steadily from one grade to another with the 
exception of grade 1 (figure 5.16). Amongst women with grade 1 prolapse, perception of 
symptoms was unexpectedly high. An increase in the perception of symptom severity was 
however not significantly different between the prolapse grades (p= 0.37, 0.38. 0.58) 
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Figure 5.15: Scatter plot of tissue pentosidine content with ICIQ-VS score. Pearson’s 
correlation coefficient, r2 =0.4 
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Figure 5.16: Symptom severity perception (ICIQ-VS) and prolapse grade (n= 7, 12, 21 
and 7 for grade 1, grade 2, grade 3 and grade 4 prolapse stages respectively) 
5.4.4 ER- AND GLO-I EXPRESSION 
Oestrogen receptors were expressed as nuclei-like spots located at the vicinity of the nuclei in 
both prolapse and control groups. Cellular nuclei were expressed in both groups. Oestrogen 
receptors were distinctively and more expressed in the control tissue sections than prolapsed 
tissues (Figure 5.17). There were few, diffusely expressed oestrogen receptors in the prolapsed 
group. The average number of visible receptors per image area was 95.5 and 19 for controls 
and prolapse respectively (Figure 5.18). The difference was significant (p=0.013). 
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Figure 5.17: Representative images showing ER- expression (red) in age-matched 
prolapsed and control tissues. Nuclei were counter-stained by DAPI (blue). Scale bar = 
50 m  
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Figure 5.18: ER- receptor count in control and prolapsed tissues based on image 
analysis, *p=0.013. n=3 per group 
The expression of the antioxidant enzyme, glyoxalase I was diffusely spread within the tissue 
and sub-epithelial regions (figure 5.19). It was more expressed in the control tissues and 
minimally expressed in prolapsed tissues. Nuclei expression was noted in both groups. 
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Figure 5.19: Representative images showing GLO-I expression (green) in age-matched 
prolapsed and control tissues. Sections counterstained by DAPI (Blue). Scale bar = 50 
m 
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5.5 DISCUSSION 
5.5.1 INFLUENCE OF TISSUE STORAGE ON PENTOSIDINE CONTENT OF 
TISSUES 
Various tissue components perform differently under storage conditions. DNA and protein, 
unlike RNA can be preserved in tissue stored at -80C for up to 5 years and histologic staining 
of nuclei can confirm tissue integrity post-storage (247). Studies investigating storage 
conditions and tissue protein analysis have found that for tissues stored for up to 10 years at -
80C, reliable quantitative results can be obtained. For protein extracts, storage at 4C for 24 h 
and repeated freeze-thaw cycles affected spot intensities in 2-D gets but did not alter 
quantification results. (248) This however is not the case with whole tissues which are better 
cryopreserved with cryoprotectants than stored at 4C (249). Studies have also show that post-
lyophilisation tissues can be stored at room temperature without significant changes to the 
protein activity after up to 2 weeks of storage (247). 0.2- 3 mm split thickness cadaveric skin 
obtained within 24 hours of death for surgical grafting can be stored for up to 7 days without 
loss of viability (250). The American association of tissue banks recommends that refrigerated 
skin and musculoskeletal human tissues can be stored for up to 14 and 5 days respectively, 
whereas frozen human tissue can be stored for up to 5 years at -40C or less to maintain tissue 
viability. Previous studies have stored vaginal tissue prior to pentosidine content determination 
with no record of duration of storage or observed changes (41). An important factor in tissue 
cryopreservation is to avoid repeated free-thaw cycles (248). In the present study, no 
significant difference was noted in pentosidine, a glycated peptide content after 12 months of 
storage of full thickness vaginal tissues at -20C. 
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We further studied the amounts of pentosidine in non-contiguous aspects of the same tissues 
and found no change in amounts of pentosidine. Another concurrent study in this project using 
rat vaginal and skin tissues (2.3.3) suggests that glycation is a generalized body process, 
affecting different tissues similarly. A study carried out using in rats suggest that the glycation 
process occurs in multiple tissues when exposed to high reducing sugar levels (239). The 
present study however for the first time notes similarity in glycation content from different 
aspects of the same prolapsed site, which is expected. 
5.5.2  GLYCATION IN PROLAPSED VAGINAL TISSUES 
Many studies have observed new crosslinks in prolapsed tissues (8). Early studies by Jackson 
et al suggested that prolapse may result from increasing trivalent non-enzymatic crosslinks 
gradually dominating slow turn-over proteins such as collagen and resulting in older, stiffer, 
connective tissue (23). In his study, higher amounts of pentosidine were present in prolapsed 
vaginal tissues. Since then similar findings have been noted in other studies (245). Divalent, 
enzymatic pyridinoline crosslinks may remain the same but the non-enzymatic advanced 
glycation of pelvic connective tissue collagen is notably higher in prolapsed tissues (8,251). In 
the present study, there were significantly higher amounts of pentosidine, a glycation 
compound in prolapsed tissues compared with controls, which is in keeping with the majority 
of published literature. These findings have raised the question of advanced glycations as a 
strong association and potential cause of prolapse. A recent study on the matrix produced by 
vaginal fibroblastic cells of prolapsed tissues noted that fibroblasts in prolapsed tissue 
produced matrix with stiffer collagen fibers (116). Advanced glycation leads to stiffening of 
tissues also noted in prolapsed tissues (201,208,252). There is thus a need to understand 
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glycation-induced mechanical property changes (tissue stiffening) as prelude to or following 
prolapse development. 
5.5.3 GLYCATION AND AGE IN PROLAPSED VAGINAL TISSUES 
Collagen has a slow turnover rate of about 15 years and this implies it is highly susceptible to 
glycation (253). As the predominant ECM protein, changes in collagen characteristics directly 
impact on connective tissue properties. With aging and an increase in tissue content of less 
soluble glycated collagen (23,254), there is reduced elasticity of tissues and increased 
stiffening. Formation of glycation products within tissues has been implicated in this process.  
Pentosidine is regarded as a measure of chronological age as it is known to accumulate within 
tissues with increase in age (255). Pentosidine and other glycation products are implicated in 
age-related diseases including neurodegenerative diseases, osteoarthritis and hypertension. In a 
study carried out on human articular cartilage obtained from 11 and 19 year olds, pentosidine 
was found to increase linearly with age (192). Several other studies have noted an increase in 
pentosidine and other advanced glycation end products such as CML in skin with advancing 
age (55). The age-dependent accumulation of the glycation products within tissues may also 
be influenced by sun exposure (19). 
Glycation accumulation in tissues result in altered mechanical properties and decreased 
elasticity (200,207). The Receptor of Advanced Glycation End Products (RAGE) mediate 
fibroblast apoptosis, a process directly proportional to amount of AGEs in the tissue 
(224,256). They are implicated in induction of inflammation within tissues and may influence 
the  ECM remodeling (55). From studies on the pathophysiology of other glycation-induced or 
modulated diseases, they influence connective tissue properties through RAGE cascading or 
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instigating pro-inflammatory processes (57). In the present study, AGEs in the vaginal tissues 
were quantified and found to be higher in prolapsed tissues than in controls. This was 
consistent with other studies and suggests a potential role of AGEs in the pathophysiology of 
prolapse (8,23,245). We studied, for the first time, the increase in pentosidine with age in 
women with prolapse and compared this with age dependent increase in controls. A novel 
finding of a significant increase in vaginal tissue pentosidine in the transition between the 6
th
 
and 7
th
 decade of life was noted. Although our results do not directly indicate that AGEs cause 
prolapse development, they strongly suggest that there is a significant difference in how AGEs 
accumulate in the tissues of women with prolapse as they age. We noted that the transition 
between the 6
th
 and 7
th
 decade was important in the accumulation of pentosidine and 
potentially prolapse development.  
5.5.4 OESTROGEN INFLUENCE ON GLYOXALASE AND GLYCATION 
(INFLUENCE OF MENOPAUSE AND AGE) 
No other studies have measured amounts of advanced glycation in human pelvic tissues and 
correlated this with oestrogen, its receptors, or a state with high oestrogen receptor expression 
such as pregnancy (237). In Chapter 4 (4.1.4.3 and 4.1.4.6), we studied glycation in the 
vaginal wall of pregnant and non-pregnant rats in relation to ER- expression and found 
reduced glycation in pregnancy, which was also associated with higher ER- expression. A 
study investigating cervical remodeling in mice in pregnancy noted a decrease in mature 
pyridinoline collagen crosslinks in relation to cervical wall softening (257). Oestrogen is a 
metabolic hormone and oestrogen treatment increases pelvic connective tissues‘ expression of 
newly synthesized collagen and reduces expression of older collagen (42). In a double-blind 
randomized trial of oestradiol valerate in women with pelvic dysfunction, oestrogen treatment 
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resulted in a decrease in advanced glycation end-products and increased immature crosslinks 
(41). Furthermore, oestrogen has been shown to improve the functionality (stretching) of 
fibroblasts, suggesting that it is a key player in the aetiogenesis of prolapse (258). 
GLO-I is a glutathione (GSH) dependent antioxidant enzyme system (69). GLO-I is part of the 
glyoxalase system present in the cytosol of cells (259). The glyoxalase systems catalyse the 
conversions of reactive acyclic α-oxoaldehydes into corresponding α-hydroxyacids. A dimeric 
Zn
2+
 metalloenzyme human glyoxalase I decreases concentrations of α-oxoaldehydes, 
important intermediates in the glycation reaction and this process is negatively affected by 
ageing (221,259). Its enzymatic sites bind methylglyoxal, glyoxal and other acyclic α-
oxoaldehydes. It is thus useful in the detoxification of methylglyoxal, an intermediate 
glycolysis product, preventing its conversion to glycation products. Research has shown that 
GLO-I expression is influenced and regulated by oestrogen (218,219). The risk of prolapse is 
higher with age and menopause (12), when there is a decline in female hormones. In this 
study, there was reduced expression of antioxidant and oestrogen receptor- in women with 
prolapse for age-matched samples. Noting that a previous study has also observed that 
oestrogen reduces glycation in prolapsed tissues (41), we propose that this effect occurs 
through the GLO-I system in pelvic tissues. We observed a significant increase in amounts of 
glycation at the transition between the 6
th
 and 7
th
 decade, suggesting significant changes in the 
metabolism at this point. Furthermore, we noted highest glycation in women with prolapse and 
menopause and elevated vaginal tissue glycation in premenopausal women with prolapse. 
Although this does not immediately answer the question of ―cause or effect‖, it sets a basis for 
understanding this. It is known that oestrogen decline precedes and leads to the state of 
menopause which is closely associated with ageing and changes within pelvic connective 
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tissues. This finding, on the role of oestrogen in advanced glycation accumulation can be 
better understood by studying the relationship between ageing and menopause. Finding out the 
―cause-effect‖ relationship between ageing and menopause would improve our understanding 
on the role of glycation in prolapse. Prolapse is commoner in menopausal and older women. 
The risk of prolapse development doubles with each decade of life (82). It is however unclear 
whether the development of prolapse is solely due to age or menopause alone. Studies have 
shown less advanced prolapse in premenopausal women with prolapse than in menopausal 
women with no hormone replacement (260). Since ageing in women cannot be separated from 
menopause, interplay between these factors may be pivotal to the understanding prolapse 
development. 
5.5.5 THE ASSOCIATION OF GLYCATION IN PROLAPSED TISSUES TO 
HYPERTENSION, DM, CHOLESTEROL AND SMOKING  
A study investigating women admitted over two and half years at Bulent Ecevit University 
hospital found the presence of hypertension and DM together to significantly increase the risk 
of prolapse (260). A observational study investigating 497 over a year and half found only the 
presence of hypertension significantly predictive of higher prolapse staging (260). Another 
case control study noted a significant association of hypertension but not DM with prolapse 
(261). In this study, we quantified amounts of pentosidine in the vaginal tissues of women 
with hypertension, diabetes, elevated cholesterol and current smokers in comparison to 
controls. We found that pentosidine is most elevated in women with both prolapse and 
hypertension; the glycation product being strongly associated with both diseases. Hypertension 
is a condition of elevated systemic blood pressure. For every increase in age there is stiffening 
of blood vessels and elevation of systemic blood pressure (262). Hypertension can be 
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associated with other diseases, in particular renal and metabolic disorders such as diabetes 
mellitus. Advanced glycation of blood vessels has been associated with stiffening of blood 
vessels and elevated blood pressure (263). Higher tissue glycation has been associated with 
higher skin autoflourescence and arterial stiffening (202). Hypertension and diabetes are 
described as a potential association or predictors of prolapse (260) but an exact understanding 
of the association between the diseases and prolapsed has not previously been known. 
Although the finding in this study does not suggest a causal relationship between hypertension 
and prolapse, it reveals a potentially similar underlying pathology and strong association 
between both diseases. The same process, glycation, which is implicated in increased arterial 
stiffening and elevated blood pressure (264) may be implicated in prolapse pathogenesis. 
Since blood pressure is a routinely checked vital sign enabling early detection of hypertension, 
it may be a useful predictive tool of prolapse development and enable prevention.  
Diabetic complications are associated with glycation of multiple proteins including fibrinogen, 
globulins and albumin and these result in many different advanced glycation products (201). 
The glycation process is involved in lens protein modification and cataract formation and 
immunoglobulin modification and immune suppression, making it a propagating agent in the 
systemic complications of diabetes (265). Pentosidine, a glycation product of collagen, is 
associated with accelerated blood vessel stiffening and atherosclerosis in patients with 
diabetes. Therefore our finding associating hypertension but not diabetes mellitus with 
glycation does not imply an exclusion of the glycation process in diabetes. Further studies to 
confirm elevation of other AGEs in prolapse tissues would be useful in understanding the 
relationship between diabetes and prolapse. 
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Few studies have investigated smoking association with prolapse. In a 5 year prospective 
observational study in women who had prolapse surgery, there was no significant risk of 
recurrence with smoking (89). Another retrospective cohort study involving 149, 554 women 
20 years and above found that approximately half of those with prolapse were former or 
current smokers. Although cholesterol has not been previously studied in women with 
prolapse it is a component of metabolic syndrome, which also includes hypertension (81). In 
this study, amongst women with prolapse, pentosidine was higher in the presence of elevated 
cholesterol and smoking. Smoking and cholesterol are independent and associated risk factors 
for hypertension and type II DM, but no previous studies have associated smoking with 
elevated pentosidine levels in prolapsed vaginal wall. In the present study, this association is 
highlighted for the first time. Studies have shown higher chronic inflammatory cells in the 
anterior vaginal wall of women with prolapse (266). Smoking however promotes a systemic 
inflammatory state which can instigate glycation formation (81).  
5.5.6 THE ASSOCATION OF SEVERITY/ICIQVS AND PROLAPSE GRADE TO 
GLYCATION OF PROLAPSED TISSUES AND PROLAPSE TYPES 
The ICIQVS questionnaire was developed to assess vaginal symptom and sexual matters‘ 
influence on quality of life in relation to prolapse from the patient‘s perspective (79,86). It was 
designed for routine clinical use, having being developed with the participation of 77 
randomly selected women attending two urogynaecology clinics in the Southern part of 
England (86). The questionnaire was shown to be reliable and sensitive to change, with good 
validity and could identify changes in symptoms after surgical intervention (86). It comprises 
of a scoring system with nine symptom categories to reflect vaginal symptoms and three 
questions to investigate sexual life together with a quality of life score (80). 
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The development of the questionnaire is a reflection of the need for an objective and patient-
based assessment of prolapse symptoms. Since its development, and the known association of 
glycation with prolapse, this study has for the first time made a comparison between glycation 
content and ICIQVS scoring showing a weak positive correlation. The pentosidine content of 
the tissues correlated similarly with symptom severity and prolapse grade. We observed a 
better relationship between ICIQVS scoring and the prolapse grade, with a steady increase in 
patient‘s perception of symptoms from grades 2 to 4, similar to findings noted during the 
development of the ICIQVS questionnaire in which symptom scoring decreased post-surgical 
intervention, which typically leads to elimination of prolapse or a lower grade of prolapse. 
These findings confirm that the questionnaire is a useful clinical tool in the management of 
women with prolapse and may further reflect underlying biochemical changes within the 
tissues. 
5.6  CONCLUSION 
Pentosidine increased with age in the entire population studied. This increase in age was 
significantly different between the 6
th
 and 7
th
 decade in the prolapse population. Hypertension 
was commoner amongst women with prolapse and it was associated with significantly more 
glycation. Although, incidence in the population studied was low, smoking and high 
cholesterol were commoner in women with prolapse and also associated with higher amounts 
of glycation. Parity was unrelated to pentosidine content of the tissues. Cystocele was the 
commonest type of prolapse in the group studied and associated with more glycation. There 
was however some relationship between pentosidine amounts, grade of predominant prolapse 
and symptom severity/effect of quality of life perception. Glycation was also a good predictor 
of prolapse stage and symptom severity. Parity and the percentage of vaginal deliveries was 
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not significantly different in prolapse and control groups. There was a low incidence of 
instrumental deliveries in the groups studied but this was slightly commoner in those with 
prolapse. There was a low incidence of HRT use in the groups studied. 
Menopause, hypertension, smoking and cholesterol levels were strongly associated with 
glycation content of vaginal tissues in women with prolapse. Decreased ER- was associated 
with decreased glyoxalase I and increased glycation in prolapsed tissues. These findings 
suggest that women with higher glycation content in their vaginal wall may be more 
predisposed to developing prolapse than others. Smoking, which also increases systemic 
oxidative stress is associated with increased glycation. The mechanism for glycation 
accumulation in prolapsed tissues may include an affectation of antioxidant-dependent 
inhibition of glycation related to decrease in ER- expression. The presence of hypertension in 
association with glycation and prolapse is suggestive of similar underlying pathology for 
prolapse and systemic hypertension. Knowledge of this association can improve prolapse 
management by promoting screening, early detection and potentially, prevention.  
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6 CHAPTER 6: A STUDY OF THE STRUCTURAL AND 
MECHANICAL PROPERTIES OF PROLAPSED VAGINAL 
TISSUES 
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6.1 INTRODUCTION 
Before the manifestation of diseases that are appreciable at the organ level, several cellular and 
tissue-level changes take place and accumulate to result in visible organ damage. This is 
particularly evident in chronic disorders (187). Therefore, the sole use of an organ level 
imaging technique to study the cause of prolapse can be likened to taking a snap shot of an 
individual in motion without knowing what triggered the motion. The problem is the absence 
of a clear understanding of what changes led to the overall disease picture - in this context 
prolapse. 
Few studies however have investigated the structural and mechanical changes in prolapsed 
tissues (5). The mechanical testing of soft tissues has particularly posed a significant challenge 
for in vitro studies. Many of the readily available tests are destructive, and do not simulate the 
in vivo environment (12,13,164). This is clearly evident in some of the early studies that 
attempted to mechanically characterize prolapsed tissues. These have inconclusive results 
(5,13,164). Therefore the current understanding of prolapse aetiology has not been 
significantly improved over the past decade. There is thus a need for a non-destructive or 
minimally destructive in vitro test to mechanically assess prolapsed tissues. 
Chapter 5 has revealed that DM and hypertension, ageing and the presence of biochemical 
markers of tissue ageing, advanced glycation end products have been consistently noted to be 
associated with prolapse (245). Glycation is known to affect tissue mechanical property but no 
study carried out in humans has demonstrated a correlation between glycation and the altered 
mechanics in pelvic tissues. 
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The vaginal wall directly supports the pelvic structures (1).Considering the central and 
supportive role of the vaginal wall (as described by Delancey‘s levels of support) in the pelvis 
(267) and being the tissue through which the pelvic organs prolapse, it is expected that a 
strong vaginal wall should be useful in limiting the prolapse of surrounding pelvic organs. 
There are however limited studies on vaginal tissue mechanical properties and a need for 
improvement on the current state of knowledge on female pelvic tissue biomechanics (118). 
Furthermore, the vaginal wall in prolapsed tissues is known to be stiffer with resulting higher 
modulus. Higher modulus is expected to result to superior mechanical properties but does not 
appear to be the case with prolapsed tissues.  
6.2 AIM 
The study aimed to investigate the structural and mechanical property of vaginal wall at 
nanoscopic, microscopic and macroscopic scales in prolapse and controls and also correlate 
mechanical properties with glycation content. The purpose was to assess vaginal tissues‘ 
structural properties with a view towards understating prolapse pathology.  
6.3 METHODS 
H&E, elastin, trichrome staining, picrosirus red staining, neural immunostaining and 
hydroxyproline colorimetric assay have been used to determine structure and collagen 
composition of the prolapsed and control tissues. Detailed methods of AFM have been 
described in section 3.2.8. PFNMAFM as described in sections 3.4.2 has been used to analyse 
tissue ultrastructure, mapping of nanomechanical property. Ball indentation and OCE 
techniques described in sections 3.4.1 and 3.4.3 have been used to assess tissue level 
mechanics characteristics. 
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6.4 RESULTS 
6.4.1 HISTOLOGY (STRUCTURE AND COMPOSITION AT THE MICRO SCALE) 
6.4.1.1 H&E 
Figure 6.1 shows that the distinct histological layers were present in the tissues. The 
connective tissue was more organized in control tissues and the transition between the 
epithelial and sub epithelial regions appeared more subtle than in prolapsed tissues. Vacant 
spaces were observed in LP and muscularis zones of many prolapsed tissue sections. Dense, 
hypercellular epithelial layers were also present with remarkably thickened (41) or shrunken 
(9) appearance in some tissues. There was a distinct or sharp transition between the epithelial 
and sub epithelial regions of prolapse tissues compared with controls. 
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Figure 6.1: Low magnification images of representative control and prolapsed samples 
showing histological layers and structure overview of vaginal tissues. E=epithelial layer, 
LP=Lamina Propria, M=muscularis, A=Adventitia. Scale bars = 250 m 
At higher magnifications (Figures 6.2) variable thickness of the epithelia was seen with more 
cellularity or apparent pigmentation in the basal lamina of prolapsed tissues. More dilated 
vessels were observed in the prolapsed tissues than in controls (Figure 6.2). The superficial 
stratified squamous layer of the epithelium observed in controls was thinned out (atrophied) or 
lost in the prolapsed tissues. Collagen densifications (observed as dark horizontal lines) were 
present in sub mucosa of some prolapsed tissues (figure 6.2). Spherical clusters of 
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macrophage-like cells were visible in the prolapsed tissues. The cell count per unit area of 
basal lamina was significantly higher in prolapsed tissues as shown in figure 6.3. 
 
Figure 6.2: Higher magnification images of control and prolapsed tissues showing 
epithelial and sub-epithelial regions. Vacant spaces, areas of denser tissue (X) and cell 
clusters (blue arrow) visible in prolapsed tissues at LP and muscularis zones. (scale bars 
= 500 m 
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Figure 6.3: Cell count at basal lamina of age-matched control and prolapsed groups. 
There is significantly higher cell count in prolapsed tissue sections, *P=0.02. 
6.4.1.2 ELASTIN 
There was expression of elastin in both prolapsed and control tissues (figures 6.4 and 6.5). 
Elastin was expressed in all 4 histological zones but mostly noted in the muscularis layers, 
epithelial zones and around blood vessels. The prolapses tissues appeared to stain for elastin 
more than controls. 
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Figure 6.4: Elastin stain with and without counter-staining by Van Gieson’s Solution in 
representative age-matched prolapsed and control tissues (scale bars: 250 m). Light 
brown and dark brown areas in counter-stained and non-counter-stained images 
represent elastin distribution within the tissues. 
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Figure 6.5: Higher magnifications of regions within tissue sections stained for elastin in 
representative age-matched prolapsed and control tissues (scale bars: 250 m) 
6.4.1.3 NEURAL STAIN 
Neural parts were observed within tissue cross sections as rounded dots with a few elongated 
processes, apparently cross sections of axons and dendritic processes (Figure 6.6). These were 
more expressed in the control tissues than in prolapsed vaginal tissues. 
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Figure 6.6: Neural stain (red) in representative age-matched prolapsed and control 
tissues. Images on the left (Nuclei+GFAP) show DAPI stained nuclei images (blue) 
superimposed on glial fibrillary acidic protein (GFAP) stained images (red). (scale bars: 
50 m) 
6.4.1.4 TRICHROME STAINING 
Differential staining (trichrome) of the tissue sections was carried out to observe different 
constituents of the layers of the tissues. Epithelial, LP and mucularis layers were visible in 
control and prolapsed tissues. A more extensive muscularis layer was evident in the control 
samples whereas prolapsed tissues appeared shrunken. A less organized structure was also 
evident in the prolapsed tissue in this region. Figure 6.7 shows that prolapsed tissues when 
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observed in full thickness contained more connective tissue (green) and less muscularis layer 
(red). Muscularis layers were filled with vacant spaces. Control tissues however contained 
more muscularis layer and less connective tissue as shown in Figures 6.7 and 6.8. The 
connective tissue layers of the prolapsed tissues are quite extensive through all tissue layers, 
particularly notable in the lower adventitial layers. At both low and higher magnification, 
Figure 6.8, the prolapsed tissue muscularis zone appeared infiltrating with connective tissue 
(blue), with remnants of muscular layer present.  
 
Figure 6.7: Trichrome stained images of representative age-matched control and 
prolapsed tissues. Blue/green= connective tissue, Red= muscular layer, orange= 
erythrocytes. Scale bars = 250 m. More intact and extensive muscular layer is notable in 
the control tissues compared to prolapsed tissues. The muscularis region in the prolapsed 
tissue appears patchy and infiltrated with connective tissue (green). 
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Figure 6.8: Higher magnifications of regions within tissue sections stained with 
trichrome stain in representative age-matched prolapsed and control tissues (scale bars: 
250 m). Muscularis layer  and erythrocytes are more notable in the control tissues 
compared to prolapsed tissues, which have extensive connective tissue also infiltrating 
the muscularis layer . Blue/green= connective tissue, Red= muscular layer, orange= 
erythrocytes. Scale bars = 250 m. More intact muscular layer is notable in the control 
tissues compared to prolapsed tissues. 
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6.4.2 COLLAGEN CONTENT  
Further evaluation of the muscularis region was carried out using picrosirus red staining aided 
by light and polarized microscopy (Figure 6.9). This was used to observe tissue structure for 
the presence of and rough estimate of amounts of collagen in the tissues. Collagen was present 
in both control and prolapsed vaginal tissue sections but denser collagen fiber groups were 
observed in the prolapsed tissues, which stained brighter red, more appreciable in the polarized 
images. Control tissues appeared to contain less collagen fibers but had a more organised 
architecture.  
 
Figure 6.9: Representative picrosirus red stained images of age-matched control and 
prolapsed vaginal wall sections. Bright field and polarized microscopy images are 
pictured. Scale bar= 100 m 
Quantification of total collagen was carried out to confirm observations. The total collagen 
was significantly higher in prolapsed tissues compared with controls (Figure 6.10).  Further 
comparison based on menopausal status revealed that the average amounts of collagen were 
highest in the prolapsed menopausal group with an average of 1.3g/mg and lowest in the 
control menopausal group (0.86 g/mg tissue, Figure 6.11. Within the menopausal group this 
difference between vaginal tissue pentosidine content in prolapsed and control tissues was also 
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significant. The p values were 0.02 for comparison between prolapsed and control groups and 
0.036 between control and prolapsed menopausal groups. In the entire study population, total 
collagen was higher in the menopausal group, p=0.02, figure 6.11 
 
 
 
 
 
 
 
 
 
Figure 6.10: Total collagen in prolapsed and control vaginal tissues, *p=0.02 (n=8 per 
group). 
 
 
 
 
* 
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Figure 6.11: Total collagen in age-matched premenopausal and menopausal prolapsed 
and control vaginal tissues, *p=0.036 (n=4 per group) 
6.4.3 AFM (STRUCTURE, MECHANICS AND ORGANIZATION AT THE MICRO 
AND NANO SCALE) 
The structural and nanomechanical property of LP and adventitial layers of the tissues were 
investigated by measuring the collagen fibril modulus per unit area and observing fibril 
morphology using peakforce quantitative nanomechanical mapping (PF) AFM. Within a 
micron region there was varying range of modulus in both control and prolapsed tissues but 
average modulus of prolapsed tissues appeared higher than control tissues in the LP region as 
shown in figure 6.12. The same variable range of modulus was observed in adventitial regions 
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of prolapsed and control tissues, with higher upper modulus limit in control tissues (figure 
6.13). 
 
Figure 6.12: Representative PF AFM images of control and prolapsed vaginal tissue 
sections viewing collagen from 1x1 m LP regions showing collagen modulus range. 
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Figure 6.13: Representative PF AFM images of control and prolapsed vaginal tissue 
sections (Adventitial layers) viewing collagen from 5 m2 areas showing collagen 
modulus range.
 
Objective measurement and quantification of the average modulus of 12 aged matched control 
and prolapsed tissues taking the average modulus of three images per tissue, revealed a 
significantly higher modulus in the prolapsed tissues at the LP regions compared with 
prolapsed tissues, p=0.02 (figure 6.14). In the prolapsed tissues, the LP was significantly 
stiffer than the adventitial region (p-=0.01).  
 
Figure 6.14: Average collagen fibril modulus extracted using the nanoscope analysis 
software from 1.4m2 and 5.0 m2 areas of LP and Adventitial zones of Control (n=8) 
and prolapsed (n=8) tissues. The average moduli (image raw mean) have been extracted 
from images represented in 6.4 and 6.5 using the nanoscope analysis software. Significant 
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differences are noted between LP zones of control and prolapsed tissues (p=0.02) and the 
different zones within the prolapsed tissues (p=0.01). 
On the contrary, the prolapsed tissues adventitial layer had slightly lower average modulus 
that the controls but this was not significantly different. Within the control tissues there was 
more homogeneity as the modulus was not significantly different between the LP and 
adventitial layers (p=0.7). In the prolapsed tissue however there was a sharp reduction in 
modulus from the LP layer to the adventitial layer (figure 6.15). This difference was 
significant (p=0.01). 
The 5 m2 images as shown in figure 6.15 enabled visualization of tissue architecture and an 
overview of the collagen bundles at the micron level. Control vaginal tissues showed the 
different ECM architecture at the micro scale. Clear bundling of collagen fibrils is visible in 
control samples with a somewhat ―basket weave, appearance of the bundles. ―Swirl-like‖ or 
twisting patterns were also noticed in some of the collagen bundles of control samples. There 
is intertwining or parallel arrangement of these bundles with occasional gaps in the control 
samples but in the prolapse tissues a complete loss of bundling is evident in some samples 
while others have very few bundles. A webbed or net appearance is seen in some of the 
prolapsed tissues. Some amorphous compound, likely glycosaminoglycan, is visible over 
fibrils. 
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Figure 6.15: Representative AFM height images showing collagen fibril organization in 5 
um
2
 areas of prolapsed and control tissues within the LP region. 
Further visualization of the arrangement of collagen fibrils within the bundles in the LP region 
was observed in the 1.4 m2 images as shown in figure 6.16. Collagen fibrils displayed the 
characteristic D period banding pattern in this region. Fibrils in the control tissues appeared 
more compacted and aligned with a predominant axis while fibrils in the prolapsed tissues 
were disorganized with most exhibiting large spaces between fibrils. These changes were more 
appreciable in 3-D images as shown in figure 6.17. 
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Figure 6.16: Representative AFM images showing collagen fibril organization in 1.4 m2 
areas of prolapsed and control tissues within the LP region. 
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Figure 6.17: Representative 3-D AFM images illustrating ultrastructural organisation 
within the LP region of prolapsed and control tissues. 5 m2 and 1.4 m2 images are 
shown on the left and right respectively. The collagen bundling and compaction is more 
evident in control samples but appears lost in the prolapsed tissues. 
 In the adventitial region, Figure 6.18, the same bundling of collagen fibers and ‗basket weave‘ 
appearance was noted in the controls samples. In prolapsed tissues, residual bundles were 
observable but disorganization was more evident and some tissues had a webbed appearance. 
The characteristic D-banding was also present in collagen fibrils in the region, enabling 
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identification visible in the 5 m2 and 1.4 m2 images (Figures 6.18 and 6.19). Within groups 
of collagen, alignment was preserved in the control samples but this was lost in the prolapsed 
tissues. Some prolapsed tissues had fibrils crossing through others in a disorderly manner. 3-D 
images (figure 6.20) further confirmed observations. The control tissues were organised into 
clear bundles which was not appreciable in the prolapsed tissues.  
 
Figure 6.18: Representative AFM height images showing collagen fibril organization in 
5.0 m2 areas of prolapsed and control tissues’ adventitial region. 
 
Figure 6.19: Representative AFM height images showing collagen fibril organization in 
1.4 m2 areas of prolapsed and control tissues in the adventitial regions. 
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Figure 6.20: Representative 3-D AFM images illustrating ultrastructural organisation 
within the adventitial region of prolapsed and control tissues. 5 m2 and 1.4 m2 images 
are shown on the left and right respectively. More obvious bundling of collagen fibrils is 
seen in the control samples but the prolapsed tissue exhibits a completely disorganized 
architecture. 
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Further quantification of the sizes of gaps between the collagen fibrils revealed wider average 
gap in prolapsed tissues compared to controls (figure 6.21). There was more variability in the 
sizes of gaps between the fibrils within prolapsed tissues with a range of 12 nm unlike in 
controls, which had more uniformly sized gaps within a range of 1nm. The standard errors of 
mean were 4.5 and 0.5 respectively. At the micron level, the gap between collagen fibrils in 
prolapsed vaginal wall was five times that of normal vaginal tissue, Figure 6.21. There was 
minimal variability in collagen fibril size in both control and prolapsed tissues (figure 6.22). 
The average collagen fibril diameter in prolapsed tissues was also significantly smaller than 
for controls (p=0.00). 
 
Figure 6.21: Average gap between collagen fibrils in 1.4 m2 areas of control and 
prolapsed vaginal tissue sections (n=8 per group). The difference is statistically 
significant (**p=0.005) 
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Figure 6.22: Average collagen fibril diameter in 1.4 m2 areas of prolapsed and control 
vaginal tissues (n=8 per group with each n number representing the average of diameters 
of all visible collagen fibers in representative prolapse and control images). Significant 
difference is noted between both groups (***p=0.00). 
There was reasonable distribution of collagen fibrils within each measured area but the 
number of fibrils was less in the prolapsed tissues (figure 6.23). There were significantly more 
collagen fibrils in the same area of control vaginal tissues. The alignment of collagen fibrils to 
the dominant axis of the tissues was significantly better in control tissues (figure 6.24). There 
was more deviation or increased angulation of collagen fibrils in the prolapsed tissues away 
from the predominant axis. 
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Figure 6.23: Collagen fibril count in 1.0 m2 per unit area in prolapsed and control 
samples, *p=0.038. n=8 per group) 
 
Figure 6.24: Collagen fibril alignment in control and prolapsed tissues (n=8 per group, 
with each n number representing average alignment of all visible collagen fibrils in 
representative images of each sample). Average alignment of each fibril to dominant axis 
in the LP and adventitial regions (***p=0.00). 
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6.4.4 RELATIONSHIP BETWEEN GLYCATION AND PROLAPSED TISSUE 
MECHANICS (FROM BALL INDENTATION DATA) 
6.4.4.1 Thickness of tissues using slicing methods 1 and 2 
The average thickness of tissues obtained using slicing methods 1 and 2 differed significantly 
as depicted in figure 6.25. The average size of tissues using methods 1 and 2 were 1.8mm and 
0.7mm respectively. Inter specimen variability was minimal using both techniques (standard 
errors of means of 0.07 and 0.04 respectively). 
 
Figure 6.25: Thickness of tissues obtained using the two methods of slicing (n=10 and9 
respectively). 
6.4.4.2 Modulus and Creep results using methods 1 and 2 
The modulus and creep of prolapsed samples have been measured by ball indentation method. 
The modulus values were within 43-110 kPa region and 24 creep were in 0.4-1.2 mm region 
by method 1, and 3-120 kPa and 0.1-1.5 mm region by method 2. It was impossible to 
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undertake a comparative study (with control samples) using the ball indentation measurement 
because the control sample sizes were approximately 4 mm
2
 in dimension and as a result could 
not be mounted on the ball indentation ring. However, plots of the creep or modulus against 
associated pentosidine value in the samples, revealed a consistent relationship between 
pentosidine content of the tissues, the tissues‘ creep and modulus using both slicing 
techniques. This has been presented in Figures 6.26 and 6.27. From both experiments, an 
inverse correlation is noted between pentosidine content of the tissues and creep, while a direct 
relationship exists with tissue modulus as expected. The strength of correlation was however 
stronger in method 1 (r
2
= 0.8) than in method 2 (r
2 
=0.7). 
 
Figure 6.26: Correlation of creep and modulus of adventitial layer of prolapsed tissues 
sliced using method 1 with pentosidine content. (r
2
=0.8) 
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Figure 6.27: Correlation of creep and modulus of adventitial layer of prolapsed tissues 
sliced using method 2 with their pentosidine content. (r
2
=0.8) 
6.4.5 OCE (MECHANICS AT TISSUE SCALE) 
To obtain mechanical property differences in the prolapse and control samples, OCE 
measurements were carried out on whole tissue segments in air and embedded in the agar 
phantom for reference. The sample size for OCE measurement was around 4.0 mm
3
. Images of 
specimen set up were obtained as shown in figure 6.28 for an understanding of sample 
orientation during data interpretation. 
There was noticeably more uniform modulus distribution within control tissues, seen in figure 
6.29. Form the pictographic scale, modulus appeared to exist between the 200-350 relative 
modulus range through the different layers of the tissues. Prolapse tissues show ‗demarcation‘ 
between layers with highest modulus in epithelial and LP zone. The first four prolapse samples 
in Figure 6.29 show weaker muscularis (middle zone/darker blue) regions.  
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Figure 6.28: OCE tissue set up with and without embedding in agar for image 
acquisition. The orientation of each sample tested (LP and adventitial zones) was noted 
to ensure accurate data interpretation. Scale bars for samples embedded in agar = 4000 
m; Scale bars for H & E stained images = 1000 m 
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Figure 6.29: Elasticity map of Control and Prolapsed tissues imaged in air. Cross-
sectional views along the y-axis of horizontally placed tissues are shown. The colour bars 
represent the relative modulus of the tissues. Scale bar= 1000 m LP = Lamina Propria 
Images obtained following immersion in agar, figure 6.30, revealed the same trend. The 
prolapsed tissues have appreciable regions with modulus around 500KPa based on the colour 
coding. This however was not the case with controls, which were mostly within 200-250 KPa 
in modulus. Within agar, the tissue stiffness was more extensive but predominantly localised 
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to the LP regions. More uniformity in modulus was noted within the control samples which 
appeared to have overall lower modulus than prolapse. Both OCE experiments strongly 
suggest that prolapsed tissues have heterogeneous distribution of stiffness within the tissue, 
confirming AFM findings of higher modulus in prolapsed LP region compared with 
adventitial layers.  
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Figure 6.30: Elasticity map of Prolapsed and control tissues imaged immersed in agar. 
Scale bar =1000 m LP = Lamina Propria 
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6.5 DISCUSSION 
6.5.1 HISTOLOGY 
Understanding the histological changes that are present in prolapsed tissue may not 
immediately answer the ‗cause or effect question‘ but can influence clinical decision making 
in terms of completely removing prolapsed areas or supporting them (268,269). The histology 
of prolapsed vaginal wall has been poorly studied and understood. Previous studies have had 
varying results (8) but common trends can be seen. Many studies have used localized biopsies 
which are poorly characterised and do not allow evaluation of histology across the full 
thickness of the vaginal wall (268). In this present study, we investigated full thickness 
prolapsed and control tissues with most prolapsed tissues obtained from the middle vaginal 
regions and the majority of the controls from apical regions. The prolapsed tissues exhibited 
disorganized connective tissue structure with notable changes in the basal cell count, tissue 
integrity and connective tissue collagen densifications. Quantitatively, total collagen was 
increased in prolapsed vaginal tissues. Our findings can be better understood by taking 
cognizance of findings from other studies. 
For example, research comparing histology and histological zones of vaginal tissues in 
different regions (apical, middle and distal thirds) of the vaginal wall have found no significant 
difference in composition of collagen in the human vagina (270). This implies that the 
consistent differences we observed in the collagen composition of prolapsed tissues 
(predominantly middle vaginal segment) and controls (largely apical segments) are differences 
associated with the disease and hence, noteworthy.  
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Structural and morphological studies have revealed more disorganized architecture in 
prolapsed tissues (271). The majority of research has noted a thinned out muscularis layer in 
prolapsed tissue and increased numbers of enlarged venous vasculature but reduced amounts 
of capillaries (272). Some studies have also noted decreased innervation of prolapsed anterior 
vaginal wall compared with controls (270). In this study, there was less oestrogen expression 
in the prolapsed tissues. Since, oestrogen induces an increase or growth in the vaginal layers of 
normal vagina (269), its decline in prolapse may explain the thinning of the superficial 
epithelial zone of the prolapsed tissues observed in this study. 
In 2006, Lin et al studied elastin expression in the anterior vaginal wall by 
immunohistochemistry in 23 prolapsed tissues and 15 controls and found no significant 
difference (273). In 1996 Jackson et al also had similar findings from studying the vaginal 
epithelium of 8 premenopausal women with prolapse and 10 controls (23). Some studies on 
localized histological zones of the tissues and a few with staining carried out for specific types 
of elastin have found decreased expression in prolapsed tissues (268,274). A study by Zong et 
al investigating eighty-seven full thickness vaginal biopsies void of epithelium in 
premenopausal controls and women with prolapse (premenopausal, menopausal not on HRT 
and on HRT) for tropoelastin (elastin precursor) and mature elastin found an increase in both 
in prolapse with more increase in postmenopausal women with prolapse but not on HRT 
(275). These suggest that although elastin content may vary across layers of prolapsed tissues 
there is an inverse influence of hormones on elastin content. The varied findings in these 
studies may be the result of biopsy taken from different histological layers, differing methods 
of analysis and non-discrimination between tropoelastin and mature elastin in some studies. 
Our study observes differential expression of elastin in the various tissue layers with more 
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expression in the epithelial and muscularis layers. By qualitative observation, elastin was more 
expressed in the prolapsed tissue sections. This is in keeping with findings by Zong et al (275). 
The differential distribution in the various histological zones may explain the varied results 
from other studies on elastin content in prolapsed tissues depending on the histological zone of 
the vaginal wall studied. Overall, the existing literature on elastin content of prolapsed tissues 
is inconclusive and requires further investigation. 
There are indications that pelvic tissue innervation is impaired in prolapse (91). In a cohort 
study to assess the sensory and motor innervation of genitals in women with prolapse, an 
abnormal genital vibration sensation was noted in women with prolapse. This worsened with 
age but was uninfluenced by surgical repair (276). Neuropeptide Y, a brain and autonomic 
nervous system neurotransmitter was found to decrease in pelvic prolapse with decrease 
correlating with severity prolapse (277). Another study that investigated the innervation 
pattern of vaginal tissues using immunostaining observed localization of nerve bundles at the 
adventitial and muscularis region with reduced size and frequency of nerve bundles in 
prolapsed tissues. We noted increased expression of neural processes in vaginal tissue sections 
from women with prolapse compared to control tissues. These findings in addition to existing 
literature consistently suggest affectation of the nerves as a significant pathology in prolapsed 
tissues. 
Cells recreate tissue matrix and remodel these when necessary. Therefore changes in tissue 
structure and histology should warrant the study of inherent cells. The few studies that have 
investigated cells in the prolapsed vaginal wall have focused on the fibroblasts (268). 
Fibroblasts from prolapsed vaginal wall have been shown to decline in number and become 
less functional by contracting less, and producing altered  ECM proteins (115). For the first 
204 
 
time, we have observed increased number of cells in the basal lamina region of prolapsed 
tissues. Basal epithelial cells, in different body tissues, are poorly differentiated cells or stem 
cells which give rise to the more specialized cells of the epithelium (278). They enable 
replenishing or renewal of the epithelium (258). Mechanical stimulus such as constant friction 
or repeated stretching has been shown to lead to proliferation of epithelial cells. In a study in 
which controlled friction was applied to hamster cheek pouch epithelium, the cells increased 
in size and number (279). Another study in which mouse epithelial skin was stretched to 
observe for effects on proliferation, noted an increase in mitotic index maintained after 4 days 
and an increase in basal progenitor cells (280). The increase in the basal vaginal epithelial 
cells noted in our study may be therefore be induced by the constant abrasion the prolapsed 
vaginal wall is exposed to and indicative of a tissue undergoing mechanical stress. 
 
6.5.2 STRUCTURE AND COMPOSITION 
Our study revealed that the connective tissue of prolapsed vaginal wall had remarkably 
dissimilar properties from controls. At the micro scale, prolapsed vaginal tissues contained 
less or patchy muscularis layer which was infiltrated with connective tissue, notable in 
trichrome stained images. There was also a disorganized architecture of prolapsed tissues. 
Collagen, a connective tissue component, was visibly increased in prolapsed vaginal tissues as 
revealed in picrosirus red stained images. This was confirmed by hydroxyproline assay. In 
published literature, inconsistent outcomes have been obtained from various studies on 
collagen and elastin content of prolapsed tissues (251,268). A study involving 10 anterior pre-
cervical vaginal fascia samples from women with prolapse and 10 from the control group and 
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another study using samples from the precervical vaginal fascia of 24 women with prolapsed 
and 21 controls noted increased total collagen in prolapsed tissue (109,273). Another study on 
samples from women with stress urinary incontinence and prolapse, 32 women with prolapse 
and 28 controls using tissues obtained from the same region of the vagina as the previous 
study found decreased collagen III (281). Some studies have found no significant difference in 
amounts of collagen types III and I in the prolapsed and control tissues (109,281). Fewer 
studies have used full thickness vaginal tissues. Kocku in 2002 found an increase in total 
collagen in full thickness prolapsed vaginal tissues from a study involving 24 premenopausal 
women with prolapse and 21 controls (273). In 2005, Moalli et al investigated full thickness 
vaginal tissue from the apical region of 16 premenopausal women and 15 controls and found 
an increase in total collagen in the premenopausal women with prolapse and non-use of HRT 
(108). Jackson et al in 1996 studied 8 premenopausal women with prolapse and 15 controls 
and found a decrease in total collagen in the epithelial region (23). These suggest that the 
different outcomes may be due to the different histological regions tested and other factors 
such as HRT use. Many studies have not described the histological zones of the tissues tested. 
Therefore variations in outcomes could be due to differences in aspects of the tissues biopsied 
and improper characterisation of the tissues. We studied full-thickness vaginal tissue samples 
and found significantly increased total collagen content in prolapsed tissues. This is 
collaborated by studies that have made use of full thickness tissues (108,273). Despite 
differences in study outcomes, it is likely that prolapsed tissues have overall increased total 
collagen content. 
In a recent study aimed at investigating morphological and immunohistochemical changes of 
tissues in 14 women with prolapse by investigating Collagen I and Collagen III, α-Smooth 
206 
 
Muscle Actin (α-SMA), Platelet-Derived-Growth-Factor (PDGF), matrix metalloproteinase 3 
(MMP3), tissue inhibitors metalloproteinase 1 (TIMP1), Caspase3 immunochemically and 
histologically and making comparisons with ten controls obtained from women admitted for 
plastic surgery, a similar finding of poorly organized myocytes, displaced by increased 
collagen III deposition leading to altered organization of the LP was noted (282). Another 
study also utilizing trichrome staining to assess smooth muscle content of the anterior apical 
aspect of the vaginal wall in women with prolapse and controls observed decreased fractional 
area of non-vascular smooth muscle in prolapsed tissues (283). Furthermore, an increase in the 
fractional area of connective tissue in prolapsed vaginal tissues was noted. These strongly 
corroborate our findings. Another histological study carried out using samples from 33 women 
with prolapse and nine controls found significantly altered smooth muscle actin expression 
and altered morphology of prolapsed tissues (284). In our study, the prolapsed tissues had 
reduced and less organised musularis layers, which were infiltrated with connective tissue. 
The extra connective tissue was likely to be collagen as noted by the significantly increased 
collagen content and increased pircrosirus red staining of the prolapsed tissues‘ muscularis 
layers. These findings are highly suggestive of changed or displaced phenotype within the 
vaginal wall of women with prolapse and such changes may be important pathological 
changes leading to altered vaginal wall functionality and prolapse.  
The altered tissue structure and composition of prolapsed tissues is reflected in the genetic 
expression. In a study investigating the expression of genes encoding smooth muscle proteins 
in prolapsed tissues a procontractile gene, SM-myosin heavy chain (MHY11) was noted to 
have up to five times down-regulation in women with prolapse compared with controls of 
similar menopausal status (285). Other genes encoding such as caldesmon (CALD 1), SM 
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gamma-actin (ACTG2), and tropomyosin (TPM1) were down-regulated in controls but not in 
prolapsed tissues. These altered genes could be the effectors of observed muscularis changes 
in prolapsed tissues or responses to the changes. Although detailed genetic studies would be 
required to better understand this, the findings strongly suggest that a dysfunctional muscularis 
region contributes to the observed pathology of prolapse. 
The organisational changes observed in the light microscopy images were more evident at the 
nano-scale. AFM studies are useful in revealing mechanical properties and structural changes 
in vaginal tissue structure and interaction with  ECM (286). Our AFM results show 
morphological signs of prolapse at the micro and nano scale. There were disorganized 
collagen fibrils with significantly wider gaps between fibrils and less bundling unlike in 
control tissues. This disorganization was noticeable in LP and adventitial regions of the 
prolapsed tissues. Notable loss of collagen bundling, disintegration and misalignment were 
evident. There are a few other AFM studies of the vaginal wall in women with prolapse and 
these have varied findings. A study on periurethral tissues in young women with prolapse 
revealed 30% less collagen than in age-matched controls (287). Another study investigating 
the uterosacral ligaments in women with prolapse observed no difference in collagen I but 
correlation of higher collagen III content with the presence of prolapsed (288). An AFM study 
in the organization of collagen fibrils in skin tissue of women with prolapse revealed changes 
in the collagen fibril bundle organization and mechanical properties in women with prolapse 
(243). It noted loosening of collagen fibers, disorganization and disintegration of the fibers in 
skin tissues of women with prolapse. This suggests that changes observed in prolapsed tissues 
are present or occur similarly in other tissues (as also noted in 4.3). Another study 
investigating early changes in prolapsed vaginal wall, observed bulkier and stiffer collagen 
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fibrils with variable width and higher amounts of the wider collagen I than III (289). This 
study also noted loose arrangement and reduced total collagen in prolapsed tissues. Some 
other studies however have revealed increased amounts of collagen III and total collagen in 
prolapsed tissues. A study investigating the remodeling of vaginal connective tissues in 
prolapse found predominant collagen in the vaginal wall to be type III and increased total 
collagen in women with prolapse (108). In the various studies, the observed variation in 
outcome may be the result of different age groups, vaginal regions and status of menopause of 
women studied. The most consistent outcomes however are the stiffening and disorganisation 
of the collagen fibrils in the vaginal wall of women with prolapse.  
6.5.3 MECHANICS AND GLYCATION 
The studies of the mechanical property of the vaginal tissues at the nano, micro and tissue 
level confirmed the heterogeneous modulus distribution in prolapsed samples with the 
presence of a higher modulus region in LP area of prolapsed tissues compared to more 
homogenous controls. There are a few other studies on the mechanics of prolapse. They 
commonly note the increased stiffening of prolapsed vaginal wall compared to controls. 
Research by Chen et al in 2007 revealed higher Young‘s modulus of prolapsed tissues, more 
so in conjunction with menopause (164). The control tissues also exhibited higher maximum 
elongation and maximum fracture suggestive of a more resilient tissue. This implies that 
increase in modulus noted in prolapse does not contribute to improved mechanical properties. 
Changes in prolapse were similar to menopausal changes in the same study (164), suggesting a 
similar underlying mechanism for vaginal wall changes in prolapse and menopause. A vaginal 
tactile imaging study however revealed a contrary result of lower elastic modulus in stage III 
prolapsed tissue (290). Although results from other prolapsed stages were not reported in that 
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study, it is interesting to note that measurement was carried out in vivo. The study made use of 
a probe used to assess vaginal wall modulus with the women in anatomical position. Another 
in vivo study noted reduced modulus in the vaginal wall of women with prolapse (130). These 
in vivo tests reflect a non-isolated study of the vaginal wall. Results may thus be representative 
of vaginal wall and surrounding pelvic tissues. The prolapsed vaginal tissue, though stiffer 
than normal vaginal tissue when isolated from its anatomical surrounding, may exhibit overall 
inferior mechanical properties in vivo. 
Due to the direct role of the vaginal wall in the support of other pelvic organs (291), changes 
in vaginal tissue mechanics will affect pelvic organs. Hence the importance of investing 
changes in vaginal tissue mechanics. There are however no other studies that investigate the 
mechanical properties of the prolapsed tissues from the nano and micro scale to the tissue 
level. We have demonstrated this for the first time through a series of experiments that 
confirm that ultrastructural changes in the tissues‘ mechanics at the nano level are also evident 
on a much larger scale. Our investigation of nanomechanical properties of the prolapsed 
tissues focused on the collagen fibrils suggesting that the overall stiffness noticed in prolapsed 
tissues is largely due to collagen modifications. This is further supported by results from a 
study carried out with the aim of investigating the mechanical properties of the vaginal wall in 
fibulin-5 knockout mice with prolapse. These were compared with the vaginal wall of non-
pregnant mice and found to have decreased maximum stress, strain and stiffness (13), 
suggesting that prolapse caused by genetically induced elastin changes may have a different 
effect on the tissue‘s modulus. Altered elastin in this case resulted in reduced stiffness of the 
vaginal wall. 
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In investigating the cause of observed stiffening of prolapsed tissues, findings of increased 
amounts of collagen type III (which is associated with reduced tissue modulus) (108,251) in 
prolapsed tissues yet higher modulus in prolapsed tissues further point to a cause other than 
the type of collagen. Glycation modifications are believed to be the cause of vaginal wall 
stiffening in prolapse as findings from previous research suggest this (8,23,245). The 
correlation of glycation and mechanical properties has been previously demonstrated in the 
vaginal wall in pregnancy (237) but not in prolapse. In the present study, we demonstrate for 
the first time that increased modulus of the vaginal tissues of women with prolapse directly 
correlates with tissue glycation content. This has previously been observed in other tissues but 
not in the human vaginal wall. In a study investigating the glycation in the Achilles tendon of 
rabbits, it was found that increased maximum load, stress, strain and Young‘s modulus 
occurred in association with non-enzymatic glycation (208). Pentosidine and insoluble 
collagen were observed to correlate positively with the tissues‘ modulus (208). In aortic 
intima, stiffening has also been correlated with pentosidine and non-fluorescent crosslinks 
(292). A strong positive correlation has also been noted between the equilibrium modulus of 
cortical bone and advanced glycation accumulation within the tissue (293). These findings 
emphasize the relationship between biochemical and mechanical properties of tissues. We 
have demonstrated this relationship in prolapsed vaginal tissues using an adaptation of the ball 
indentation technique. The ball indentation device has been successfully used in characterizing 
hydrogels and thin tissues but for the first time it has been adapted for the study of the human 
vaginal wall in vitro and revealed the relationship between vaginal wall glycation and 
increased stiffness of the same in prolapse. Although there was the disadvantage of tissue 
slicing, the ball indentation method is minimally destructive and enables the application of 
211 
 
multiaxial force to the tissue. This implies that it reasonably simulates the multidirectional 
force received by the tissue in vivo (11,168).  
Furthermore, in our study, modulus assessment revealed a discrepancy between LP and 
adventitial layers of the prolapsed tissues. The LP layer was stiffer in prolapsed tissues when 
compared with LP regions of control samples and adventitial layers of prolapsed samples. This 
heterogeneity in stiffness observed in histological sections of prolapsed tissues was confirmed 
with OCE. OCE can provide both 2 and 3 dimensional elastographic images of tissues and this 
mechanical property has been found useful in distinguishing between disease and healthy 
states in some conditions (196) and also quantification of tissue mechanical property (199). 
Compared to techniques like AFM, OCE is minimally destructive (196). It has been used in 
the study of other diseases such as prostate cancer, where histological findings in the tissues 
correlate with OCE findings (294)  and myocardial infarction but for the first time, it has been 
applied to the study of prolapse. In a research investigating the use of OCE in the study of 
carcinogenic changes in prostrate tissues, OCE findings were shown to correlate with 
histological findings. OCE is able to detect within tissue, changes such as localized alterations 
in mechanical properties or mechanical property mapping of the individual samples.  
In our study of full thickness control and prolapsed vaginal tissue segments, notable 
heterogeneity in the stiffening of prolapsed tissues was observed. In the prolapsed tissues, 
stiffening was localized to the top zones of the tissues, particularly around the LP region. This 
is an interesting observation with noteworthy implications on the pathology of prolapse. 
Although it is known that prolapsed tissues are stiffer than controls, no previous study has 
observed this ―within-tissue‖ modulus difference in prolapsed tissue. In a weight bearing 
tissue such as the bone, intra tissue variation in modulus can negatively impact on the tissues‘ 
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overall strength and function. A study carried out to determine the effect of tissue 
heterogeneity in modulus on trabecular bone mechanics revealed that significant intra tissue 
variation in modulus can lead to overall lowering of the tissue‘s modulus (295). Another study 
investigating strength and modulus of trabecular bone noted that heterogeneity of the tissue 
played an important role in preventing failure and fragility (296). It was suggested that a 
heterogeneous tissue architecture would negatively impact on strain concentration, promotion 
and accumulation of damage. For materials of the same geometry and composition, 
homogeneity results in overall improved mechanical property (295) and this is important in 
load bearing tissues.  
This is an important observation with implications in prolapse aetiology and may also explain 
the findings from the in vivo study by Egorov et al discussed earlier (290). The stiffening of 
the more superficial LP regions may lead to a downward and outward pull of the tissue in the 
anatomical position (illustrated in figure 6.31) or propagate intra tissue damage leading to 
overall tissue weakness that enables prolapse. 
 
Figure 6.31: Illustration of glycation stiffening in prolapsed tissues and potential to 
initiate prolapse. 
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 Taken together, these research findings imply that the prolapsed tissue is stiffer than control 
tissues and this stiffening is more notable in specific regions but the associated higher modulus 
does not translate to superior mechanical properties of the prolapsed tissue. As noted from 
studies by Jaasma et al and Zysset et al , within tissue heterogeneity may negatively affect the 
functional mechanics of the tissue (295,296). Homogeneity of the vaginal wall as observed in 
the control tissues is more likely to result in a mechanically strengthened vaginal wall. 
The agar based OCE study also confirms overall higher moduli of prolapsed tissues compared 
to controls. Although the stiffness of tissues has the potential to vary based on the nature of the 
load applied and whether or not different elements of a tissue are investigated or aggregates 
are studied, the rate of deformation and whether or not it is cyclic or monotonic (297), our 
study of vaginal tissue stiffness across the nano, micro and macro levels of tissue organisations 
using three different mechanical tests has revealed a consistent trend. At nano, micro and 
macro scale, the prolapsed tissues were stiffer than the controls in vitro. AFM and OCE 
studies also noted the heterogeneity within prolapsed tissues. In addition to this heterogeneity 
being a likely cause of overall inferior effective mechanical properties of the prolapsed tissues, 
tissue ageing is implicated. The age-related stiffening of soft tissues further limits its 
mechanical protection as stiffer tissues are likely to have less deformation before failure (298). 
This increases the risk of injury, mechanical weakening and potentially, prolapse.  
6.6 CONCLUSION 
6.6.1 MAIN FINDINGS 
By studying the structure and mechanical changes within prolapsed tissues using histological 
techniques, various soft tissue mechanical test devices and adaptations of the same, notable 
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differences have been identified. The ultra-structural organisation and regional modulus of the 
prolapsed tissues were significantly altered in comparison to controls. Prolapsed tissues 
exhibited disorganized connective tissue structure with notable histological and biochemical 
changes. For the first time, prolapsed tissue mechanics has been investigated at multiple levels 
of tissue organization – nano, micro and macro levels - and our study confirms that prolapsed 
tissues are stiffer than controls as reflected by the higher modulus of prolapsed tissues. The 
correlation of glycation and modulus was also studied for the first time in human prolapsed 
tissues. The consistent positive correlation obtained between glycation and tissue modulus 
suggests that glycation changes are responsible for the increase in modulus noted in prolapsed 
tissues. Improved insights into changes that lead to prolapse were obtained by localising 
collagen fibril stiffening within the tissues to the LP regions and understanding of the role of 
glycation in tissues.  
A novel observation of remarkable heterogeneity existing within the prolapsed tissues has 
been made using two different mechanical techniques. This finding suggests that glycation 
induced stiffening of the vaginal wall in prolapsed tissues may be asymmetrically increased in 
the superficial regions of the tissue compared to other aspects of the tissue, making it a 
mechanically less homogeneous tissue than normal vaginal tissue. This loss of homogeneity 
may lead to easy overall inferior strength and increased susceptibility to damage and 
ultimately prolapse. Findings were also congruent between multiple techniques used 
suggesting that these were genuine trends in the tissues observable at all levels of structural 
organization.  
A method of tissue slicing has been developed and adapted for use with vaginal tissue assessed 
via the ball indentation technique. Using this method, it was confirmed that pentosidine 
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content of the prolapsed tissues using two methods of tissue preparation was strongly 
predictive of changes in the tissues‘ mechanical property.  
6.6.2 STUDY IMPLICATIONS  
Although these observations do not directly answer the question of cause and effect, review of 
other research on the effects of heterogeneity on tissue mechanical strength strongly suggests 
that the observed differences in prolapsed tissues would lead to inferior mechanical strength 
and further prolapse at the least. Mechanical inhomogeneity is therefore a potential cause or 
propagator of the prolapse disease process. The data in Chapters 4 and 5 have highlighted the 
role of oestrogen in preventing glycation accumulation and it is known that oestrogen levels 
are lower with menopause, a largely age-dependent process. It is therefore possible to 
experimentally modulate glycation accumulation in animal models (for example) and look for 
alterations in tissue mechanics. Further studies along these lines may be useful in answering 
the question of cause and effect. Nonetheless, the outcome of the present study is a significant 
step towards unraveling the aetio-pathogenesis of prolapse. 
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7 CHAPTER 7: GENERAL DISCUSSION AND 
CONCLUSIONS 
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7.1 OVERVIEW 
Prolapse incidence increases with age and glycation markers of ageing are higher in 
prolapsed tissues (5, 23). This has led to an interest in the effect of age, especially age-linked 
changes that take place in the prolapsed tissues, with the aim of understanding prolapse 
pathology and proffering better treatment. Prolapse manifests as a change in the mechanical 
properties of the connective tissue of these pelvic organs which results from mechanical or 
biochemical damage in the tissue (5). There are also known biochemical changes in prolapsed 
tissues such as higher glycation and variable amounts of collagen but minimal understanding 
of the interplay between all these factors leading to prolapse.  Ageing and notably, glycation-
associated ageing in particular is being investigated to obtain a better understanding of the 
cause and progression of prolapse (8,23,91,245). Characterizing these biochemical effects in 
the prolapsed vaginal tissues with a view towards understanding the role the ageing process 
has in disease development is crucial.  
Pregnancy is another biological state in which the mechanics and structure of vaginal tissue is 
altered but the changes are physiological and occur in preparation for delivery of the baby with 
minimal injury and return to pre-delivery states by the end of puerperium in most women  
(1,2,4, 30). Oestrogen, a notable pregnancy related hormone influences fibroblasts and pelvic 
connective tissues metabolism and remodelling (5-7). These actions may influence the 
proportion of old and new collagen within the tissues, thereby altering their mechanical 
properties. Therefore studying the vaginal tissue in pregnancy should provide an improved 
understanding of the biomechanical behaviour of the vaginal wall in relation to ovarian 
hormonal influence and glycation changes. 
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The present study uniquely characterizes vaginal tissues in pregnancy and prolapse and fills 
current knowledge gaps on why glycation is higher in prolapsed tissues and why the stiffer 
prolapsed vaginal wall exhibits overall inferior mechanical properties. Multiple mechanical 
test methods have been applied in the characterisation of the vaginal tissue in pregnancy and 
prolapse, with consistent outcomes where the same property was observed for.  The effect of 
glycation on the vaginal wall‘s mechanics has been demonstrated in pregnancy and prolapse 
with corroborative outcomes. A relationship between ER-, GLO-I and glycation has been 
demonstrated. An age-dependent significant increase in vaginal tissue glycation content was 
noted in the entire population and between the 6
th
 and 7
th
 decades in the prolapse group. 
7.2 NOVEL APPLICATION OF MECHANICAL MEASUREMENT MODALITIES 
IN THE STUDY OF THE VAGINAL TISSUE 
The quest for better prolapse treatment has been ongoing for over 400 years [1]. Many 
researches investigating prolapse seek to gain a better understanding of its cause, with the aim 
of improving current treatment options. Described as a multifactorial disease, the cause of 
prolapse has remained elusive for decades. The early studies focused on pelvic floor weakness, 
looking mainly at supporting ligaments and structures in the pelvis. Some of these studies 
made use of non-invasive imaging techniques such as MRI to assess tissue weakness. MRI 
imaging has been used to assess the function of pelvic floor before and after surgical repair 
(299) and also pre and post vaginal delivery (300). Dynamic imaging had gained particular 
usefulness in the grading of prolapse but is of little use in understanding its cause (301). The 
present study demonstrates the role of some newer imaging techniques in the study of 
prolapse. We have utilized three different mechanical tests in the characterization and 
visualisation of vaginal tissues. OCE and ball indentation methods have not previously been 
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used in the study of human vaginal tissue and only few past studies have investigated the 
vaginal wall using PFQNAFM. This AFM technique has the advantage of obtaining the 
nanomechanical properties of tissue sections as well as revealing structural properties and 
organization of the collagen fibrils in nanoscopic and microscopic areas (302). The test tissue 
is clearly visualized at the ultrastructural level and some ECM changes responsible for the 
disease phenotype are identified. OCE and ball indentation enable further characterization of 
tissue bulk mechanical properties in a non-destructive manner (168,196). With ball indentation 
and tissue adaptation we have been able to demonstrate the creep property and modulus of 
segments of the vaginal wall and relate this to the pentosidine content. OCE revealed within-
tissue changes in whole intact full thickness vaginal wall segments. By using these three 
techniques to study the same tissue in the case of prolapse, it has been possible to observe the 
build-up of tissue mechanical property at all levels of tissue organization, noting the nanosopic 
changes responsible for the disease phenotype. 
7.3 RELATIONSHIP BETWEEN AGEs, GLYCATION AND THE PRESENCE OF 
PROLAPSE 
Our study further investigated the observed higher accumulation of the glycation marker, 
pentosidine in prolapsed vaginal wall. Prolapse is described  as a multifactorial disease caused 
by a combination of factors such as age, vaginal delivery, trauma, connective tissue disorders, 
obesity and neurovascular damage (303). The focus of many of such studies has been the 
pelvic floor as an entity. Whilst this is a holistic approach towards understanding the disease 
process, it is also important to acknowledge the central role of the vaginal tissue in pelvic 
support. This means that changes to the vaginal wall would impact on the entire pelvis. With 
the mean age of prolapse development as 56 and 50% of women 80 years of age having pelvic 
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floor disorders, age can be considered a vital factor in prolapse development. Many studies 
have consistently noted higher amounts of advanced glycation markers in prolapsed vaginal 
wall (8,23,245). In the present study we observed a similar increase in glycation content of 
prolapsed vaginal tissues. We also noted a steady non-significant increase in vaginal wall 
glycation with age in the control group and for the first time, a significant difference in 
glycation content of tissues in women with prolapse was observed between the 6
th
 and 7
th
 
decade of life. This implies that the average age at which most women develop prolapse falls 
within the decade of life in which a significant increase in glycation occurs in the prolapse 
population. In the present study, prolapse was also commoner in older women but within the 
same age groups the vaginal wall glycation content in women with prolapse was higher than in 
controls. Our findings corroborate other studies (6,82) on the importance of age as a risk factor 
in prolapse development and also suggest a role of accelerated advanced glycation 
accumulation in the process. 
7.4 NEW UNDERSTANDING ON THE RELATIONSHIP BETWEEN 
GLYCATION LEVEL, OESTROGEN AND GLYOXALASE I EXPRESSION 
In the past decade, since the discovery of increased amounts of pentosidine in prolapsed 
vaginal tissues, the focus of investigative studies has shifted towards the composition and 
mechanics of prolapsed tissues, including the vaginal wall. Researchers have studied the 
amounts and presence of physiologic and non-physiologic protein modifications and cellular 
changes in various pelvic tissues in women with prolapse (8,251). Despite the consistent 
findings of elevated glycation content of prolapsed tissues and association of the disease with 
age, many questions remained unanswered. We aimed to elucidate the role of oestrogen and 
glyoxalase I in glycation accumulation. The present study has resulted in key outcomes that 
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lay a foundation for an improved understanding of prolapse. In both pregnancy and prolapse, 
ER-was more expressed in inverse relation to the pentosidine content of the tissue. We 
sought for a link between ER- and advanced glycation reduction to better understand the 
pathophysiology of the process and observed higher amounts of the antioxidant, glyoxalase I 
in the controls and in pregnancy, states of higher ER- receptor expression. Studies have 
shown that oestrogen reduces pelvic tissue glycation (41,42). Oestrogen also up regulates the 
activity of glyoxalase I, a glycation lowering antioxidant (218,219). A review of the known 
role of oestrogen in improving the activity of glycation lowering antioxidant, glyoxalase I has 
led to the proposal of a pathway for the accumulation of glycation in prolapsed tissues.  This 
provides an understanding of why glycation is commoner is commoner in prolapsed tissues 
and is suggestive of a role of oestrogen in the mechanical changes, particularly the stiffness 
noted in prolapsed tissues. 
7.5 CORRELATION OF GLYCATION AND VAGINAL TISSUE MECHANICS IN 
PREGNANCY AND PROLAPSE 
Furthermore, this study revealed a good correlation between the prolapsed tissues‘ mechanical 
property with their glycation content. Our case-control study cannot directly address the cause 
and effect question regarding the role of glycation in prolapse development but it brings to 
light the result of glycation on vaginal wall mechanics. In pregnancy, where the glycation 
marker was reduced, the tissue exhibited higher creep and lower modulus but in prolapse 
where the glycation content of the tissues was elevated, the tissues were stiffer and had less 
24-hour creep. We also noted that glycation inversely correlated with the stiffness of the 
vaginal wall in pregnancy. This proves that the modulation of vaginal wall glycation affects its 
mechanical property. Whilst this correlation between glycation and tissue mechanics has been 
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demonstrated previously in other body tissues including lens and blood vessels (239–241), it is 
demonstrated in vaginal tissues of female Sprague-Dawley rats and humans for the first time. 
In the rat study, vaginal wall glycation in pregnancy correlated well with skin glycation in the 
same subjects in pregnant and non-pregnant states. Due to the private nature of the vaginal 
tissue and potential inconvenience vaginal tissue screening poses to women, skin glycation 
detection would be useful in predicting vaginal wall glycation. In this way, the mechanical and 
functional property of the vaginal wall can be predicted and potentially detect early signs of 
prolapse. Such predictions would also be useful in pregnancy, where higher glycation content 
would signify stiffer vaginal wall and potentially difficult delivery. 
7.6 NEW CO-MORBIDITIES IN PROLAPSE: HYPERTENSION, SMOKING, 
CHOLESTEROL 
Hypertension could be a noteworthy co-morbidity in women with prolapse. It has been 
associated with an increased risk of prolapse or higher prolapse stage (260,261). Increased 
glycation is also known to be implicated in the development of stiffer blood vessels and 
hypertension (263) but no previous study has quantified glycation in the vaginal wall of 
women in relation to hypertension as a comorbidity. We quantified glycation in the vaginal 
wall of women with and without prolapse and found that pentosidine content was higher in 
women with both prolapse and hypertension. The strong association of both hypertension and 
prolapse with glycation and the tendency for both diseases to co-exist in the same women 
places hypertension as a possible risk factor of prolapse. Smoking, a highly prevalent 
condition is also associated with higher glycation. Smoking promotes systemic inflammation 
which has also been implicated in prolapse (81,266). Our research notes higher presence of 
glycation in the vaginal wall of women with prolapse who were smokers or had elevated 
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cholesterol. There are few studies on the relationship between smoking and prolapse (266) but 
the recent findings warrant further research on these potential new associations of the disease 
or its underlying pathology. 
7.7 IMPROVED KNOWLEDGE OF HISTOPATHOLOGY AND 
ULTRASTRUCTURAL CHANGES IN THE VAGINAL WALL IN 
PREGNANCY AND PROLAPSE  
In pregnancy, the vaginal tissue had higher creep and lower stiffness as also noted in previous 
studies (4). This is thought to be a delivery adaptation to prevent injury (1,2,4). The lower 
modulus and higher creeping of the vaginal wall in pregnancy was also in keeping with lower 
glycation since crosslinking results in stiffening of tissues (19). Collagen fibrils within the 
vaginal wall also undergo progressive disorganisation and remodelling through the middle and 
later stages of pregnancy (48). We also noted merging of collagen fibrils in pregnancy, a 
process which did not result in overall higher modulus of the fibers (209) but may be linked to 
higher amounts of sGAG present in the pregnant tissues. sGAG was significantly higher in the 
vaginal wall of the pregnant rats. This has also been noted in previous studies (48,211). sGAG 
are known to modulate collagen fibrillogensis (27,28,227) and may function to prevent 
completed fiber disorganisation during stretching. Our in vitro collagen engineering study 
confirmed that collagen fibrillogenesis is altered in the presence of sGAG. We noted faster 
kinetics and more merged fibrils and tenency towards bundling when the collagen fibers were 
formed in the presence of sGAG. This confirmed that observations in the native tissue of 
merged collagen fibrils in pregnancy were likely due to the higher sGAG content of the tissues 
in pregnancy.  
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 The prolapsed vaginal wall exhibited significantly different histology from control tissues. 
They has reduced epithelial cell count, reduced muscularis region with connective tissue 
infiltrates and collagen content when compared with controls. Biochemical quantification and 
histological staining noted higher connective tissue and collagen in prolapsed tissues than in 
controls.  
This is in keeping with outcomes from other studies (271). The majority of research has noted 
thinned out muscularis layer in prolapsed tissues and increased numbers of enlarged venous 
vasculature but reduced amounts of capillaries (272). Prolapsed tissues had reduced neural 
tissue expression, as also noted in other studies (91,270). Several other studies have noted a 
decrease in neurone expression or neurotransmitters in the prolapse vaginal tissue (276,277). 
Studies using full thickness vaginal tissues, as was used in this study also noted increased total 
collagen in prolapse vaginal tissues (108,273).  
Light microscopy and AFM revealed organizational differences between prolapse and control 
tissues but these were more evident at the nano scale. Collagen fibrils were scattered within 
the ECM and had notably wider gaps between fibrils. Bundling was less evident in prolapsed 
tissues, which also had poorly aligned fibrils. Changes were present in both LP and adventitial 
regions of the tissues. Similar changes in the skin collagen fibrils of women with prolapse 
were noted in another study (243). The skin tissue of the women with prolapse contained 
loose, disintegrated and disorganized fibers. Another study revealed loose arrangement and 
reduced total collagen in prolapsed vaginal tissues (289). Taken together, the histological and 
ultrastructural changes noted in the present study contribute to the present understanding of 
prolapse pathology as a foundation for future therapies. 
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7.8 MECHANICAL CHANGES IN PROLAPSED TISSUES: NEW INSIGHT ON 
HETEROGENEITY OF PROLAPSED TISSUES  
We studied the mechanical changes in prolapsed tissues, building up from nano, micro to 
macro scale and made consistent striking observations. Multiple mechanical test devices were 
utilized in this study, with consistent outcomes. The prolapsed vaginal wall was found to be 
stiffer at all levels of tissue organisation. Other in vitro studies have made similar observations 
(12,164). AFM revealed overall stiffer collagen fibrils with higher modulus noted at the LP 
region. This was confirmed with OCE which revealed the within tissue modulus of whole 
tissue segments. A novel finding of within-tissue heterogeneity was noted in prolapsed tissue, 
while controls were more homogenous. These observations have significant implications to 
the present understanding of prolapse pathology. Previous studies have noted that 
heterogeneity within tissues results in overall inferior functional mechanical property 
(295,296). This new observation might explain the apparent contradiction that currently exists 
in literature, which notes that prolapsed tissues are of higher modulus or stiffness but inferior 
support function. Taking cognizance of our recent finding of a positive correlation between the 
glycation content of prolapsed tissues and tissue stiffness, this heterogeneity may also imply 
differential location of the glycation compound within the prolapsed tissues and warrants 
further research to unravel this. However, the understanding of differential stiffening within 
prolapsed tissues adds to the current understanding of the disease and can inform mechanical 
changes required in future therapies.  
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7.9 CONCLUSIONS AND FUTURE CONSIDERATIONS 
Pregnancy significantly alters the pelvic tissues in adaptation for delivery. The pelvic tissues 
are exposed to higher levels of female hormones like oestrogen, which decline as women age 
and approach menopause. This makes the state of pregnancy a condition that potentially 
contrasts the biological state of the ageing woman. In this project, pregnancy has been studied 
in parallel with prolapse and key outcomes, implications and findings were consistent. 
This study revealed that vaginal tissue pentosidine in pregnancy and prolapse is inversely 
related to their oestrogen receptor and glyoxalase I expression. In view of the influence of 
glycation on tissue mechanics, this study suggests a vital role of oestrogen in vaginal tissue 
mechanics and has important implications in our understanding of prolase pathology. We have 
demonstrated for the first time, in the human and rat vaginal wall, relationships between 
mechanical changes in prolapse and pregnancy and glycation changes. A direct correlation has 
been demonstrated between glycation and vaginal tissue modulus in both human and animal 
tissues. Using our rat model in conjunction with in vitro collagen fibrillogeneis study, we have 
demonstrated the role of sGAG in vaginal tissue collagen ultrastructure in pregnancy. We have 
also demonstrated a relationship between skin and vaginal tissue glycation for the first time, 
providing a foundaton for further research into glycation screening and prolapse prediction. 
Pelvic organ prolapse was confirmed to be a disease of ageing with higher occurrence with age 
and higher glycation content and age-related glycation increase of prolapsed tisssues. For the 
first time, the glycation content of the vaginal wall in control and prolapsed cases from various 
age-groups was quantified and compared. Within the same age-group, the vaginal tissues from 
women with prolapse had higher glyction marker levels and a significant difference in 
glycation content of tissues in the 6
th
 and 7
th
 decade of life was noted in the prolapse group but 
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not in controls. Whilst this did not prove that glycation is a causative factor in prolapse 
development, accelerated vaginal tissue ageing cannot be excluded as a potential cause and is 
worth investigating further. A summary of the proposed relationship between ageing, 
glycation and prolapse has been shown is figure 33, which also highlights the understood role 
of oestrogen and glyoxalse I in limiting tissue glycation.  
 
Figure 7.1: Proposed relationship between glycation, oestrogen, GLO-I antioxidant, 
accelerated ageing,altered tissue mechanics and pelvic organ prolapse. 
Futher co-morbidities of prolapse in assocition with glycation have been noted. Hypertension, 
smoking and elevated cholesterol were all associated with higher vaginal tissue glycation and 
prolapse. Although further studies will be needed to better understand this, it further 
emphasizes a pivotal role of glycation in not only the initial screening but also the follow up of 
patients with prolapse. Further investigations tracking glycation accumulation or effects of 
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such in relation to prolapse-induced tissue mechanics would give further insight to the 
development of non-traumatic vaginal wall prolapse. 
The prolasped tissues also had ultrastructural organisational differences and different 
histological composition. They had disorganised  ECM and were notably higher in collagen 
content and lower in neural expression. This is in keeping with the observed stiffening of the 
tissues at the nano, micro and macro scale. Prolapsed vaginal tissues were particularly stiffer 
in the LP region. This heterogenity was observed for the first time using PFQNM AFM and 
OCE, and may account for overall inferior functioning of the tissues (figure 7.1) despite higher 
modulus when compared with controls.  
This study has utilized various techniques, some applied for the first time in the study of 
vaginal tissues in pregnancy and prolapse. It has resulted in an improved understanding of the 
pregnancy-induced vaginal wall changes and relevance in understanding prolapse. New 
insights have been gained into the vaginal wall pathology in prolapse. Skin glycation was 
shown to be reflective of vaginal wall glycation making it a potential marker for non-invasive 
prediction of or early diagnosis of prolapse. OCE revealed within tissue changes that have 
functional implications in prolapsed vaginal tissue segments. This device can also be adapted 
as a screening tool for vaginal wall heterogeneity. Overall, the findings in this work add to the 
current understanding of the disease and help to direct future research. 
The findings from the present study have direct implications for future studies and clinical 
practise. For example, the outcomes in chapters 5 and 6 suggest that oestrogen receptor 
expression would be inversely related to the mechanical changes observed in prolapsed 
tissues. Results from this research would inform further pre-clinical studies on oestrogen‘s 
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effect on tissue mechanics. Future use of locally applied oestrogen and glycation breakers in 
changing vaginal tissue mechanics may be considered as a medical treatment for prolapse. 
This research is a case-control study and hence does not demonstrate a cause and effect 
relationship between all observed changes in the prolapsed tissues but is a good foundation for 
future prospective or interventional studies following adequate safety and ethical 
considerations. Due to difficulties obtaining control vaginal tissues, fewer and smaller sized 
control samples were obtained and this limited the use of control tissue for ball indentation 
mechanical study. Future work should focus on obtaining more and, if possible, larger control 
samples and re-adapting the ball indentation device for use with smaller samples. 
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